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ABSTRACT  
Improving the effectiveness and efficiency of medication error reporting is key to 
enhancing patient safety. The aim of this research was to explore medication error 
reporting in the United Arab Emirates (UAE), examining the attitudes, beliefs, 
behaviors and experiences of health professionals. 
The first phase was a Joanna Briggs Institute registered systematic review of the 
beliefs, attitudes and experiences of health professionals relating to medication error 
reporting. Findings indicated the need for original research employing a mixed 
methods approach to quantify and generate in-depth information, grounded in 
theories of behaviour change.  
In the second phase, a cross-sectional survey of health professionals in the UAE was 
conducted to determine the behavioural determinants and facilitators and barriers of 
medication error reporting. Principal component analysis of responses from 294 
health professionals identified six components: knowledge and skills related; 
feedback and support related; action and impact related; motivation related; effort 
related; and emotions. Responses were neutral for the motivation and effort related 
components, but negative for the emotions component.  Comparison of component 
scores identified that, nurses, females, those with greater experience and being older 
were more likely to be positive in their responses (p<0.05). In terms of emotions, 
the component with the lowest scores, older respondents with greater experience 
gave more positive responses (p<0.05).   
In the final phase, face-to-face semi-structured interviews with 29 health 
professionals explored in-depth the behavioural determinants of medication errors 
reporting in the UAE.  
The theoretical domains framework was employed in constructing the interview 
schedule and interpreting  the findings. ‘Goals’ and ‘intentions’ were determinants 
which acted as facilitators while ‘beliefs of the consequences’, ‘emotions’,’ ‘social 
influences and environmental context’ were barriers. 
This doctoral research has generated original findings which can support the 
development of interventions, based on behaviour change techniques, to enhance 
medication error reporting. These changes could impact at the levels of the 
organisation, health professional and patient. 
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CHAPTER 1:  GENERAL INTRODUCTION  
This chapter commences with an overview of the global emphasis on patient 
safety in all healthcare settings, followed by description of Reason’s model of 
error causation. The term ‘medication error’ and associated terms are defined 
along with coverage of key systematic reviews. Attention is then paid to 
medication error reporting, with the overall aim of the doctoral research and 
the aims of the research phases stated.  
 
1.1 PATIENT SAFETY  
1.1.1 To Err is Human 
The United States (US) Institute of Medicine (IOM) in 1999 published the 
seminal report, ‘To Err Is Human: Building a Safer Health System’ which aimed 
to increase awareness of medical errors (errors in healthcare).1 This report 
stimulated deeper examination of patient safety research and associated 
practices and has now been cited over 15,000 times in the academic literature. 
At the time of publication, it was described as ‘groundbreaking’, suggesting 
that 2-4% of all deaths in the US were attributed to medical errors.2 The main 
content was based on the analysis of multiple studies which had been 
conducted by a variety of organisations, concluding that 44,000-98,000 people 
died each year as a result of preventable medical errors. The authors called for 
comprehensive, coordinated efforts by health care providers, governments, 
consumers and others to promote patient safety and set a minimum goal of 50 
percent reduction in errors over the next five years. It was noted that 
preventing death and injury from medical errors would require dramatic, 
system wide changes and moving the focus from medical errors to patient 
safety. 
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The report recommended a four-tiered strategic approach to achieve a better 
safety record: 
1. Establishing a national focus to create leadership, research, tools, and 
protocols to enhance the knowledge base about safety. 
2. Identifying and learning from errors by developing a nationwide public 
mandatory reporting system and by encouraging health care 
organisations and practitioners to develop and participate in voluntary 
reporting systems. 
3. Raising performance standards and expectations for improvements in 
safety through the actions of oversight organisations, professional 
groups, and group purchasers of health care. 
4. Implementing safety systems in health care organisations to ensure safe 
practices at the delivery level. 
It has been stated that the report impacted greatly the management of 
healthcare globally in that it ‘brought the issues of medical error and patient 
safety to the forefront of national [and international] concern’, attracting the 
attention of healthcare providers.3 
 
1.1.2 Models of error causation 
While there are many different models and theories of error causation, the two 
which are described mostly within healthcare are ‘the Swiss Cheese Model’ and 
‘Human Error Theory’. Orlandella and Reason (1990) proposed the ‘Swiss 
Cheese Model of system failure and accident causation, which has gained 
widespread acceptance in many fields including healthcare.4 The principle 
behind this model is based on layered security as shown in Figure 1.1. This 
illustrates that, while many layers of defence lie between ‘hazards’ and ‘losses’ 
(accidents or errors), there are flaws in each layer that, if aligned, can allow 
the losses to occur.  
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Figure 1.1: The ‘Swiss Cheese Model’ of how defences, barriers, and safeguards 
may be penetrated by an accident trajectory (adapted from Reason, 2000)5 
 
Human error theory originated from the work of Reason (1990) in a range of 
industries including aviation and engineering.4 Reason’s human error theory 
has been applied widely to healthcare, considering institutional and strategic 
issues, influencing factors, unsafe acts and failed defences. The classification 
of errors based on a psychological approach is shown in Figure 1.2, highlighting 
four broad types of errors.  
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Figure 1.2: The classification of errors based on a psychological approach 
(adapted from Aronson et al, 2009)6 
 
There are two broad categories of errors, which are mistakes and skill-based 
errors.  
Mistakes are classified as:  
(i) knowledge-based errors, due to deficient knowledge (general, 
specific, professional)  
(ii) rule-based errors, the misapplication of a good rule or the failure 
to apply a good rule; and the application of a bad rule. 
Failures of skill are classified as: 
(iii) action-based errors, 'slips', the performance of an action that was 
not what was intended  
(iv) memory-based errors, ‘lapses’, when something is forgotten. 
 
 
 
 
 
 
5 
 
1.2 MEDICATION ERRORS 
1.2.1 Definitions 
While ‘To err is human’ used the term ‘medical errors’, ‘medication errors’ is 
the term which is applied specifically to medication. The most widely used and 
accepted definition of the term ‘medication error’ is that of the United States 
(US) National Coordinating Council for Medication Error Reporting and 
Prevention (NCCMERP). A medication error is defined as, ‘any preventable 
event that may cause or lead to inappropriate medication use or patient harm 
while the medication is in control of the health care professional, patient or 
consumer’.7  
The United Kingdom (UK) National Patient Safety Agency (NPSA) proposes a 
similar definition of ‘any incident where there has been an error in the  process  
of  prescribing, dispensing, preparing, administering, monitoring, or providing 
medicines advice, regardless of whether any harm occurred or was possible’.8  
In a philosophical discussion on the construction of the term, Ferner and 
Aronson (2006) suggest a definition of ‘failures in the treatment process that 
lead to, or have the potential to lead to harm to the patient’.9 All definitions 
emphasise harm and prevention. 
There is some overlap and often confusion between the terms ‘medication 
error’ and ‘adverse drug reaction’. The United Kingdom (UK), Medicines and 
Healthcare products Regulatory Agency (MHRA) defines an ‘adverse drug 
reaction’ as ‘a harmful and unintended reaction that occurs at a dose normally 
used for the prophylaxis, diagnosis or treatment of disease or the modification 
of physiological functions’10  
Those adverse drug reactions which are deemed preventable are also 
considered to be medication errors.11  
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Whatever the definition of ‘medication error’, it is clear that these greatly affect 
patient care. According to a report published by the US Institute of Medicine in 
2006, medication errors accounted for 1.5 million injuries annually at a cost of 
up to $1.35 billion in the form of lost productivity, wages, and additional 
medical expenses.12 Data from the UK, collated and reported by the National 
Patient Safety Agency for the period from October 2010 to September 2011, 
illustrated that medication errors were the second most common cause of 
patient safety issues (following patient accidents) during hospital stay, 
contributing to 11% of all incidents, affecting 134,684 patients.8 
The medication use process involves three key steps of prescribing, dispensing 
and administration of medication. These are generally considered to be the 
three classifications of medication errors and any errors arising during these 
processes are considered as medication errors, even if these are intercepted 
and corrected prior to reaching the patient (i.e. near misses).13 
Prescribing errors are the most commonly occurring of all medication errors. 
Dean et al (2000) developed a comprehensive definition of the term 
‘prescribing error’ using a consensus based approach.14 The term ‘prescribing 
error’ is defined as, ‘the result of a prescribing decision or prescription writing 
process that results in an unintentional but significant reduction in the 
probability of the treatment given being timely and effective or an increased 
risk of harm compared with generally accepted practice’.  This definition 
encompasses the two distinct processes of decision-making and prescription 
writing. 
The definition of a ‘dispensing error’ was proposed by Beso et al (2005) as, 
‘one or more deviations from an interpretable written prescription or 
medication order, including written modifications to the prescription made by 
a pharmacist following contact with the prescriber’.15  
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Keers et al (2013) proposed a definition of ‘a medication administration error’ 
as, ‘a deviation from the prescriber’s medication order as written on the 
patient’s chart, manufacturers’ instructions or relevant institutional policies’.16 
 
1.2.2 Related systematic reviews 
This section provides an overview of published systematic reviews related to 
medication errors, as highlighted in Table 1.1. Emphasis is placed on the 
limitations of the primary studies reviewed. Key limitations of the literature in 
this area are: the lack of consistent terminology and definitions of ‘medication’, 
‘prescribing’, and ‘administration’ errors; and often poorly defined outcome 
measures. Furthermore, Alsulami et al (2013) noted that there was a paucity 
of high quality research which originated from the Middle East and none of the 
systematic reviews covered medication error reporting,17 which is the focus of 
this doctoral research.  
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Table 1.1 Summary of systematic reviews relating to aspects of medication errors 
Authors, year of 
publication 
Stated review aim Search terms Databases Literature 
inclusion 
dates 
Stated key limitations of 
literature 
Maisoon et al, 
200618 
To systematically locate and 
review studies that have 
investigated the incidence 
of medication errors (MEs) 
in pediatric 
inpatients and identify 
common errors 
medication error(s), administration 
error(s), prescribing error(s), dispensing 
error(s), drug error(s), drug mistake(s), 
drug mishap(s), medication mistake(s), 
medication mishap(s), administration 
mistake(s), dispensing mistake(s), 
prescribing mistake(s), wrong drug(s), 
wrong dose(s), incorrect drug, incorrect 
dose, incorrect route of administration, 
and drug death, combined with the 
following key words: pediatric(s), 
paediatric(s), child, infant(s), 
adolescent(s), neonates(s), and 
neonatal. 
 
Medline, Embase, Pharmline, 
International Pharmaceutical 
Abstracts, CINAHL, British 
Nursing Index  
Varied 
depending 
on database, 
generally 
1951-2006 
1. Literature was hindered by 
variation in definitions 
employed by different 
researchers, varying research 
methods and setting. 
2. Lack of theory-based 
research.  
3. The initial concern about 
MEs in pediatrics was 
validated but the actual size 
of the problem remained 
unknown. 
Miller et al, 
200719 
To synthesise peer 
reviewed knowledge on 
medication errors in 
paediatrics  
 
paediatric and medication errors, 
preventable adverse event 
PubMed, Embase, CINAHL  2000 - 2005 1. The definition of 
medication error was non-
uniform across the studies. 
2. Dispensing and 
administration errors were 
most poorly evaluated.  
3. Unique recommendations 
for strategies to reduce 
medication errors were 
identified; none were based 
on evidence. 
 
Ross et al, 200920 
 
 
In order to inform the 
design of an educational 
intervention, a systematic 
review of the literature on 
prescribing errors made by 
junior doctors was 
undertaken. 
prescribing adj4 error$.tw, prescription 
adj4 error$.tw, prescription or 
prescribing adj4 mistake$.tw, drug adj1 
error$.tw, medication adj error$.tw, 
adverse adj2 drug$ adj2 event$.tw, 
adverse adj2 drug$ adj2 reaction$, .tw, 
medication adj2 adverse adj2 event$.tw, 
exp Prescriptions, Drug, exp Medication 
Errors, Patient Care, exp Physicians, exp 
Medical Staff, exp Hospitals, exp Primary 
Health Care, junior.tw, doctor$.tw, 
medical staff.tw. 
Medline, Embase, Science 
and Social Sciences Citation 
Index, CINAHL, Health 
Management Information 
Consortium, PsychINFO, ISI 
Proceedings, The 
Proceedings of the British 
Pharmacological Society, 
Cochrane Library, 
National Research Register, 
Current Controlled Trials 
1990-2007 1. Considerable variation was 
seen in design, methods, 
error definitions and error 
rates reported. 
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Lewis et al, 
200921 
To review the prevalence, 
incidence and nature of 
prescribing errors in 
hospital inpatients 
error(s), medication error(s), near 
miss(es), preventable adverse event(s), 
prescription(s), prescribe, medication 
order(s), incident report(s), incidence, 
rate(s), prevalence, epidemiology, 
inpatient(s), hospital(s), hospitalization 
Medline, Embase, CINAHL, 
International Pharmaceutical 
Abstracts   
1985 - 2007 1. The reported rates of 
prescribing errors varied 
greatly due to variations in 
the definition of a prescribing 
error, the methods used to 
collect error data and the 
setting of the study. 
2. Lack of standardization 
between severity scales 
prevented any comparison of 
error severity across studies. 
 
Alsulami et al,  
201317 
To review studies of the 
incidence and types of 
medication 
errors in Middle Eastern 
countries and to identify the 
main contributory factors 
involved. 
Medication error(s), prescribing error(s), 
dispensing error(s), administration 
error(s), documentation error(s), 
transcribing error(s), medication 
mistake(s), drug mistake(s), prescribing 
mistake(s), dispensing mistake(s), 
administration mistake(s), 
transcribing mistake (s), wrong 
medication, wrong drug(s), wrong 
dose(s), wrong route of administration, 
wrong calculation(s), physician(s), 
pharmacist(s) and nurse(s) 
 
Embase, Medline, 
Pubmed, the British Nursing 
Index, CINAHL 
1980-2011 1. Most studies were of poor 
quality 
2. There was a lack of 
standardisation of terms, 
methods and outcome 
measures.  
 
Keers et al, 
201316 
To systematically review 
and appraise empirical 
evidence relating to the 
causes of medication 
administration errors in 
hospital 
settings. 
error(s), medication error(s), 
incident report(s), near miss(es), drug 
error(s), treatment error(s), medication 
safety, drug safety, preventable 
adverse event(s), adverse event(s), 
medical error(s), clinical incident(s), 
adverse drug event(s), adverse health 
care event(s), health care error(s), 
medication incident(s), cause(s), 
factor(s), reason(s), aetiology, 
etiology, causality, causalities, 
predictor(s), association(s) and drug/ 
medication/ medicine administration(s), 
dose/drug/medicine/medication 
preparation(s), drug/ medication/ 
medicine delivery, omission(s), drug 
utilisation, commission(s), drug/ 
medication/medicine supply, 
drug/medication/medicine handling 
Medline, Embase, 
International Pharmaceutical 
Abstracts, ASSIA, 
PsycINFO, British Nursing 
Index, CINAHL, Health 
Management 
Information Consortium, 
Social Science 
Citations Index  
 
1985-2013 1. Few studies sought to 
determine the causes of 
intravenous administration 
errors 
2. Limited use of established 
error causation frameworks to 
analyse data and a focus on 
issues other than the causes 
of administration errors 
among studies. 
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Metsala et al, 
201422 
To identify the types of  
medication errors which 
happen in elderly acute 
care. 
pharmacy or drugs, medical error or 
deviation, elderly, nursing or acute care 
or intensive care 
CINAHL, Medline, Cochrane, 
JBI Connect+ databases 
and Finnish healthcare 
databases Medic and 
Ohtanen 
2001 -2011 1. Overall poor quality of 
studies included in the review 
Karthikeyan et 
al, 201523 
To review studies of the 
incidence and types of 
medication errors and to 
identify the main 
contributory factors 
involved.  
medication error(s), prescribing error(s), 
dispensing error(s), administration 
error(s), documentation error(s), 
transcribing error(s), medication 
mistake(s), drug mistake(s), prescribing 
mistake(s), dispensing mistake(s), 
administration mistake(s), transcribing 
mistake(s), wrong medication(s), wrong 
drug(s), wrong dose(s), wrong route of 
administration(s), wrong calculation(s), 
physician(s), pharmacist(s) and nurse(s) 
 
Embase, Pubmed, EBSCO, 
Scopus, the British Nursing 
Index, CINAHL 
Not stated 1. Limited number of studies 
2. Lack of consistency in 
terminology of the studies 
included in the review 
Salmasi et al, 
201524 
To systematically identify 
and review research 
conducted on medication 
errors in Southeast Asian 
countries in order to 
identify common types of 
errors and estimate its 
prevalence in this region. 
medication error(s), prescribing error(s), 
dispensing error(s), administration 
error(s), documentation error(s), 
transcribing error(s), medication 
mistake(s), drug mistake(s), prescribing 
mistake(s), dispensing mistake(s), 
administration mistake(s), transcribing 
mistake (s), wrong medication, wrong 
drug (s), wrong dose (s), wrong route of 
administration, wrong medication history 
taking, wrong calculation(s), 
physician(s), pharmacist(s) and nurse(s) 
 
Embase, Medline, Pubmed, 
ProQuest Central and the 
CINAHL 
Not stated 1. Lack of studies on errors in 
Southeast Asian countries  
Aldhwaihi et al 
201625 
To review published studies 
exploring the incidence and 
types of dispensing errors 
in hospital pharmacies and 
factors contributing to these 
errors. 
 
Dispensing, Drug(s), Medication, 
Medicine(s), Error(s), Incident(s), Near 
miss(es), Mistake(s), Hospital, Secondary 
care, Inpatient, Outpatient, Pharmacy, 
Pharmacist, and Dispensary. 
PubMed, Scopus, Ovid, and 
Web of Science  
2000-2015 1. Limited number of studies 
2. Lack of consistency in 
terminology 
 11 
 
1.3 MEDICATION ERROR REPORTING  
Effective and efficient medication error reporting systems and processes are 
key to promoting patient safety. Two key organisations within this field are the 
NCCMERP and the National Patient Safety Agency (NPSA) in the UK. Both the 
NCCMERP and the NPSA place much focus on medication error reporting. In 
1995, the US Pharmacopeial Convention spearheaded the formation of the 
NCCMERP, the key role of NCCMERP is to lead 25 US national healthcare 
organisations collaborating and cooperating to address the interdisciplinary 
causes of errors and to promote the safe use of medication.26  
The goals of NCCMERP are: 
i. Stimulating the ‘development and use of reporting and evaluation 
systems by individual health care organizations’ 
ii. Stimulating ‘reporting to a national system for review, analysis, and 
development of recommendations to reduce and ultimately prevent 
medication errors’ 
iii. Examining and evaluating the causes of medication errors 
iv. Increasing awareness of medication errors and methods of 
prevention throughout the health care system. 
v. Recommending strategies for system modifications, practice 
standards and guidelines, and changes in packaging and labeling. 
 
The strategies stated for achieving these goals in relation to medication error 
reporting are to: 
i. Heighten awareness of reporting systems available to or within health 
care organizations 
ii. Stimulate and encourage reporting and sharing of medication errors 
both nationally and locally 
iii. Develop standardization of classification systems for the collection of 
medication error reports so that databases will reflect reports and 
categorization systems 
iv. Encourage systems and provide targeted feedback so that appropriate 
prevention strategies can be developed and implemented in facilities. 
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In the UK, the NPSA was established in 2001 to develop the National Reporting 
and Learning System (NRLS), to collect information on reported patient safety 
incidents aiming to reduce risks to patients receiving NHS care and improve 
safety. The NPSA describes ‘tools and guidance to help organizations improve 
their reporting levels’.10 These include: 
i. ensuring quality reports 
ii. engaging frontline staff and management 
iii. reporting regularly 
iv. reporting serious incidents quickly 
v. making reporting matter by reviewing the steps they can take to 
increase reporting and ensuring consistency  
 
Adopting these tools and guidance into practice should increase reporting 
system efficiency with subsequent impact on the incidence, prevalence, nature 
and severity of medication errors thus improving patient safety and care. 
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1.4 HEALTHCARE IN THE UNITED ARAB EMIRATES  
1.4.1 Background 
This doctoral primary research was conducted in the United Arab Emirates 
(UAE), which comprises seven emirates: Abu Dhabi, Dubai, Fujairah, al-
Qaywayn, al-Khaimah, Ajman and Sharjah (see Figure 1.3). The UAE 
neighbours Oman to the South East and North, and Saudi Arabia to the West 
and South. The UAE has one of the most well developed and wide ranging 
healthcare systems within the Asian region, aiming to meet the health needs 
of the society.27 Hospital provision is a combination of private enterprises and 
government funded hospitals. According to the World Health Organisation 
(WHO), the government financial support for healthcare for the period 1999-
2006 amounted to $43 billion.28 About 2.9% of the UAE’s gross domestic 
product is spent on the healthcare, in line with WHO standards and recently 
free healthcare has been made available for all citizens.27   
There are five government healthcare regulators: the Ministry of Health; 
Ministry of Finance; Federal Health Insurance Authority; Dubai Health Authority 
(DHA); and the Health Authority Abu Dhabi (HAAD). As of 2016, the population 
in the UAE was estimated at 9,266,971, of which Emirati nationals represented 
19%, with the remainder being expatriates, predominantly from south and 
southeast Asia (around 60% of the UAE population), and western Europe 
(around 10%). (National Bureau of Statistics 2014) While Arabic is the official 
language, English is spoken widely, particularly within professional settings.  
There are currently 104 hospitals throughout the seven Emirates and the World 
Health Organization (WHO) reports that there are currently 19.3 physicians 
and 40.9 nurses and midwives per 10,000 persons.27 
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Figure 1.3 Map of the United Arab Emirates 
 
 
1.4.2 Medication error reporting in the UAE 
The policy of medication error reporting in UAE (Abu Dhabi) was established in 
May 2009 by the health authority of Abu Dhabi (HAAD) (Appendix 1.1). The 
purpose of the policy is to provide guidance for the health care professionals 
to take responsibility in medication error detection, reporting, evaluation, and 
prevention. The NCCMERP definition of ‘medication error’ has been adopted 
and all health professionals are mandated to report all medication errors, 
including those which have ‘been detected and corrected through intervention 
by another health care professional or patient, before actual medication 
administration’. 
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1.5 MEDICAL RESEARCH COUNCIL FRAMEWORK  
Any intervention which are developed and implemented with the aim of 
enhancing medication error reporting is a ‘complex intervention’. These are 
defined by the UK Medical Research Council (MRC) framework as ‘interventions 
with several interacting components’.29 The dimensions of complexity can be 
multiple, such as the: 
 number of and interactions between components within the 
experimental and control interventions 
 number and difficulty of behaviours required by those delivering or 
receiving the intervention 
 number of groups or organizational levels targeted by the 
intervention 
 number and variability of outcomes 
 degree of flexibility or tailoring of the intervention permitted. 
 
The MRC states that the process from development through to implementation 
of a complex intervention may take a wide range of different forms and 
emphasises the need for a good theoretical understanding of how an 
intervention could bring about change. The key elements of the development 
and evaluation process are illustrated in Figure 2.2.  
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Figure 2.2: Elements of the development and evaluation process (adapted 
from Medical Research Council, 2008)29  
 
This doctoral research focuses on the initial stages of the development of a 
complex intervention: 
 Identifying the Evidence Base 
 Identifying/Developing Appropriate Theory 
 Modelling Process and Outcomes 
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1.6 STUDY AIMS  
The overall aim of this research was to explore health professional reporting of 
medication errors in Abu Dhabi, the UAE, as a preliminary step to the 
development of interventions to improve and optimise the effectiveness and 
efficiency of medication error reporting thus impacting patient safety.  
The research was conducted in three phases, each with aims as described 
below. 
Phase 1: To critically appraise, synthesize and present the available evidence 
on health professionals’ beliefs, attitudes and experiences of medication error 
reporting.  
More specifically, the review sought to answer the following questions in 
relation to health professionals (i.e. doctors, nurses and pharmacists): 
 What are their beliefs and attitudes towards medication error reporting? 
 What are their experiences of medication error reporting? (e.g. nature 
of feedback obtained, any subsequent changes in their practice, ease of 
use of the reporting system, any improvements required to optimize 
medication error reporting). 
 What are the reasons given or factors which are associated with under-
reporting of medication errors? (e.g. lack of awareness or understanding 
of the reporting system, fear of possible consequences of reporting, and 
forgetting to report). 
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Phase 2:  To quantify the behavioural determinants of health professional 
reporting of medication errors in Abu Dhabi, the UAE. 
The detailed research questions were: 
 Which behavioural determinants impact error reporting,? Which of 
these are facilitators or barriers to error reporting? 
 Are there significant differences in behavioural determinants between 
demographic variables? 
 
Phase 3: To provide more depth to and explain the quantitative findings. In 
particular, this phase aimed to describe and understand the behavioural 
determinants of health professional reporting of medication errors in the Abu 
Dhabi, the UAE.  
The detailed research questions were:  
 How do specific behavioural determinants impact error reporting? 
 Why do specific behavioural determinants impact error reporting? 
 Are there any differences between health professions? 
 How could error reporting be improved and optimised? 
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CHAPTER 2: METHODOLOGY 
This chapter introduces research paradigms, methodologies and methods with 
justification for those selected for this doctoral research. Aspects of robustness 
in quantitative research and rigour in qualitative research are introduced, with 
emphasis on data validity, reliability, trustworthiness and bias.  
 
2.1 RESEARCH PHILOSOPHY 
There are four philosophical assumptions that impact the direction of all 
research: 
1. Ontology, which relates to the nature of reality and its 
characteristics.  Researchers embrace the idea of multiple realities and 
report on these multiple realities by exploring multiple forms of evidence 
from different individuals’ perspectives and experiences; 
2. Epistemology, how researchers know what they know. Researchers try to 
get as close as possible to participants being studied.  Subjective evidence 
is assembled based on individual views; 
3. Axiology, the role of values in research. Researchers make their values 
known in the study and actively report their values and biases; and  
4. Methodology, the theoretical framework of the methods used in the 
research processes.30 
 
2.1.1 Philosophical paradigms 
Fossey et al refer to a ‘paradigm’ as, ‘a system of ideas, or world view, used 
by a community of researchers to generate knowledge’.31 Bowling (2009) and 
Cresswell (2013) state that a paradigm is the ‘process of scientific practice 
based on people’s philosophies and assumption about the world and the nature 
of knowledge.30,32  
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To ensure the most appropriate research design, the paradigm should be 
congruent with researcher beliefs in terms of the nature of reality.33  
Research paradigms are traditionally classified into four philosophically distinct 
categories of positivism, constructivism, transformative and pragmatic. Each 
relates to accepted scientific frameworks, as illustrated in Table 2.1.  
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Table 2.1: Features of research paradigms (adapted from Guba and Lincoln 
1990, Onwuegbuzie 2004, Bowling 2009, and Creswell 2013)32,34-37 
 Positivism Constructivism Transformative Pragmatic 
O
n
to
lo
g
y 
  
Naive realism. 
Researcher may 
not be able to 
understand it or get 
to it because of lack 
of absolutes 
Relativism: local and 
specific constructed 
and co-constructed 
realities 
Participation between 
researcher and 
communities/ 
individuals being 
studied. Often a 
subjective-objective 
reality emerges 
 
Reality is what is 
useful, is practical, 
and ‘works’ 
Ep
is
to
m
o
lo
g
y Reality can only be approximated. 
Interaction with 
research subjects is 
kept to a minimum. 
Validity comes 
from peers, not 
participants 
Reality is co-
constructed 
between the 
researcher and 
the researched and 
shaped by individual 
experiences 
Co-created findings 
with multiple ways of 
knowing 
Reality is known 
through using many 
tools of research 
that reflect both 
deductive (objective) 
evidence and 
inductive subjective) 
evidence 
 
A
xi
o
lo
g
y 
Researchers’ biases 
need to be controlled 
and not expressed in 
a study 
 
 
 
 
 
Individual values are 
honoured, and are 
negotiated among 
individuals 
Values need to be 
interrogated 
Values are discussed 
because of the way 
that knowledge 
reflects both the 
researchers’ and the 
participants’ views 
M
et
h
o
d
o
lo
g
y Experiments/surveys Verification of 
hypotheses; chiefly 
quantitative methods 
Researcher is a 
‘passionate 
Participant’ within 
the world being 
investigated 
Use of collaborative 
processes of 
research. 
Questioning of 
methods, 
highlighting issues 
and concerns 
Research process 
involves both 
quantitative and 
qualitative 
approaches to data 
collection and 
analysis 
 
 
 
This doctoral research was conducted in three specific phases aligned to the 
research aims. The field work of primary data collection and generation in 
phases two and three employed paradigms of positivism in phase two (cross 
sectional survey) and constructivism (phenomenological interviews) in phase 
three. The characteristics of these are given in Table 2.2. 
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Table 2.2: Summary of the distinct research paradigms employed in this 
research 
Characteristic  
 
Positivist  Constructivist 
 
Research approach  Quantitative 
(deductive) 
Qualitative (inductive) 
 
Research 
methodology 
Cross-sectional survey Phenomenology 
 
Research 
instrument/tools 
 
Online questionnaire In-depth semi-
structured, face to face 
interviews 
Study sample  
 
Entire population 
studied. 
Detailed inclusion and 
exclusion criteria 
 
Purposive sample  
Data analysis  
 
Descriptive and 
inferential  
analysis. 
Content analysis 
Descriptive and 
framework approach 
 
 
2.2 EVIDENCE SYNTHESIS THROUGH SYSTEMATIC REVIEW  
The first phase of this research was a systematic review of the literature. This 
was conducted for several reasons: to identify and characterise gaps in the 
literature; to explore methodological strengths and weaknesses; and to inform 
later stages of the research. Furthermore, conducting systematic reviews is 
highlighted within the first stage of the MRC complex interventions framework 
described in Chapter 1.  
The most commonly cited definition of evidence based practice is that of 
Sackett, ‘the conscientious, explicit and judicious use of current best evidence 
in making decisions about the care of the individual patient. It means 
integrating individual clinical expertise with the best available external clinical 
evidence from systematic research.38 
There is an accepted hierarchy of research evidence, with well-designed 
systematic reviews and meta-analyses of randomised controlled trials at the 
top of the pyramid as shown in Figure 2.1. 
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Figure 2.1: Hierarchy of evidence (adopted from Markman and Callanan 1984, 
Greenhalgh 1997)39,40 
 
 
A systematic review is defined as a ‘well-planned review to answer specific 
research questions using a systematic and explicit methodology to identify, 
select, and critically evaluate results of the studies included in the literature 
review’. Systematic review differs from more traditional (narrative) literature 
reviews in several ways, as described in Table 2.3.  
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Table 2.3 Comparison of narrative and systematic reviews (adapted from Cook 
et al, 1997)41 
Feature  Narrative review  Systematic review  
 
Question Broad Scope, overview Focussed, specific 
 
Search 
 
Not usually specified Comprehensive and explicit 
Appraisal 
 
Variable Robust and rigorous; 
checklist driven 
 
Synthesis 
 
Narrative only Meta-analysis, meta-
synthesis, narrative; answers 
question 
 
Inferences Sometimes evidence-based Always evidence-based 
 
 
Greenhalgh stated that systematic reviews have specific advantages as a result 
of using explicit methods. These include: limiting bias; generating reliable and 
accurate conclusions; delivering required information to healthcare providers, 
researchers, and policymakers; and generating new hypotheses about 
subgroups of the study population.40 
 
Key characteristics of a systematic review are: 
 a clearly defined question; 
 an explicit, reproducible method with clear inclusion and exclusion 
criteria for studies; 
 a systematic search that attempts to identify all studies that would meet 
the eligibility criteria; 
 an assessment of the validity of the findings of the included studies, for 
example through the assessment of risk of bias; and 
 a systematic presentation, and synthesis, of the characteristics and 
findings of the included studies, which includes the search methodology 
(adapted from Cochrane handbook)42 
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2.2.1 Systematic review organisations 
There are several public and private sector organisations, including the 
Cochrane Collaboration, Campbell Collaboration and the Joanna Bridge 
Institute (JBI), which have been established with the specific aim of supporting 
systematic reviews.  
The Cochrane Collaboration produces systematic reviews of healthcare 
interventions based largely on quantitative evidence (although there are moves 
to extend to qualitative evidence) while the Campbell Collaboration produces 
systematic reviews on the effects of social interventions based on quantitative 
evidence. JBI, however, has a more pluralistic view of evidence on quantitative 
and qualitative evidence,43 hence the systematic review in this doctoral 
research was registered with JBI. 
JBI was founded in 1996 and is an international not-for-profit, research and 
development arm of the school of the translational science based within the 
Faculty of Health Sciences at the University of Adelaide in South Australia. JBI 
specialises in evidence-based healthcare, producing systematic reviews of 
healthcare practices with an interest in improving healthcare internationally.44  
JBI collaborates with more than 70 entities across the world including affiliates 
such as the Scottish Centre for Evidence-based Multi-professional Practice,45 
based at Robert Gordon University. The SEMP’s activities include training in 
conducting systematic reviews, promoting and supporting the synthesis, 
transfer, and use of evidence through identifying feasible, appropriate, 
meaningful, and effective healthcare practice to assists in the improvement of 
healthcare globally.45 The doctoral student (principal investigator) undertook 
JBI training prior to conducting this review; the principal supervisor is also an 
accredited trainer with the JBI.  
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2.3 QUANTITATIVE VERSUS QUALITATIVE METHODOLOGIES 
Research methodologies are categorised as quantitative or qualitative (or 
mixed); key characteristics are provided in Table 2.4. Quantitative and 
qualitative research methodologies differ generally in their aim, research 
questions, objectives, data collection and generation instruments they use, and 
the forms of data they produce.46 
Quantitative research has been described as, ‘explaining phenomena by 
collecting numerical data that are analysed using mathematically based 
methods’ and the data are usually collected  to test a hypothesis, resulting in 
accepting or rejecting the null hypothesis of no difference35 In contrast, 
qualitative research refers to inductive, holistic, subjective and process-
oriented approaches to understand, interpret, describe and phenomena or to 
develop. It is a systematic, subjective approach used to describe life 
experiences and give them meaning.47,48  
Phase two of this research employed a quantitative approach to quantify 
aspects of medication error reporting while a qualitative approach was 
employed in phase 3 to explore and describe the phenomenon of medication 
error reporting in greater depth. 
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Table 2.4: Comparison of qualitative and quantitative methodologies (adapted 
from Johnson and Onwuegbuzie 2004, Bowling 2009, Creswell 2013)32,35 
Characteristic Qualitative Quantitative 
Research aim Focuses on providing a 
complete, detailed and 
rich description of the 
research topic 
 
To quantify, classify, 
count, construct and test 
statistical models in an 
attempt to explain what 
is observed 
Design May be planned or 
emerge as the study 
unfolds 
All aspects of the study 
are designed carefully 
before data are collected 
 
Sample Tend to be small sample 
sizes 
 
Tend to be large sample 
sizes 
Data gathering, 
collection 
The researcher is the 
data-gathering 
instrument 
The researcher uses 
tools (e.g. 
questionnaires, 
equipment) to collect 
data 
 
Form of data Data are in the form of 
words (interviews), 
pictures (videos) or 
objects (artifacts) 
  
Data are in the form of 
numbers and statistics 
Data Qualitative data are 
more richer, time 
consuming, and should 
not be generalized  
Quantitative data are 
more efficient, able to 
test hypotheses, but may 
miss contextual data 
 
2.4 QUANTITATIVE METHODOLOGIES 
The two main quantitative methodologies are those described as experimental 
and cross-sectional surveys. An experimental research design (correlational, 
causal) assumes that the cases being studied can be manipulated by the 
researcher in order to measure a change or a difference49 These methodologies 
are described in Table 2.5. 
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Table 2.5: Quantitative research methodologies  
Common quantitative 
methodologies 
Description 
Survey  Explores and describes phenomena in real-
life situations to determine meanings and 
frequencies of the phenomenon under 
investigation, and describe and categorise 
information related to the 
phenomenon (Burns and Grove, 2011) 
 
Experimental 
(correlational) 
Explores relationships between variables to 
determine the degree of relationship 
between the two variables without 
introducing an intervention (Walker, 2005; 
Burns and Grove, 2011) 
 
Experimental (causal) The researcher manipulates an independent 
variable and observes the outcome on a 
dependent variable whilst keeping other 
unrelated variables constant (Walker, 2005) 
 
 
 
Given the research aim of the phase two, the quantitative phase, a survey 
methodology was more appropriate. Creswell (2003) describes a survey design 
as one which ‘provides a quantitative or numeric description of trends, 
attitudes, or options of a population by studying a sample of that population’.34 
Survey design is used to make inferences about certain characteristics, and to 
make claims about the study population. Surveys are commonly used in 
research, largely due to the ease of use, structured format, easily coded and 
quantifiable data, and the ability to statistically compare cases. However, there 
are disadvantages due to many inherent biases (see later). 
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2.4.1 Survey data collection tools  
The questionnaire is the most commonly used tool in survey research, with the 
two main formats being paper based and online. While the popularity of the 
online approach is increasing, there are several advantages and disadvantages 
to consider, as highlighted in Table 2.5.  
The online approach was selected for phase two for reasons of lower cost, ease 
of distribution and data entry.  
 
Table 2.6: Advantages and Disadvantages of e-mail Survey Methods   
(adapted from Wright, 2005)50 
Advantages Disadvantages 
The cost of data collection is low 
 
Possibility of problems of cooperation  
Participants can access and save the 
responses in real time 
 
The researcher may not probe the 
respondents for further information 
The method is convenient for 
respondents due to self-
administration 
 
Possibility of failing to reach the 
response target 
 
 
2.4.2 Sampling and data analysis in quantitative research 
Garson (2012) describes sampling as the process of selection of a particular 
group of participants for a study, noting that collecting data from a target 
population does not necessitate researching all members of that population.51 
Probability sampling techniques are most commonly employed in quantitative 
research and are described in greater detail in Table 2.6. However, as 
described in Chapter 4, the entire population of health professionals was 
researched, without sampling. 
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Table 2.7: Probability Sampling (adapted from Morgan, 2008)52 
 
Probability 
Sampling 
Procedure Common 
Usage 
Advantages Disadvantages 
Simple 
random 
Selected from 
population 
according to 
chance. Each 
member has 
same 
probability of 
being selected.  
 
Large, easily 
accessible 
populations. 
 
High chance of 
being 
representative. 
Not much 
information 
about population 
required. 
Can be 
inefficient, 
expensive. 
Systematic Similar to 
simple random 
sampling, but 
participants 
are chosen at 
specific 
intervals 
Large, 
homogenous 
populations. 
High chance of 
being 
representative. 
Underlying 
patterns or 
non-random 
variations in 
the population 
can cause a 
sampling bias. 
 
Stratified  Population is 
divided into 
homogenous 
subgroups, 
based on prior 
knowledge of 
the population, 
before 
randomly 
sampling from 
each subgroup.  
Large, well-
known 
populations. 
More 
representative 
of population 
than simple 
random 
sampling, data 
can be more 
manageable, 
can control for 
regional 
differences in 
population size. 
 
Requires 
accurate 
knowledge of 
subgroups and 
sizes. 
Cluster Similar to 
stratified 
sampling, but 
a sample of 
subgroups is 
first taken, and 
then samples 
within each 
selected 
subgroup are 
taken. Data is 
grouped 
according to 
subgroups, or 
‘clusters’. 
Very large 
populations 
with known 
subgroups. 
Often cheaper 
and more 
efficient than 
other 
techniques. 
High chance of 
sampling 
error, a 
systematic 
bias in a 
particular 
cluster can 
influence the 
impression of 
the larger 
population. 
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2.5 QUALITATIVE METHODOLOGIES 
Qualitative methodologies are viewed generally as ‘naturalistic’ or 
ethnographic, aiming to explore and explain the lived experience. Table 2.7 
provides a comparison of the five methodologies most commonly employed in 
the qualitative, namely narrative, phenomenology, grounded theory, 
ethnography and case study methodologies.30 
 
Table 2.8: Description of the five common qualitative methodologies (adapted 
from Czarniawska, 2004, Petty et al, 2012,Teddlie and Tashakkori, 2009 and 
Baxter and Jack, 2008)53-56 
 
Methodology Description  
Narrative 
 
Relates to spoken or written text of a single 
event or a series of events which are 
chronologically connected  
 
Phenomenology Provides an in-depth understanding of the 
distinctive lived experience of individuals by 
exploring the meaning of a phenomenon 
 
Grounded theory Attempts to develop a theory constructed from 
the data of participants with an experience of 
the phenomena under investigation, to explain 
these phenomena  
 
Ethnography Describes and interprets human cultures using 
methods such as participant-observation or 
interviews with the aim of getting an indepth 
understanding of a particular culture  
 
Case study Explores a case (or multiple cases) through in-
depth data collection involving multiple sources 
of information rich in context  
 
A qualitative, phenomenological approach was employed in phase three of this 
study. This was considered most appropriate to allow generation of in-depth, 
rich data to describe and understand participants’ experiences and behaviours 
of the phenomenon of medication error reporting.  
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2.5.1 Qualitative methods 
Van Maanen (1983) defines qualitative methods as an array of interpretive 
techniques which seek to describe, decode, translate and otherwise come to 
terms with the meaning, not the frequency of certain more or less naturally 
occurring phenomena in the social world.57 The three most common qualitative 
methods are the use of participant observation, focus group discussions and 
in-depth interviews.32,34  
 
Given that medication error reporting could be a highly sensitive topic, one-to-
one interviews were selected as the method. 
 
The most common types of interview are structured, semi-structured and 
unstructured, as summarised in Table 2.8. A semi-structured approach was 
selected for phase three.  
 
Table 2.9: Features of structured, semi-structured and unstructured interviews 
(adopted from Bowling, 2009)32 
 
Structured Semi-structured Unstructured  
Set of questions 
asked in a standard 
way across all 
participants 
Specific topic areas and a 
general set of questions but 
the interview flows like a 
conversation and topics are 
covered as they come up 
 
Topic area to be explored 
but what gets covered is left 
up to the participant. An 
opening question might 
introduce the topic 
Fixed questions with 
fixed order 
Open questions, order can 
vary 
Non-directive in-depth 
interview 
Control lies with 
researcher 
 
Control lies with both 
researcher and participant  
Control lies with participant 
Data will be probably 
coded in advance 
Data will be probably coded 
and analysed after each 
interview (iterative 
development) 
 
Data will probably be coded 
and analysed after interview 
(iterative development) 
Data generation tool: 
questionnaire 
Data generation tool: 
interview schedule  
Data generation tool: 
interview guide 
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2.5.2 Sampling and data analysis in qualitative research 
Qualitative research uses non-probability sampling as it does not aim to 
produce a statistically representative sample or draw statistical inference. 
Purposive sampling is one of the most common sampling strategies; it groups 
participants according to preselected criteria relevant to a particular research 
question.  
Purposive sample sizes are often determined on the basis of theoretical 
saturation (the point in data collection when new data no longer brings 
additional insights to the research questions).58 In this sense then 
generalizability is not sought by the researcher and the focus is less on sample 
size and more on sample adequacy.59 Bowen argues that adequacy of sampling 
relates to the demonstration that saturation has been reached, which means 
that depth as well as breadth of information is achieved. 
Francis et al (2010) described an approach to qualitative sample size 
determination as follows:60  
i. initial analysis sample - researchers should specify in advance the 
sample size at which the first round of analysis will be complete; 
ii. stopping criterion - researchers should specify in advance how many 
more interviews will be conducted, without new themes emerging, 
before the research team can conclude that the data saturation has 
been achieved (usually taken as three consecutive interviews); 
iii. independent coders - the initial analysis sample should be reviewed 
independently; and 
iv. the data saturation methods and findings should be reported so that 
the readers can evaluate the evidence. 
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Qualitative data analysis is a recursive process, where the researcher needs to 
move back and forth, as needed, to interpret and reinterpret the data 
throughout.55 The Framework Approach is one of the broad families of analysis 
methods often termed thematic analysis or qualitative content analysis. It was 
developed by researchers, Ritchie and Spencer in 1980s and is used 
increasingly in healthcare research where the objectives and research 
questions are defined clearly in advance.61  
It is most commonly used for the thematic analysis of semi-structured 
interview transcripts and consists of steps of: familiarization; identifying a 
thematic framework; indexing; charting; and mapping and interpretation.62  
 
2.6 MIXED METHODOLOGIES AND MIXED METHODS 
Many researchers such as Creswell (2003),63 Thomas (2003),64 and Krathwohl 
(1993)65have viewed quantitative and qualitative methodologies and methods 
as complementary and can be combined within one study.  
A mixed method study has been defined as focusing on ‘collecting, analyzing, 
and mixing both quantitative and qualitative data in a single study or series of 
studies’. The use of quantitative and qualitative approaches, in combination, 
provides a better understanding than either approach alone. There are four 
basic mixed methods designs, the convergent parallel design, explanatory 
sequential design, exploratory sequential design and the embedded design 
Creswell and Plano Clark (2011),66 as illustrated in Figure 2.2 
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(a) The convergent parallel design 
 
 
 
 
 
 
 
 
Figure 2. 
 
 
(b) The explanatory sequential design 
 
 
  
 
 
   
 
(c) The exploratory sequential design 
 
 
 
 
 
 
 
 
 
 
(d) The embedded design 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Mixed methods designs 
 
 
 
 
 
 
Quantitative 
data collection 
and data 
analysis 
Qualitative data 
collection and 
data analysis 
Interpretation Follow up 
with 
Qualitative data 
collection and 
data analysis 
Follow up 
with 
Quantitative 
data collection 
and data 
analysis 
Interpretation 
Interpretation 
Compare or 
relate 
Quantitative 
data collection 
and data 
analysis 
Qualitative data 
collection and 
data analysis 
Quantitative (or Qualitative design) data 
collection and data analysis 
 
Interpretation 
Data collection and data 
analysis (before, during or 
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Overall, this study employed a mixed methods sequential explanatory design, 
of survey (phase two) followed by in-depth, face-to-face interviews (phase 
three) with a purposively selected sample. The quantitative approach allowed 
collection of statistical data around facilitators and barriers to medication error 
reporting while the qualitative approach provided further explanation and rich 
data.  
 
2.7 THE USE OF THEORY IN RESEARCH  
Theories are formulated to explain, predict, and understand phenomena and, 
in many cases, to challenge and extend existing knowledge. The theoretical 
framework introduces and describes the theory that explains why the research 
problem under study exists.67 Theories can connect pieces of research data to 
generate findings which fit into a larger framework of other studies. The MRC 
complex interventions highlight the need to consider theory as part of 
intervention design.29  
 
2.7.1 The Theoretical Domains Framework 
The Theoretical Domains Framework (TDF) was developed by a group of 
psychological theorists, health service researchers and health psychologists.68 
It is derived from 33 theories of behaviour change and comprises of 14 domains 
and 84 constructs that allows synthesis of a multitude of coherent behavior 
change theories into a single framework. TDF allows assessment and 
explanation of behavioral problems and associated barriers and enablers, and 
inform the design of appropriately targeted interventions.69 TDF was applied 
throughout phases two and three. The TDF domains and their descriptors are 
outlined in Table 2.9.  
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Table 2.10: The Theoretical Domain Framework (adapted from Cane, O’Connor 
and Michie 2012)69 
 
Domain Examples 
Knowledge An awareness of the existence of something 
 
Skills An ability or proficiency acquired through practice 
 
Social/Professional Role and 
Identity 
A coherent set of behaviours and displayed 
personal qualities of an individual in a social or 
work setting 
 
Beliefs about Capabilities Acceptance of the truth, reality, or validity about 
an ability, talent, or facility that a person can put 
to constructive use 
 
Optimism The confidence that things will happen for the 
best or that desired goals will be attained 
 
Beliefs about Consequences Acceptance of the truth, reality, or validity about 
outcomes of a behaviour in a given situation 
 
Reinforcement Increasing the probability of a response by 
arranging a dependent relationship, or 
contingency, between the response and a given 
stimulus 
 
Intentions A conscious decision to perform a behaviour or a 
resolve to act in a certain way 
 
Goals Mental representations of outcomes or end states 
that an individual wants to achieve 
 
Memory, Attention and 
Decision Processes 
The ability to retain information, focus selectively 
on aspects of the environment and choose 
between two or more alternatives 
 
 
Environmental Context and 
Resources 
Any circumstance of a person's situation or 
environment that discourages or encourages the 
development of skills and abilities, independence, 
social competence, and adaptive behaviour 
 
Social influences Those interpersonal processes that can cause 
individuals to change their thoughts, feelings, or 
behaviours 
 
 
Emotion A complex reaction pattern, involving experiential, 
behavioural, and physiological elements, by which 
the individual attempts to deal with a personally 
significant matter or event 
 
Behavioural Regulation Anything aimed at managing or changing 
objectively observed or measured actions 
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2.8 ROBUSTNESS AND RIGOUR  
2.8.1 Robustness in quantitative research	
The traditional criteria to achieve the goal of robustness in quantitative 
research are internal validity, external validity and reliability.  
Validity is referred to as, ‘the accuracy and truth of the data being produced in 
terms of the concepts being investigated’.70 The internal validity is concerned 
with the confidence placed in the processes and data collected, and external 
validity (generalizability) of the findings.71 While there are a number of 
different approaches to determining validity (e.g. face, content, construct, 
criterion, concurrent, predictive etc.)32,72-74 those employed in this study were 
face and content. Face validity considers the extent to which the tool 
(questionnaire) covers he concept it purports to measure in terms of 
transparency or relevance. Content validity considers the extent to which the 
tool represents all facets of a given construct.75   
Reliability is referred to as, the extent to which results are consistent over 
time.76 While there are several approaches to determining reliability of the tool 
(e.g. test-retest validity), these could not be applied due to the online nature 
of the method of data collection. Internal consistency was determined (see 
later).  
 
2.8.2 Rigour in qualitative research 
Guba 1981, proposed four criteria that need to be considered by qualitative 
researchers in pursuit of a trustworthy study,77 as described in Table 2.11. 
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Table 2.11: Components of trustworthiness (Adapted from Guba 1981, Hasson 
and Keeney, 2011; Farrelly, 2013)36,70,71,77 
 
Trustworthiness  Description 
Credibility  Ensuring that findings are an accurate reflection of a 
wider reality by: employing well-established 
methodologies and methods; providing detailed 
description of the phenomenon under investigation; 
encouraging participant honesty through direct 
instructions, developing rapport, and giving 
opportunities for withdrawing from the study; and 
meeting with team members frequently for debriefing 
sessions and peer review 
 
Dependability  Similar to reliability, described as the extent to which 
similar findings if the study were repeated with the 
same methods etc.  
 
Transferability Similar to external validity (generalisability) and is 
described as the extent to which the findings can be 
applied to other contexts and settings. Achieved by 
providing detailed information so that readers can 
judge the applicability of the study to their own 
setting etc.  
 
Confirmability  Relates to the basis of the findings, and the extent to 
which they have arisen from data gathered rather 
than the biases and preconceived notions of the 
researcher, team etc. 
 
 
 
 
  
 40 
 
2.8.3 Bias as a threat to validity, reliability and trustworthiness 
Research bias arises when ‘systematic error is introduced into sampling or 
testing by selecting or encouraging one outcome or answer over others’.78 
Quantitative, qualitative and mixed methods studies have particular 
methodological issues and constraints hence there is potential for bias. There 
are different forms of bias; the most common categories of bias are described 
in Table 2.12. 
 
Table 2.12: Forms of bias (Adapted from Bowling 2009)78 
 
Type of bias or 
error 
 
Description 
Acquiescence 
response set  
Participants will more frequently endorse a statement than 
disagree, ‘yes-saying’ 
 
Design bias Faulty methods, sampling and analysis  
 
Evaluation 
apprehension 
Participant anxiety may lead to giving responses which they 
think are expected  
 
Interviewer bias The interviewer may subconsciously, or consciously, bias by 
appearing to hold certain values or by asking leading 
questions 
 
Non-response bias Non-response reduces effective sample size. Differences 
between responders and non-responders reduces 
generalisability 
 
Recall (memory) 
bias 
 
Selective memories in recalling events 
Reporting bias Failure of the participant to reveal full information 
 
Sampling bias Non-representative selection of participants  
 
 
Measures taken to minimize bias were considered and described throughout 
chapter 4 and 5. 
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2.9 SUMMARY 
In summary, this chapter has presented many underlying methodological 
concepts which are applied in all phases of the research. The specific research 
methods are described in detail in Chapters 3, 4 and 5.   
Figure 2.3 gives a schematic summary of the research paradigms, 
methodologies and methods employed for each phase of the research. 
 
 
 
 
Figure 2.3: Methodological phases of current research 
  
Phase one - systematic review
• methodology, quantitative and qualitative 
• methods, critical appraisal, data extraction and 
synthesis 
Phase two - survey of health professionals
• paradigm, positivism 
• methodology, cross-sectional survey
• method, online questionnaire
Phase three - interviews of health professionals
• paradigm, constructivism
• methodology, phenomenology
• method, semi-structured face-to-face 
interviews 
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CHAPTER 3: A SYSTEMATIC REVIEW OF HEALTH PROFESSIONALS’ 
BELIEFS, ATTITUDES AND EXPERIENCES OF MEDICATION ERROR 
REPORTING 
 
3.1 INTRODUCTION 
This chapter provides the aim, method, results and discussion of a Joanna 
Briggs Institute (JBI) registered systematic review of health professionals’ 
beliefs, attitudes and experiences in relation to the medication error reporting. 
As illustrated in Chapter 1, a number of systematic and narrative reviews have 
been published which focus on the incidence, nature and causes of medication 
errors (including classifications of prescribing, administration and dispensing 
errors). There is, however, a lack of any review which focuses on any aspect 
of medication error reporting by health professionals.  
A preliminary search of the JBI Database of Systematic Reviews and 
Implementation Reports, the Cochrane Library and the Centre for Reviews and 
Dissemination revealed that there was neither a systematic review published 
nor underway on this topic. This indicates a major gap in the literature in terms 
of the beliefs, attitudes and experiences of health professionals in relation to 
medication error reporting. In order that error reporting systems operate 
efficiently and optimize their positive contribution to medication errors and thus 
patient safety, it is vital that all health professionals understand the reporting 
processes. This includes key components such as appropriate errors reporting 
and feedback at the individual practitioner and organizational level to allow 
reflection on and implementation of changes to practice to further improve 
patient safety.  
This systematic review focused on these aspects and synthesized the available 
literature on issues of beliefs, attitudes and experiences, with specific attention 
to issues around under-reporting of medication errors by health professionals. 
At this stage, any studies, which focus on patient reporting of medication 
errors, were excluded.  
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3.1.1 Review aim and questions 
The aim of this review was to critically appraise, synthesize and present the 
available evidence on health professionals’ beliefs, attitudes and experiences 
of medication error reporting.  
More specifically, the review sought to answer the following questions in 
relation to health professionals (i.e. doctors, nurses and pharmacists): 
 What are their beliefs and attitudes towards medication error reporting? 
 What are their experiences of medication error reporting? (e.g. nature 
of feedback obtained, any subsequent changes in their practice, ease of 
use of the reporting system, any improvements required to optimize 
medication error reporting). 
 What are the reasons given or factors which are associated with under-
reporting of medication errors? (e.g. lack of awareness or understanding 
of the reporting system, fear of possible consequences of reporting, and 
forgetting to report). 
 
3.2 METHODS 
A review protocol was developed according to best practice.79 Following peer 
review within RGU, subsequent modification and further peer review within JBI, 
the protocol was registered with the JBI Database of Systematic Reviews and 
Implementation Reports and published.80 
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3.2.1 Inclusion criteria 
Types of participants 
This review only considered studies that included health professionals, 
specifically doctors, nurses and pharmacists, as these are the health 
professionals involved in the patient medication journey and in the processes 
of prescribing of medicines (doctors, nurses and pharmacists all have 
prescribing rights in certain countries, e.g. the UK), administering medicines 
(all are involved) and dispensing medicines (all may be involved to some extent 
in different countries).  
 
Phenomena of interest 
While there was no intervention (as would be the case in reviews of 
effectiveness or cost-effectiveness), the qualitative component of this review 
considered studies that investigated the phenomenon of medication error 
reporting from a number of different health professional perspectives (i.e. 
doctors, nurses, pharmacists). The quantitative component considered studies 
(most likely survey-based) which measured attitudes and beliefs using tools 
such as Likert-type scales.  
 
Types of outcomes 
This review only considered studies which reported beliefs, attitudes and 
experiences of health professionals (doctors, nurses, pharmacists) in relation 
to medication error reporting. 
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Types of studies 
This review considered any research design (quantitative, qualitative and 
mixed). Quantitative studies were included with outcomes around attitudes and 
beliefs, while qualitative with outcomes around attitudes, beliefs and 
experiences. Quantitative studies focused on observational (e.g. cross-
sectional surveys to measure attitudes and beliefs using Likert type scales) and 
qualitative included ethnography, phenomenology and grounded theory 
studies most likely using either interview (e.g. structured, semi-structured, 
unstructured) and focus group approaches for data generation. No studies were 
excluded on the basis of the design or approach to data generation.  
 
3.2.2 Search strategy 
The search strategy aimed to find published studies. A three-step search 
strategy was utilized in this review as follows: 
1. An initial scoping search of MEDLINE and CINAHL was undertaken, 
using search terms of [‘belief*’ or ‘attitude*’ or ‘experience*’] and 
‘medication error reporting’; 
2. To ensure that all relevant papers were captured, the keywords, main 
title and abstract words/phrases were identified. Searches of all 
databases were undertaken. The search string was: 
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a. ‘medication error*’ or ‘prescribing error*’ or ‘transcribing error*’ 
or ‘dispensing error*’ or ‘administration error*’ 
and 
b. ‘report*’ 
and 
c. ‘health professional*’ or ‘healthcare professional*’ or ‘doctor*’ or 
‘general practitioner*’ or ‘physician*’ or ‘consultant*’ or ‘nurse*’ 
or ‘pharmacist*’ 
and 
d. ‘belief*’ or ‘view*’ or ‘experience*’ or ‘opinion*’ or ‘attitude*’; 
3. The search string was applied with results and exceptions recorded. The 
reference lists of all identified papers were reviewed for additional 
studies. Studies were identified from the bibliographic databases 
described in Table 3.1. 
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Table 3.1 Scope of selected bibliographic databases  
 
Searched 
databases 
Scope 
Medline Medical Literature Analysis and Retrieval System Online, or 
MEDLARS Online is a bibliographic database of life sciences 
and biomedical information. It includes bibliographic 
information for articles from academic journals covering 
medicine, nursing, pharmacy, dentistry, veterinary medicine, 
and health care.it contains over 14 million records.81 
Cumulative 
Index of 
Nursing and 
Allied Health 
Literature  
CINAHL is the largest and most in-depth nursing research 
database. The CINAHL Plus with Full Text database provides 
full text for 734 journals, and indexing for 5,000 journals from 
the fields of nursing and allied health.82 
International 
Pharmaceutical 
Abstracts  
IPA is an online database produced in conjunction with the 
American Society of Health-System Pharmacists. It provides a 
comprehensive collection of information on drug use and 
development from 1971 to the current day.83 
Embase Embase is a biomedical and pharmacological database of 
published literature designed to support information 
managers and pharmacovigilance in complying with the 
regulatory requirements of a licensed drug.84 
Scopus Scopus is a bibliographic database containing abstracts and 
citations for academic journal articles. It covers nearly 22,000 
titles from over 5,000 publishers, of which 20,000 are peer-
reviewed journals in the scientific, technical, medical, and 
social sciences (including arts and humanities).85 
Psycharticles A robust database offering complete access to the full text of 
more than 80 landmark journals in behavioural science and 
related fields spanning education, nursing, business and 
neuroscience85,86 
Cochrane 
Database of 
Systematic 
Reviews 
Cochrane Reviews are systematic reviews of primary research 
in human health care and health policy, and are 
internationally recognised as the highest standard in 
evidence-based health care.87 
JBI Database 
of Systematic 
Reviews 
The JBI Database of Systematic Reviews and Implementation 
Reports is a peer-reviewed, online journal that publishes 
systematic review protocols and systematic reviews of 
healthcare research following the JBI methodology.88 
Database of 
Abstracts of 
Reviews of 
Effectiveness 
(DARE)  
DARE, is focused primarily on systematic reviews that 
evaluate the effects of health care interventions and the 
delivery and organization of health services.89 
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All studies identified during the database search were assessed for relevance 
to the review aim and questions by two independent reviewers (principle 
researcher and principal supervisor). The full article was retrieved for all those 
that appeared to meet the inclusion criteria. A search of Google Scholar (online 
search engine) was undertaken to ensure that all relevant studies have been 
identified. Only studies published as peer reviewed papers were included; 
abstracts, conference proceedings and letters etc. were excluded. The search 
included peer reviewed studies published in English between 1992 and 2013 
(i.e. a 20-year timeframe as the scoping search identified a body of literature 
published within that time period).  
 
3.2.3 Assessment of methodological quality 
All studies identified during the database search were assessed for relevance 
to the review protocol based on information via the title, abstract and full study 
review by two independent reviewers.80  
Quantitative papers selected for review were assessed by the two independent 
reviewers for methodological validity prior to inclusion in the review using 
standardized critical appraisal instruments from the JBI Meta- Analysis of 
Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix 3.1).  
Qualitative papers selected for retrieval were assessed by the  two 
independent reviewers for methodological credibility prior to inclusion in the 
review using standardized critical appraisal instruments from the JBI 
Qualitative Assessment and Review Instrument (JBI-QARI) (Appendix 3.2).  
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3.2.4 Data collection 
Quantitative and qualitative data were extracted independently by the two 
reviewers from papers included in the review using standardized data 
extraction tools. The data extracted included specific details about the 
populations, study methods and outcomes of significance to the aim and 
specific review questions.  
 
3.2.5 Data synthesis 
It was considered that pooling of data derived from quantitative studies was 
likely to be inappropriate due to an observational study design; hence the 
findings were presented in narrative form including tables and figures to aid in 
data presentation where appropriate. 
Qualitative research findings were, where possible, pooled using JBI-QARI. This  
involved the aggregation or synthesis of findings to generate a set of 
statements that represent that aggregation, through assembling the findings 
(Level 1 findings) rated according to their quality, and categorizing these 
findings on the basis of similarity in meaning (Level 2 findings). These 
categories were then subjected to a meta-synthesis in order to produce a single 
comprehensive set of synthesized findings. Where textual pooling was not 
possible, the findings were presented in narrative form. 
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3.3 RESULTS  
3.3.1 Hits 
Table 3.2 shows the number of ‘hits’ generated through applying the search 
string. 
Table 3.2 Number of hits generated from applying the search string  
1  medication error* 21,107 
2  prescribing error* 1,402
3  transcribing error* 51
4  dispensing error* 899
5  administration error* 1,996
6 (types of medication 
errors) 
1 or 2 or 3 or 4 or 5 14,704 
7  health professional* 77,243 
8  healthcare professional* 14,471 
9  doctor* 109,064 
10  general practitioner* 37,129 
11  physician* 426,933 
12  consultant* 30,933 
13  nurse* 463,528 
14  pharmacist* 58,247 
15 (health professionals)  7 or 8 or 9 or 10 or 11 or 12 
or 13 or 14 
990,181 
 
16 (reporting)  report* 2,092,366 
17 (experiences etc.)  experience* or opinion* or 
view* or belief* or attitude* 
1,190,547 
18 (review questions)  6 and 15 and 16 and 17 724
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3.3.2 Description of studies 
The Transparent Reporting of Systematic and Meta-Analyses (PRISMA) 
flowchart is given in Figure 3.1. Database searching yielded 724 titles, 100 of 
which were duplicates. Title, abstract and full paper screening resulted in 13 
papers for critical appraisal. The 13 papers reported 13 studies; eight of these 
were quantitative in design (survey methodology) and five qualitative 
(methodology not stated but methods of focus groups (n=3) and semi-
structured interviews (n=2)).  
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Figure 3.1 PRISMA flowchart for the search and study selection process  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Abstract screening  
    (n  = 158)  
 
 
 
 
 
 
 
 
  
Full -text articles assessed 
for eligibility  
(n = 74)  
Studies included in quantitative 
textual synthesis 
(n = 8) 
 
Full - text articles excluded  
not addressing the three  
review objectives  
(n = 61)  
MEDLINE, CINAHL, IPA, Psyc, 
Embase, Scopus 
 
(n = 724) 
  
Qualitative synthesis 
(n = 5) 
  
   
 
COCHRANE, JBI, DARE  
(n = 0)
 
Titles screened  
(n = 624 ) 
      Records after duplicates removed  
         (n = 624) 
Records excluded not 
addressing the review topic  
(n = 466)  
Records excluded not 
addressing the review topic  
(n = 84)  
 
  
     
Cross-sectional 
studies 
(n = 8) 
 
      
       
Semi-structured 
interviews 
  
(n = 2)
Focus groups 
(n = 3) 
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3.3.3 Methodological quality   
The methodological quality of the 13 studies, based on application of JBI 
MASTARI and JBI-QARI by the two independent reviewers, is reported in Tables 
3.3 and 3.4.  
The quantitative studies were generally robust with respect to all of the stated 
criteria. Limitations included the absence of clearly defined inclusion and 
exclusion criteria and any strategies to deal with confounders90 Notably, the 
outcomes were measured using objective criteria with consideration of data 
validity. All quantitative studies were considered appropriate to include in the 
stages of data extraction and synthesis.   
The key limitations of all five qualitative studies surrounded the absence of 
description of study philosophy (e.g. constructivism) and methodology (most 
presumed to be phenomenology since none included any aim around the 
generation of new theory as would be the case for grounded theory 
methodology or appeared to employ case study methodology). All studies were 
considered to be sufficiently rigorous to be included in data extraction and 
synthesis.  
3.3.4 Data extraction 
Data extraction of these 13 studies is given in Tables 3.5 and 3.6 for the 
quantitative and qualitative studies respectively. 
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Table 3.3: JBI-MASTARI quality assessment of eight quantitative studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Y, yes; N, no; U, unclear; N/A, not applicable (cross-sectional design hence no follow-up) 
Criteria/ Author, 
Year            
Wakefield 
et al 
(1999)91 
Stratton  
et al  
(2004)92 
Wild  
et al 
(2005)93 
Evans  
et al  
(2006)94 
Patrician  
et al 
(2009)95 
Sarvadikar 
et al 
(2010)96 
Chiang  
et al  
(2010)97 
Bahadori 
et al  
(2013)90 
Was study based on 
a random or 
pseudo-random 
sample? 
U U U Y Y Y  Y  Y  
Were the criteria 
for inclusion in the 
sample clearly 
defined? 
Y Y  Y Y  Y Y Y N  
Were confounding 
factors identified 
and strategies to 
deal with them 
stated? 
Y Y  Y Y  Y Y Y N  
Were outcomes 
assessed using 
objective criteria? 
Y Y  Y Y  Y Y Y Y  
Was follow up 
carried out over a 
sufficient time 
period? 
N/A N/A N/A N/A N/A N/A N/A N/A 
Were the outcomes 
of participants who 
withdrew described 
and included in the 
analysis? 
N/A N/A N/A N/A N/A N/A N/A N/A   
Were outcomes 
measured in a 
reliable way? 
Y  Y  Y Y Y Y Y Y  
Was appropriate 
statistical analysis 
used? 
Y  Y  Y Y  Y  Y  Y  Y  
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Table 3.4: JBI-QARI quality assessment of five qualitative studies  
Criteria/ Author, Year McArdle  
et al 
(2003)98 
Kingston  
et al  
(2004)99 
Sanghera  
et al 
(2007)100 
Hartnell  
et al  
(2013)101 
Williams  
et al  
(2013)102 
There is congruity between the stated 
philosophical perspective and the 
research methodology 
U U U U U 
There is congruity between the research 
methodology and the research question 
or objectives 
U U U U U 
There is congruity between the research 
methodology and the methods used to 
collect data 
U U U U U 
There is congruity between the research 
methodology and the representation 
and analysis of the data 
U U U U U 
There is congruity between the research 
methodology and the interpretation of 
the results 
U U U U U 
There is a statement locating the 
researcher culturally and theoretically 
N N  Y N N 
The influence of the researcher on the 
research, and vice versa, is addressed 
U U U U U 
Participants, and their voices, are 
adequately represented 
Y  Y  Y  Y  Y  
The research is ethical according to 
current criteria or, for recent studies, 
there is evidence of ethical approval by 
an appropriate body 
Y  Y  Y  Y  Y  
Conclusions drawn in the research 
report do appear to flow from the 
analysis, or interpretation, of the data 
Y Y  Y  Y  Y  
Y, yes; N, no; U, unclear 
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Table 3.5 Data extraction of quantitative studies 
Authors, year Specified 
aim/objective 
Setting (country, 
institution) 
Design Participants Key findings Conclusion 
Wakefield et al 
1996  
To analyse and 
assess nurses’ 
perceptions of why 
medication 
administration 
errors may go 
unreported 
United States (Iowa) 
Acute care hospitals 
Cross-sectional 
survey  
Nurses in 24 
hospitals 
No sample size 
stated; responses 
from 1384 
Factor analysis 
revealed four 
factors explaining 
why may not report 
errors: fear; 
disagreement over 
whether an error 
occurred; 
administrative 
responses to 
errors; and effort 
required to report 
errors 
Potential changes 
to systems and 
management 
responses could 
improve current 
practice 
Changes need to 
take into account 
influences of 
organisational, 
professional and 
work group culture 
 
Stratton et al  
2004  To obtain nurses’ 
reasons why 
medication 
administration 
errors are not 
reported  
 
United States 
(Colorado) 
 
Hospitals  
Cross-sectional 
survey 
No sample size 
stated; responses 
from 284 nurses 
The fear of adverse 
consequences was 
the primary reason 
for not reporting 
errors 
There is a need to 
explore both 
individual and 
systemic 
safeguards to focus 
on the reported 
causes and 
underreporting of 
errors 
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Wild & Bradley 
2005   
To suggest differing 
needs for training 
and other 
interventions to 
enhance error 
reporting 
  
United States 
(Connecticut) 
Community hospital 
Cross-sectional 
survey 
No sample size 
stated; responses 
from 24 residents 
and 36 nurses 
Fewer residents 
than nurses knew 
of and had used 
the reporting 
system 
Residents were less 
likely than nurses 
to report being 
comfortable 
discussing errors 
with supervisors 
and to rate the 
hospital 
administration as 
non-supportive of 
error reporting 
 
Error reporting 
systems may give a 
biased picture of 
errors 
 
Hospitals may need 
to initiate other 
interventions to 
improve reporting  
Evans et al 2006  To assess 
awareness and the 
use of the current 
incident reporting 
system and to 
identify factors 
inhibiting reporting 
of incidents in 
hospitals 
Australia (south) 
Principal referral 
hospitals, major 
referral hospital, rural 
base hospitals 
Cross-sectional 
survey 
263 doctors and 
799 nurses in 6 
hospitals 
773 responses, 
72.8%  
 
Most were aware of 
the reporting 
system 
More likely to 
report incidents 
which were 
habitually reported, 
often witnessed 
and associated with 
immediate 
outcomes 
Most frequently 
reported barrier to 
reporting was lack 
of feedback 
To improve incident 
reporting 
clarification is 
needed of which to 
report, the process 
should be simplified 
and feedback given  
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Patrician & Brosch 
2009  
To assess nurses’ 
perceptions of the 
reasons for not 
reporting errors 
and the extent of 
underreporting 
Assume United States, 
although not stated 
explicitly 
One hospital  
Cross-sectional 
survey  
268 nurses in one 
hospital 
43 responses, 16% 
The top 5 reasons 
for not reporting 
were: perceptions 
that the 
administration 
focused on the 
individual and not 
the system; blame 
attributed; fear of 
adverse 
consequences; peer 
will consider the 
reporter 
incompetent; and 
error not important 
enough 
A positive 
organisational 
culture, or 
perception thereof, 
prevents truthful 
reporting  
Sarvadikar et al 
2010  
To investigate 
attitudes of health 
professionals in 
reporting 
medication errors 
United Kingdom 
(Aberdeen) 
Tertiary referral 
hospital  
Cross-sectional 
survey 
98 health 
professionals 
(doctors, nurses 
and pharmacists) 
surveyed 
56 responses, 57% 
Doctors were 
unlikely to report 
less serious errors 
Nurses and 
pharmacists were 
likely to report less 
serious as well as 
serious errors 
despite fears of 
disciplinary action 
All were more likely 
to report an error 
as clinical scenarios 
had worsening 
patient outcomes  
 
There are differing 
attitudes to 
reporting errors 
hence different 
approaches are 
required to 
encourage 
reporting 
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Chiang et al 2010  To examine the 
factors that 
influence the failure 
to report 
medication adverse 
events by nurses 
  
Taiwan (southern) 
Tertiary hospitals 
Cross-sectional 
survey 
1000 nurses in 5 
hospitals 
872 responses, 
87.2% 
The strongest 
predictors of not 
reporting were the 
experience of 
making errors, 
differences in 
attitude of 
reporting self and 
co-workers and 
perceived error rate 
 
Educating nurses 
about the goals of 
reporting and using 
reporting data to 
enhance patient 
safety culture is 
recommended 
Bahadori et al 2013  To study the 
factors influencing 
not reporting 
medication error, 
from nurses’ 
viewpoints  
Iran (Miandoab) 
University hospital 
Cross-sectional 
survey 
100 nurses in one 
hospital 
83 responses, 83% 
The most important 
reasons for not 
reporting were 
related to 
managerial factors, 
factors related to 
the process of 
reporting and fear 
of the 
consequences of 
reporting 
 
Establishing a 
mechanism to 
improve quality 
rather than focus 
solely on finding 
the culprits and 
blaming them can 
result in improving 
patient safety 
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Table 3.6 Data extraction of qualitative studies 
Authors, year
   
Specified aim/objective
  
Setting 
(country, 
institution) 
Design Participants Key findings  
(level 1 themes) 
Conclusion 
McArdle et al 2003  To investigate doctors’ 
attitudes and beliefs about 
medication error reporting  
Assume United 
Kingdom, 
although not 
stated explicitly 
One hospital 
Semi-
structured 
interviews 
15 doctors of 
varying 
grades  
Key themes were 
the importance of 
reporting, the use of 
the reporting 
process, fear of 
disciplinary action, 
loss of peer respect 
and lack of feedback 
  
Errors should be a 
learning experience but 
only if relevant and 
timely feedback is given 
Kingston et al 2004  To examine attitudes of 
medical and nursing staff 
towards reporting incidents 
(adverse events and near-
misses), and to identify 
measures to facilitate 
incident reporting 
Australia 
(Adelaide) 
Metropolitan 
public hospitals  
Focus 
groups 
14 medical 
and 19 
nursing staff 
in 5 focus 
groups 
conducted in 
3 hospitals 
Key themes were 
lack of knowledge, 
time constraints and 
complexity of the 
process, lack of 
feedback, culture of 
blame, and no value 
 
Strategies to improve 
incident reporting must 
address cultural issues 
Sanghera et al 
2007 
To explore the attitudes 
and beliefs relating to the 
reporting of medication 
errors  
United Kingdom  
Hospital intensive 
care unit 
 
 
Semi-
structured 
interviews  
 
 
13 health 
professionals 
(doctors and 
nurses) who 
had 
committed a 
medication 
error  
Key themes were 
not being aware an 
error had occurred, 
process of reporting, 
no benefit, 
motivational and 
cultural factors 
Greater feedback on 
errors seems essential to 
improve current practice 
and increase reporting 
 61 
 
Hartnell et al 2013   To enhance the 
understanding of barriers to 
medication error reporting 
in healthcare organisations   
Canada (Nova 
Scotia) 
Community 
hospitals 
Focus 
groups and 
in-depth 
interviews  
One focus 
group at each 
of 4 hospitals 
with 30 
health 
professionals 
(doctors, 
nurses and 
pharmacists) 
Interviews 
with the 
director of 
risk 
management 
at each 
hospital 
 
Key themes 
identified incentives 
to reporting of 
patient and provider 
protection and 
professional 
compliance 
Themes of barriers 
were reporter 
burden, professional 
identity, information 
gap, organisational 
factors and fear 
Reporting should be 
made as easy as possible 
with timely feedback  
and up to date education  
Williams et al 2013  
 
To explore and understand 
the attitudes of hospital 
pharmacists to reporting 
medication incidents 
United Kingdom 
(Manchester) 
Hospitals 
Focus 
groups  
One focus 
group 
conducted at 
each of 4 
hospitals with 
17 
pharmacists 
Key themes were 
around the working 
environment, 
anxieties, the 
incident, the 
reporting system 
and learning 
The decision to report 
was a complex process 
that depended on the 
severity of patient harm, 
anxieties about harming 
interprofessional 
relationships, prior 
experience of the 
outcomes from 
reporting, and the 
perceived effort required 
to use reporting forms 
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3.3.5 Data synthesis 
This was a systematic review which encompassed studies employing 
quantitative and qualitative methodologies and methods.  None of the 
individual studies were mixed methods (i.e. combining both approaches within 
the same study).  
The majority of studies were conducted in the USA,92,93,95,103 and the 
UK,96,98,100,102 with fewer in Australia,94,99 Taiwan,97 Canada,101 and Iran.90 
 
Quantitative studies 
The eight quantitative studies were all of cross-sectional design, all of which 
focused on aspects of awareness, knowledge and experiences of the 
medication error reporting system, as well as attitudes towards and beliefs of 
reporting, with emphasis on barriers to reporting.   
All studies were based in hospital; five included nurses only,90,92,95,97,103 two 
were of doctors and nurses,93,94 and one of doctors, nurses and pharmacists96 
The number of respondents varied from 43 (16% response rate)95 to 1384 (no 
response rate stated).103   
A range of terms was used to describe the phenomenon under study. These 
were ‘medication errors’,90,96 ‘errors’,93,95 ‘medication administration 
errors’,92,103 ‘medication adverse events’,97 and ‘incidents’.94 
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Studies did not report clearly aspects of awareness, knowledge, experiences, 
attitudes and beliefs, and focused largely on barriers towards reporting. These 
were:  
 Fear of adverse consequences following reporting90,92,95,97,103 
 Disagreement over error identification;92,95,103 
 Managerial factors;90,97 
 Aspects of knowledge and awareness;94,96 
 Lack of feedback;94 and 
 Training.93 
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Qualitative studies 
Five qualitative studies met the inclusion criteria and were included in the 
systematic review. Of these five studies, two used semi-structure interviews to 
generate the data,98,100 and three focus groups.99,101,102 
Studies were based in hospital settings. One studied doctors, pharmacists and 
nurses,101 two doctors and nurses,99,100 one doctors only,98 and one 
pharmacists only.102 The number of participants ranged from 13,100to 33,99 with 
a combined total of 108 participants.  
The phenomena under study were ‘medication errors’,98,100,101 ‘medication 
incidents’,102 and ‘incidents’.99 
Table 3.7 summarises the level 2 findings.   
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Table 3.7 Level 2 findings derived from the five qualitative studies 
Study Aspects of 
the working 
environment 
and culture 
Knowledge 
and skills 
related 
Aspects 
of the 
reporting 
process 
Fear of 
consequences 
of reporting 
Time 
constraints 
Aspects 
of 
reporting 
feedback 
McArdle 
et al 2003 
✓      
Kingston 
et al 2004 
✓ ✓ ✓ ✓ ✓ ✓ 
Sanghera 
et al 2007 
✓ ✓ ✓    
Hartnell 
et al 2013 
✓ ✓ ✓ ✓  ✓ 
Williams 
et al 2013 
✓  ✓ ✓  ✓ 
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3.4 DISCUSSION  
3.4.1 Key findings  
The aim of this review was to critically appraise, synthesize and present the 
available evidence on health professionals’ beliefs, attitudes and experiences 
of medication error reporting. While a number of studies were identified 
employing quantitative and qualitative approaches, no individual study 
employed mixed methods approaches. Most studies were conducted within 
Europe and the USA, with only one study based in the Middle East. That cross-
sectional study, which was based in Iran, reported only data from 83 nurses.90 
One key limitation of the studies reviewed is the absence of any behavioural 
change theories in the development of the data collection and generation tools, 
data analysis or interpretation of study findings. While most studies did not 
clearly separate attitudes, beliefs and experiences, there were similarities in 
terms of the barriers around reporting, the main ones of which being aspects 
of fears of the consequences of reporting, disagreement over what constituted 
an error worthy of reporting, aspects of the environment and culture, 
knowledge and skills related, and training related.  
 
3.4.2 Review strengths and weaknesses 
One strength of this review is that it was conducted using the standardised JBI 
approaches, with the review protocol being peer reviewed through JBI and 
published,80 prior to the review being conducted. This highlighted the need for 
the review and a gap in the literature, evidencing the originality of the review. 
Best practice was followed in conducting the review in that two reviewers 
working independently conducting both the quality assessment and data 
extraction phases.  
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However, there are several limitations to this review and hence the findings 
should be interpreted with caution. None of the qualitative studies described 
the research paradigm or research methodology prior to describing the study 
methods in detail.  
As described earlier, the data extraction and synthesis is derived from only 13 
studies, none of which used a mixed methods approach nor grounded the 
research in established theories of behaviour and behaviour change. There is 
therefore a need for further research in this field.  
 
3.4.3 Interpretation 
The barriers to reporting medication error reporting identified in this review 
highlight the need for the development, implementation and evaluation of 
interventions which aim to enhance and improve medication error reporting. 
The process described by the UK Medical Research Council for the development 
and implementation of complex interventions,29 describes clearly a staged 
approach. A key element of this is identifying theory on which to base this 
intervention. While not specifying specific theory, TDF would appear to be 
appropriate as it is derived from 33 behavioural theories and is also for use by 
non-specialist health psychology experts.69 Using TDF to aid the identification 
of behavioural determinants will result in an intervention to target specific 
determinants.  
The specific factors leading to suboptimal reporting identified in this review 
align to determinants of: 
 knowledge; 
 beliefs of consequences; and 
 emotions. 
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However, there is a need for research which is designed based on TDF at the 
outset and incorporated into processes of data collection and generation, 
analysis, and interpretation. Such research should also employ a mixed 
methods approach and provide clear definition of the term (e.g. ‘medication 
errors’) and scope (e.g. prescribing, dispensing, administration etc.) 
 
3.4.4 Further research phases 
This systematic review has identified the paucity of research conducted within 
the Middle East. Given the cultural diversity, there is a need for original 
research which employs a mixed methods approach to quantify issues around 
medication error reporting, while at the same time providing depth and 
richness of data derived from qualitative research. Such research should be 
grounded in theories of behaviour and behaviour change. This will be the focus 
for the remainder of the doctoral research.  
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CHAPTER 4: CROSS-SECTIONAL SURVEY OF HEALTH PROFESSIONALS 
IN THE UNITED ARAB EMIRATES   
 
4.1 INTRODUCTION 
The findings of the systematic review presented in chapter 3 highlighted that 
while a number of cross-sectional surveys have been conducted on aspects of 
medication error reporting, most were based within Europe and the USA, with 
only one in the Middle East. One further key limitation is that none of these 
made any reference to behavioural theories throughout the processes of 
research data collection, analysis or interpretation. This chapter presents the 
method, results and discussion of a cross-sectional survey of beliefs, 
behaviours and experiences of health care professionals relating to the 
reporting of medication errors. 
 
4.1.1 Study aim and research questions 
To aim was to quantify the behavioural determinants of health professional 
reporting of medication errors in Abu Dhabi, the UAE. 
The detailed research questions were: 
 Which behavioural determinants impact error reporting?  
 Which of these are facilitators or barriers to error reporting? 
 Are there significant differences in behavioural determinants between 
demographic variables? 
 
 70 
 
4.2 METHOD 
4.2.1 Design 
A quantitative, cross-sectional survey of health professionals was employed in 
this phase of the study to achieve the study objectives. As described in chapter 
2, cross-sectional approaches provide a snapshot at one point in time. The 
collection and analysis of quantitative data would provide an opportunity to 
generate novel findings which could be used to develop an intervention to 
impact the effectiveness and efficiency of the medication error reporting 
systems and processes.  
 
4.2.2 Governance  
A detailed research protocol was prepared and reviewed by the team members, 
following which the protocol was approved four weeks later by the ethical 
review panel of the School of Pharmacy and Life Sciences, Robert Gordon 
University (Appendix 4.1). 
All three hospitals in which the research was conducted had independent 
ethical review processes, documentation, requirements and committees. Prior 
to commencing any field work in the UAE, approval was also sought and 
obtained from each of the hospitals involved as follows:  
i. The Ethics and Research Committee of Al Mafraq Hospital (Appendix 
4.2). This required an online application submission along with evidence 
of approval at RGU.  
ii. The Ethics and Research Committee of Zayed Military Hospital (Appendix 
4.3) this required an online application submission along with evidence 
of approval at RGU. In addition, a face-to-face interview was conducted 
with the ethics committee with the principal researcher, during which 
questions focused on the recruitment process and protection of 
participants.   
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iii. The Al Ain Medical District Human Research Ethics Committee in Tawam 
Hospital (Appendix 4.4). This required submission on an online 
application along with evidence of approval at RGU. In addition, the 
principal researcher had to present for a face-to-face interview with the 
committee, during which questions focused on the appropriateness of 
online recruitment. After detailed discussion on precautions included to 
protect anonymity, the research was approved.  
The process lasted six months from the time of submission to RGU to obtaining 
approval from the third hospital. Throughout the research, attention was paid 
to the research governance policies of RGU 104, the School of Pharmacy and 
Life Sciences and the UAE 105.  
 
4.2.3 Setting 
The research was conducted within the Abu Dhabi emirate of the UAE. This 
emirate was selected for several reasons: 
i. Abu Dhabi is the largest emirate, both in terms of geographical size and 
population hence researching health professionals in Abu Dhabi was 
likely to produce research findings which could be generalised to other 
emirates. 
ii. For logistical reasons as the principal researcher was based in Abu 
Dhabi. 
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While the sampling frame for the study was all 22 hospitals in Abu Dhabi, the 
following three major hospitals were selected:  
i. Tawam Hospital, with a bed capacity of 461 and professional staff 
numbering around 3400.   
ii. Al-Mafraq Hospital, with a bed capacity of 451 and professional staff 
numbering almost 2000.   
iii. Zayed Military Hospital, with a bed capacity of 365 and professional staff 
numbering almost 2000. It provides medical services to the families of 
the UAE Armed Forces. 
These three study hospitals provide care for 72.8 % of the Abu Dhabi 
population106 
 
4.2.4 Participant inclusion and exclusion criteria 
All health professionals (doctors, nurses and pharmacists) working within the 
three study hospitals were included in the study; there were no exclusions.  
 
4.2.5 Participant sampling 
The entire population of health professionals (doctors, nurses and pharmacists) 
was used, with no sampling. This was estimated to be around 7,400 health 
professionals, although the hospitals were unable to give the exact number of 
health professionals. The reason for using the entire population was simply a 
matter of logistics in that the recruitment method (see later) was via email 
from hospital administrators. It was considered easier to email all health 
professionals rather than the administrators carrying out the sampling using a 
simple or stratified sampling approach.  
In terms of sample size, a response from 370 health professionals was required 
to give a margin of error of 5% and confidence intervals of 95%.107 
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4.2.6 Questionnaire development and review 
A draft questionnaire was developed in relation to the research aim and 
objectives informed by the literature presented in the systematic review in 
Chapter 3 and based on the TDF (as described in Chapter 2). The Determinants 
of Implementation Behavior Questionnaire was used as a basis for the 
development of the individual items, adapted as relevant to medication error 
reporting.108 These items were presented as 5-point Likert scales (strongly 
agree to strongly disagree). In addition, demographic items were developed as 
appropriate to health professionals in the UAE. 
The draft questionnaire was reviewed for face and content validity (see Chapter 
2) by a panel of experts in medication error reporting, health professional 
practice and health services research in the UK and the UAE. Responses were 
received from: 
i. Sherine EL Din, Head of the Quality Management Department in Zayed 
Military Hospital in Abu Dhabi.  
ii. Mohamad Alsaiari, Consultant in Respiratory Medicine, American Board 
of Medical Quality, UAE. 
iii. Katie MacLure, Senior Research Fellow, Robert Gordon University. 
iv. Cristin Ryan, Senior Lecturer, Royal College of Physicians of Ireland. 
v. Gordon Rushworth, Lead Pharmacist, Highland Pharmacy Education and 
Research Centre. 
Detailed comments were received from each, mainly in relation to specific 
wording of items. The draft questionnaire was revised accordingly prior to 
piloting. The pilot questionnaire was developed in Snap 10 Professional® 
(software for web and email questionnaire design, publication, data entry and 
analysis).  
A participant information leaflet was developed to provide information on study 
purpose, selection of participants, benefits of taking part, estimated duration 
to complete, and confidentiality and anonymity.  
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4.2.7 Pilot study 
A pilot study was conducted for several reasons: 
i. to estimate likely response rates; 
ii. to identify and resolve any issues with the process of administering the 
questionnaire particularly since this was an electronically administered 
questionnaire; 
iii. to obtain feedback to allow refining of the open-ended questions; 
iv. to familiarise the researcher with process of content analysis;109 and 
v. to overall increase study robustness thereby increasing the likelihood of 
a well-constructed and content-valid questionnaire.110,111 
The pilot sample was conducted in three different hospitals in Abu Dhabi, with 
a convenience sample of 29 HCPs (9 doctors, 10 nurses, 10 pharmacists). 
Findings indicated that no amendments to the questionnaire were necessary 
as the questions were clear, not too difficult, taking around 20 minutes to 
answer and the process of administration was appropriate.  
 
4.2.8 Full study recruitment 
Data collection was conducted from June 2014 to September 2014. Email 
invitations (Appendix 4.5) were sent by	the human resources departments in 
each hospital	to all doctors, nurses and pharmacists. The email contained a link 
to the participant information leaflet and questionnaire (Appendix 4.6), with 
respondents submitting the questionnaire electronically. 
At the end of the questionnaire, respondents were invited to express interest 
in participating in the interview phase of the study. Two reminder emails were 
sent by the hospital administration to the entire population at two weekly 
intervals. An instruction was given asking those who had already completed 
and submitted the questionnaire to ignore the reminder.  
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Several evidence based strategies were employed to maximize the response 
rate: 
i. providing information which clearly stated the research aim and 
potential benefits; 
ii. assuring confidentiality and anonymity; 
iii. the research originated from an academic institution; 
iv. a well-designed and attractive questionnaire; and 
v. two email reminders at 2-weekly intervals.112 
 
4.2.9 Data analysis 
The survey instrument generated anonymised emails of online submissions 
which were imported into Snap before direct export to SPSS,113 and cleaned 
prior to analysis. 
Descriptive statistics (e.g. frequencies, percentages, mean (standard 
deviation), median (interquartile range) were used to describe respondent 
demographics and their responses. Inferential statistics (see later) were used 
in the study to explore and compare the differences in responses between 
variables of health profession, gender and years of experience.  
 
Principal component analysis 
All items included in the questionnaire was subjected to exploratory factor 
analysis (principal component analysis (PCA) with varimax rotation),	to identify 
a smaller number of factors (or components) of interrelated variables. The 
number of factors to be retained was decided based on the Kaiser criterion 
(eigenvalues greater than 1), the screen plot and meaningfulness of the results 
according to the theoretical framework.114,115 The analysis included items that 
were not freestanding, cross-loading or decreasing the scale’s internal 
consistency, and that displayed acceptable communalities, with factor 
pattern/structure coefficients above 0.4.114,116-118  
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In performing PCA, the Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy and the Bartlett’s Test of Sphericity were used to assess the 
suitability of the sample for PCA.119 
 
Internal consistency 
Following PCA, an internal consistency analysis	 (a form of reliability) was 
performed by determining the Cronbach’s coefficient alpha for each component 
identified.120 This statistic provides an indication of the average correlation 
among all of the items that make up the component scale. Values range from 
0 to 1, with higher values indicating greater reliability.113	 Nunnally (1978) 
suggests a minimum level of 0.7 for the component scale to be considered 
reliable.121  
If shown to be reliable, total component scores were obtained by assigning 
scores of 1 (strongly agree) to 5 (strongly disagree) to each of the Likert 
statement responses, with negatively worded items being reverse scored. 
 
Comparison between groups 
The Mann-Whitney U test was used to explore any relationship between 
demographic variables (health profession, gender and years of experience) and 
component scores. This statistic is a comparison of medians and rankings 
across the two groups. A probability value (p) less than or equal to 0.05 was 
considered statistically significant.113 
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4.2.10 Promoting quality in research: validity and reliability 
A number of measures were implemented to promote validity and reliability 
and thus study robustness: 
i. questionnaire items were developed from the results of systematic 
review, published literature, the theoretical frameworks, and 
together with using established measurement scales, enhanced 
criterion validity; 
ii. the draft questionnaire was reviewed for face and content validity; 
iii. a pilot study was carried out to ensure robustness; and 
iv. statistical testing was undertaken to determine the component scale 
reliability. 
A number of measures were taken to reduce bias and thus improve data 
validity and reliability: 
i. attention and social desirability bias were minimised by emphasising the 
purpose of the research;  
ii. questionnaire items were mainly in the form of Likert scales and close-
ended questions to prevent acquiescence response set bias; and 
iii. questionnaires responses were anonymous to minimise evaluation 
apprehension. 
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A summary of the methodological steps is provided in Figure 4.1 
 
 
Figure 4.1 Summary of all methodological steps in cross-sectional survey 
Draft questionnaire 
developed based on :
1. Research aim  2. SR 
findings 3. TDF (DIBQ)
Reviewed by  a panel of 
expert for face and 
content validity; 
comments reviewed and 
questionanire modified
Final questionnaire 
imported to SNAP
Piloted using 
convenience sample of 
29 health professionals 
Findings:
- no changes needed; 
questions clear, taking 
20 mins to answer
- appropriate 
administration process
Pilot study results not 
ncluded in the study to 
remove response and 
social desirabitlity biases
Email invitation 
requested to be sent 
from HR departments to 
all doctors, nurses and 
pharmacists
Online survey responses 
imported to SNAP before 
direct export to SPSS to 
be cleaned prior to 
analysis
Step 1: Descriptive analysis 
prior to PCA wih varimax 
rotation 
Data subjected to PCA 
(allows combining of all 
variables into small 
number of components 
of interelated variables)
6 components be 
retained out of 13 
extracted based on: 
eigenvalue > 1, scree 
plot and 
meaningfulness of 
components
Data checked for 
suitability using 4 PCA 
assumptions via SPSS
Step 2 : Internal Consistency
(Cronbach's alpha)
Reliability of each 
component  determined 
using Cronbach's alpha
Minimum level of 0.7 for 
component scale to be 
considered reliable.
If reliable, total 
component scores 
obtained with median 
and IQR calculated
Step 3: Mann Whitney U test 
to compare between groups
Relationship between 
demographics and 
component variables 
explored using Mann 
Whitney U test
6 coponent scores 
compared to profession, 
gender, age and years 
of experience.
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4.3 RESULTS  
A total of two hundred and ninety-four responses were received over the study 
period. 
 
4.3.1 Respondent Demographics  
Respondent demographics are given in Table 4.1. Just over half of the 
respondents (53.1%) were nurses, female (59.5%), almost two thirds were 35 
years of age and above (63.7%), and had been registered as health 
professionals for over ten years (65.9%).  
 
Table 4.1: Respondent demographics (N=294) 
 
Characteristic Percentage Frequency, n 
Profession   
Doctor 27.6 81 
Nurse 53.1 156 
Pharmacist 15.6 46 
Missing 3.7 11 
Gender   
Male 37.4 110 
Female 59.5 175 
Missing 3.1 9 
Age, years   
<25  1.0 3 
25-34 33.0 97 
35-44 36.1 106 
45-54  18.4 54 
>54  9.2 27 
Missing 2.4 8 
Years registered as health 
professional 
  
< 6 years 10.5 31 
6-10 years 22.1 65 
11-15 years 24.8 73 
16-20 years 17.3 51 
> 20 years 23.8 70 
Missing 1.4 4 
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4.3.2 Behavioural determinants 
Responses to items within each of the TDF domains (as per questionnaire 
development and validation) are given in Tables 4.2-4.15. 
 
1. Knowledge 
(An awareness of the existence of something; constructs of knowledge and role 
clarity).  
While almost all respondents strongly agreed or agreed with items such as 
awareness of medication error definition (96.6%) and awareness of 
responsibilities for medication error reporting (92.2%), there was slightly less 
agreement around awareness of the reporting policy in Abu Dhabi hospitals 
(77.2%). 
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Table 4.2: Responses to statements around knowledge related to medication 
error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I am aware of the 
definition of a 
medication error 
 
63.6 
(187) 
33.0 
(97) 
2.0 
(6) 
0 0 1.4 
(4) 
I am aware of the 
distinction between 
a medication error 
and an adverse 
drug reaction 
 
66.0 
(194) 
30.6 
(90) 
2.0 
(6) 
0 0 1.4 
(4) 
I am aware of my 
responsibilities for 
medication error 
reporting 
 
43.9 
(129) 
48.3 
(142) 
3.7 
(11) 
0.3 
(1) 
0.7 
(2) 
3.4 
(9) 
I am aware of 
what is expected of 
me in relation to 
medication error 
reporting 
 
38.4 
(113) 
47.6 
(140) 
10.2 
(30) 
0.7 
(2) 
0.7 
(2) 
2.4 
(7) 
I am aware of 
which medication 
errors should be 
reported 
 
34.4 
(101) 
45.9 
(135) 
11.9 
(35) 
3.7 
(11) 
2.4 
(7) 
1.7 
(5) 
I am aware of the 
policy relating to 
medication error 
reporting in Abu 
Dhabi hospitals 
33.7 
(99) 
43.5 
(128) 
17.7 
(52) 
3.1 
(9) 
0.7 
(2) 
1.4 
(4) 
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2. Skills 
(An ability or proficiency acquired through practice) 
While the majority of the respondents strongly agreed or agreed that they had 
the ability to report medication errors (86.8%) and had the necessary 
experience to report (80.3%), there was less agreement around having 
received sufficient training in medication error reporting (66.0%).	 
 
Table 4.3: Responses to statements around skills related to medication error 
reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I have received 
been sufficient 
training in 
medication error 
reporting 
 
22.1 
(65) 
43.9 
(129) 
13.6 
(40) 
16.3 
(48) 
1.4 
(4) 
2.7 
(8) 
I have the ability 
to report 
medication errors 
 
36.1 
(106) 
50.7 
(149) 
7.5 
(22) 
2.7 
(8) 
0.7 
(2) 
2.4 
(7) 
I have the 
necessary 
experience to 
report medication 
errors 
 
29.6 
(87) 
50.7 
(149) 
10.5 
(31) 
5.4 
(16) 
0.3 
(1) 
3.4 
(10) 
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3. Social/professional role and identity  
(A coherent set of behaviours and displayed personal qualities of an individual 
in a social or work setting)  
Almost all strongly agreed or agreed with both statements regarding 
professional duty to report errors they had made (94.2%) or that others had 
made (87.0%). 
 
Table 4.4: Responses to statements around social/professional role and 
identity related to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I believe that it is 
my professional 
duty to report 
medication errors 
which I have made 
 
47.6 
(140) 
46.6 
(137) 
2.7 
(8) 
0.3 
(1) 
0 2.7 
(8) 
I believe that it is 
my professional 
duty to report 
medication errors 
which others have 
made, irrespective 
of their 
professional 
background 
 
38.4 
(113) 
48.6 
(143) 
8.5 
(25) 
2. 0 
(6) 
0 2.4 
(7) 
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4. Beliefs about capabilities  
(Acceptance of the truth, reality, or validity about an ability, talent, or facility 
that a person can put to constructive use) 
The majority of the respondents strongly agreed or agreed with statements 
around their confidence in their ability to recognise (90.5%) and report 
(86.4%) medication errors, less respondents strongly agreed or agreed that 
they found the policy straightforward to apply in practice (73.8%). Just under 
half (41.9%) strongly agreed or agreed that they found it difficult to accept 
that they had made an error.  
 
Table 4.5: Responses to statements around beliefs about capabilities related 
to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I am confident in 
my ability to 
recognise all 
medication errors 
 
42.2 
(124) 
48.3 
(142) 
8.2 
(24) 
0.3 
(1) 
0 1.0 
(3) 
I am confident that 
I will report 
medication errors 
even if others I 
work with do not 
 
35.8 
(102) 
 
50.5 
(144) 
 
11.6 
(33) 
 
2.1 
(6) 
 
0 3.1 
(9) 
I report medication 
errors even if there 
is very little time 
available 
 
32.3 
(95) 
48.0 
(141) 
12.2 
(36) 
3.4 
(10) 
1.4 
(4) 
2.7 
(8) 
I find the policy 
straightforward to 
interpret 
 
26.5 
(78) 
50.7 
(149) 
17.7 
(52) 
2.4 
(7) 
0.7 
(2) 
2.0 
(6) 
 
I find the policy 
straightforward to 
apply in practice 
 
27.9 
(82) 
45.9 
(135) 
22.1 
(65) 
2.4 
(7) 
0.3 
(1) 
1.4 
(4) 
It is sometimes 
difficult for me to 
accept that I have 
made a medication 
error 
 
10.9 
(32) 
31.0 
(91) 
9.5 
(28) 
35.4 
(104) 
11.6 
(34) 
1.7 
(5) 
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5. Beliefs about consequences  
(Acceptance of the truth, reality, or validity about outcomes of a behaviour in 
a given situation)  
The majority of respondents strongly agreed or agreed in terms of the 
contribution of medication error reporting to aspects such as their professional 
practice (94.9%) and to patient care (91.2%). There was, however a 
perception that there was, less appreciation of their error reporting by other 
members of the multidisciplinary team (54.7%), and their seniors (63.2%). 
52.4% felt that they got professional reassurance by medication error reporting 
(52.4%). 
 
Table 4.6: Responses to statements around beliefs about consequences 
related to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to my 
professional 
practice 
 
56.1 
(165) 
38.8 
(114) 
3.1 
(9) 
0 0 2.4 
(7) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to the 
professional 
practice of others 
 
48.3 
(142) 
40.5 
(119) 
7.5 
(22) 
1.0 
(3) 
0 2.0 
(6) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to 
patient care  
 
47.3 
(139) 
43.9 
(129) 
 
6.1 
(18) 
 
0.3 
(1) 
0 2.4 
(7) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to 
patient safety   
 
55.4 
(163) 
 
37.8 
(111) 
 
3.7 
(11) 
 
0.7 
(2) 
0 2.4 
(7) 
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I believe that each 
medication error 
report I submit can 
make a significant 
contribution to my 
organisation 
 
48.3 
(142) 
41.2 
(121) 
7.1 
(21) 
0.7 
(2) 
0 2.7 
(8) 
 
I believe that each 
medication error 
report I submit will 
be appreciated by 
my peers 
 
 
47.3 
(139) 
 
43.9 
(129) 
 
6.1 
(18) 
 
0.3 
(1) 
 
0 
 
2.7 
(8) 
I believe that each 
medication error 
report I submit will 
be appreciated by 
my 
multidisciplinary 
team 
 
19.0 
(56) 
35.7 
(105) 
29.3 
(86) 
11.2 
(33) 
2.0 
(6) 
2.4 
(7) 
I believe that each 
medication error 
report I submit will 
be appreciated by 
my seniors 
 
22.4 
(66) 
40.8 
(120) 
26.5 
(78) 
5.1 
(15) 
2.7 
(8) 
2.7 
(8) 
I get professional 
reassurance from 
each medication 
error report that I 
submit 
 
16.3 
(48) 
36.1 
(106) 
34.4 
(101) 
8.2 
(24) 
2.0 
(6) 
2.4 
(7) 
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6. Motivation and goals  
(Mental representations of outcomes or end states that an individual wants to 
achieve) 
More than three quarters of the respondents (77.3%) strongly agreed or 
agreed that they prioritised reporting errors that they considered to be serious 
and a similar proportion	strongly disagreed or disagreed that error reporting 
was low priority compared to other professional duties (79.0%) and that they 
were too busy to report errors (69.8%).  
 
Table 4.7: Responses to statements around motivation and goals related to 
medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I prioritise 
reporting those 
medication errors 
which I consider to 
be more serious 
 
25.9 
(76) 
51.4 
(151) 
6.5 
(19) 
9.9 
(29) 
3.1 
(9) 
3.4 
(10) 
For me, reporting 
medication errors 
is low priority 
compared to other 
professional duties 
 
1.4 
(4) 
11.2 
(32) 
8.4 
(24) 
61.8 
(176) 
17.2 
(49) 
3.1 
(9) 
I am too busy to 
report medication 
errors 
 
3.7 
(11) 
13.9 
(41) 
9.9 
(29) 
51.4 
(151) 
18.4 
(54) 
2.7 
(8) 
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7. Memory, attention and decision processes  
(The ability to retain information, focus selectively on aspects of the 
environment and choose between two or more alternatives) 
Less than half of the respondents (48.3%) strongly agreed or agreed that they 
seldom forgot to report medication errors and one fifth (20.7%) strongly 
agreed or agreed that they had to be constantly reminded by others to submit 
error reports. 
 
Table 4.8: Responses to statements around memory, attention and decision 
processes related to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
Reporting 
medication errors 
is something I 
seldom forget 
 
12.6 
(37) 
35.7 
(105) 
14.3 
(42) 
24.1 
(71) 
8.5 
(25) 
4.8 
(14) 
I need to be 
constantly 
reminded by 
others to submit a 
medication error 
report 
 
5.4 
(16) 
15.3 
(45) 
10.9 
(32) 
46.6 
(137) 
18.0 
(53) 
3.7 
(11) 
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8. Environmental context and resources  
(Characteristics of the innovation, socio-political context, characteristics of the 
organisation and participants) 
Around half strongly agreed or agreed that reporting medication errors took 
very little time (53.7%) and effort (53.0%). Just under two thirds strongly 
agreed or agree that there was a positive organisational safety culture 
(65.9%); less than half that there was a no blame culture (44.0%).  
 
Table 4.9: Responses to statements around environmental context and 
resources related to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
For me, reporting 
medication errors 
takes very little 
time 
 
9.5 
(28) 
44.2 
(130) 
21.4 
(63) 
20.4 
(60) 
1.7 
(5) 
2.7 
(8) 
For me, reporting 
medication errors 
takes very little 
effort 
 
8.8 
(26) 
44.2 
(130) 
21.8 
(64) 
21.1 
(62) 
1.4 
(4) 
2.7 
(8) 
Reporting 
medication errors 
is compatible with 
my daily practice 
 
13.0 
(37) 
61.8 
(176) 
17.5 
(50) 
7.4 
(21) 
.4 
(1) 
3.1 
(9) 
I receive sufficient 
encouragement 
and support from 
my organisation to 
report medication 
errors 
14.3 
(41) 
48.1 
(138) 
25.8 
(74) 
9.4 
(27) 
2.4 
(7) 
2.4 
(7) 
I feel that there is 
a positive safety 
culture in my 
organisation in 
relation to 
medication errors 
 
18.9 
(54) 
47.0 
(134) 
23.2 
(66) 
6.0 
(17) 
4.9 
(14) 
3.1 
(9) 
I feel that there is 
a ‘no blame’ 
culture in my 
organisation in 
relation to 
medication errors 
11.1 
(32) 
32.8 
(94) 
30.7 
(88) 
18.5 
(53) 
7.0 
(20) 
2.4 
(7) 
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9. Social influences  
(Those interpersonal processes that can cause individuals to change their 
thoughts, feelings, or behaviours) 
While more than half of respondents strongly agreed or agreed with items such 
as receiving sufficient encouragement and support from their multidisciplinary 
team (56.0%), seniors (66.7%) and peers (80.7%) to report medication 
errors, less than half strongly agreed or agreed others would think less of them 
if they submitted an error report they (41.6%) or their peers (41.6%) had 
made.  
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Table 4.10: Responses to statements around social influences related to 
medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I receive sufficient 
encouragement 
and support from 
my 
multidisciplinary 
team to report 
medication errors 
 
10.6 
(30) 
45.4 
(129) 
30.6 
(87) 
9.2 
(26) 
4.2 
(12) 
3.4 
(10) 
I receive sufficient 
encouragement 
and support from 
my seniors to 
report medication 
errors 
 
15.1 
(43) 
51.6 
(147) 
19.6 
(56) 
9.8 
(28) 
3.9 
(11) 
3.1 
(9) 
I receive sufficient 
encouragement 
and support from 
my peers to report 
medication errors 
 
20.0 
(57) 
 
60.7 
(173) 
 
15.1 
(43) 
 
3.9 
(11) 
 
0.4 
(1) 
3.1 
(9) 
I am likely to 
report medication 
errors even if my 
peers do not 
 
20.0 
(57) 
60.7 
(173) 
15.1 
(43) 
3.9 
(11) 
0.4 
(1) 
3.1 
(9) 
I am likely to 
report medication 
errors even if my 
seniors do not 
 
18.8 
(54) 
61.3 
(176) 
15.0 
(43) 
4.2 
(12) 
0.7 
(2) 
2.4 
(7) 
Others I work with 
will think less of 
me if I submit a 
report for a 
medication error I 
have made 
 
7.6 
(22) 
34.0 
(98) 
29.9 
(86) 
22.9 
(66) 
5.6 
(16) 
2.4 
(7) 
Others I work with 
will think less of 
me if I submit a 
report for a 
medication error 
they have made 
 
7.6 
(22) 
34.0 
(98) 
29.9 
(86) 
22.9 
(66) 
5.6 
(16) 
2.0 
(6) 
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10. Emotional regulation  
(A complex reaction pattern, involving experiential, behavioural, and 
physiological elements, by which the individual attempts to deal with a 
personally significant matter or event) 
Around half of the respondents strongly agreed or agreed with items of concern 
around medication error reporting relating to potential impact on career 
(55.6%) and reprimand following reporting (54.9%). Similar proportions 
strongly agreed or agreed with concern around naming patients (49.7%) and 
health professionals (59.0%) as part of the report.  
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Table 4.11: Responses to statements around emotional regulation related to 
medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I feel 
uncomfortable 
about submitting a 
medication error 
report for an error 
others have made 
 
6.3 
(18) 
29.1 
(83) 
13.3 
(38) 
40.7 
(116) 
10.5 
(30) 
2.0 
(6) 
I feel 
uncomfortable 
about submitting a 
medication error 
report for an error 
I have made 
 
7.3 
(21) 
30.9 
(89) 
20.1 
(58) 
32.6 
(94) 
9.0 
(26) 
3.1 
(9) 
I am concerned 
about the potential 
impact on my 
career following 
submission of a 
medication error 
report 
 
11.2 
(32) 
44.4 
(127) 
15.4 
(44) 
26.2 
(75) 
2. 8 
(8) 
3.4 
(10) 
I am concerned 
about patient 
confidentiality by 
having to include 
the patient name 
on a medication 
error report 
 
10.5 
(30) 
39.2 
(112) 
16.1 
(46) 
29.0 
(83) 
5.2 
(15) 
2.7 
(8) 
I am concerned 
about the potential 
consequences of 
having to include 
the name of the 
professional on a 
medication error 
report 
 
15.5 
(44) 
43.5 
(123) 
17.0 
(48) 
21.2 
(60) 
2.8 
(8) 
3.7 
(11) 
I am concerned 
about any potential 
reprimand 
following 
submission of a 
medication error 
report 
10.9 
(31) 
 
44.0 
(125) 
 
23.2 
(66) 
 
19.0 
(54) 
 
2.8 
(8) 
3.4 
(10) 
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11.  Behavioural regulation  
(Anything aimed at managing or changing objectively observed or measured 
actions) 
The majority of respondents strongly agreed or agreed that they were clear 
about how to submit medication error report (82.0%) and had a clear plan of 
those circumstances when a medication error report should be submitted 
(81.9%).  
 
 
Table 4.12: Responses to statements around behavioural regulation related to 
medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I have a clear plan 
of how to submit a 
medication error 
report 
 
32.7 
(96) 
49.3 
(145) 
12.9 
(38) 
2.4 
(7) 
1.0 
(3) 
1.7 
(5) 
I have a clear plan 
of under what 
circumstances I 
should submit a 
medication error 
report 
 
31.6 
(93) 
50.3 
(148) 
12.9 
(38) 
2.0 
(6) 
0.7 
(2) 
2.4 
(7) 
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12. Nature of the behaviour  
(The nature of the aggregate of all responses made by an individual in any 
situation) 
Just over three quarters of respondents strongly agreed or agreed that 
submitting a medication error report was something they do automatically 
(76.9%). 
 
Table 4.13: Responses to statements around nature of the behaviour related 
to medication error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
For me, submitting 
a medication error 
report is something 
I do automatically 
 
31.3 
(92) 
45.6 
(134) 
11.9 
(35) 
8.8 
(26) 
0.3 
(1) 
2.0 
(6) 
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13.  Optimism  
(The confidence that things will happen for the best or that desired goals will 
be attained) 
Around two thirds of respondents strongly agreed or agreed with items on their 
confidence in receiving feedback from their organisation following reporting 
(63.6%), but less that feedback would be rapid (53.1%), constructive 
(53.8%), focusing on the system (54.6%) and appropriate to the severity of 
the error (64.1%). 
 
Table 4.14: Responses to statements around optimism related to medication 
error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
When I submit a 
medication error 
report, I am 
confident that I will 
receive feedback 
from the 
medication error 
reporting 
organisation 
 
10.5 
(30) 
 
53.1 
(152) 
 
23.8 
(68) 
 
8.4 
(24 
 
4.2 
12 
2.7 
(8) 
When I submit a 
medication error 
report, I am 
confident that I will 
receive rapid 
feedback from the 
medication error 
reporting 
organisation  
 
9.4 
(27) 
43.7 
(125) 
30.1 
(86) 
12.6 
(36) 
4.2 
(12) 
2.7 
(8) 
When I submit a 
medication error 
report, I am 
confident that I will 
receive 
constructive 
feedback from the 
medication error 
reporting 
organisation 
 
 
 
7.7 
(22) 
46.1 
(131) 
31.3 
(89) 
10.9 
(31) 
3.9 
(11) 
2.7 
(8) 
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When I submit a 
medication error 
report I am 
confident that I will 
feedback from the 
medication error 
reporting 
organisation which 
focuses on the 
system and not the 
individual 
 
11.2 
(32) 
 
43.4 
(124) 
 
31.5 
(90) 
 
9.1 
(26) 
 
4.9 
(14) 
3.4 
(10) 
When I submit a 
medication error 
report I am 
confident that I will 
feedback from the 
medication error 
reporting 
organisation which 
is appropriate to 
the severity of the 
error 
 
8.5 
(24) 
 
55.6 
(158) 
 
28.5 
(81) 
 
4.9 
(14) 
 
2.5 
(7) 
3.4 
(10) 
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14. Intentions  
(A conscious decision to perform a behaviour or resolve to act in a certain way) 
The majority of respondents strongly agreed or agreed with their intention to 
report all medication errors (86.0%).  
 
Table 4.15: Responses to statements around intentions related to medication 
error reporting (N=294) 
 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I intend to report 
all medication 
errors 
42.5 
(125) 
43.5 
(128) 
9.5 
(28) 
2.7 
(8) 
 1.7 
(5) 
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4.3.3 Principal component analysis 
All items were subjected to PCA to identify a smaller number of factors (or 
components) of interrelated variables. This was considered appropriate for a 
number of reasons: 
a) the number of responses (294) was greater than the required 150; 
b) the number of responses (294) was greater than five times the number 
of items (58x5=290); 
c) the Kaiser–Meyer–Olkin measure of sampling adequacy (0.884) and 
Bartlett’s test of sphericity (significance <0.001) confirmed the 
factorability of the items; and 
d) the correlation matrix scores were all greater than 0.3. 
 
Using Varimax rotation, the Scree plot shown in Figure 4.1 was obtained 
 
  Figure 4.1: Scree plot  
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Thirteen components with eigenvalue of greater than 1.0 explained 72% of the 
variance. Table 4.16 gives the eigenvalues for each of the components and the 
number of items per component. As many of the components had only a very 
small number of items loading, only those components with more than six 
items loading were retained (eigenvalues ≥ 1.9), explaining 57% of the 
variance.  
 
Table 4.16: Components, items and eigenvalues following Varimax rotation 
 
Component 
number 
Number of items  Eigenvalues 
1 51 16.037 
2 25 5.657 
3 14 4.642 
4 10 3.247 
5 7 2.378 
6 8 1.900 
7 3 1.593 
8 3 1.506 
9 1 1.304 
10 1 1.245 
11 2 1.095 
12 4 1.043 
13 2 1.005 
  
Tables 4.17-4.22 list the items within each component, the matrix scores for 
each item and the TDF domain as per the original questionnaire. 
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Table 4.17: Component 1 items related to knowledge and skills (n=15) 
Component 1, knowledge and skills related 
 
Statements 
 
Matrix score Original TDF 
I am aware of the policy relating to medication error 
reporting in Abu Dhabi hospitals 
  
0.795 Knowledge 
I have a clear plan of how to submit a medication 
error report 
0.781 Behavioural 
regulation 
I have a clear plan of under what circumstances I 
should submit a medication error report 
 
0.762 Behavioural 
regulation 
I find the policy straightforward to interpret  
 
0.750 Beliefs of 
capabilities 
I have the ability to report medication errors 
 
0.741 Skills 
I am confident in my ability to recognise all 
medication errors 
 
0.712 Beliefs of 
capabilities  
I have received sufficient training in medication error 
reporting 
 
0.705 Skills 
I find the policy straightforward to apply in practice  
 
0.703 Beliefs of 
capabilities  
I have the necessary experience to report medication 
errors 
 
0.701 skills 
I am aware of what is expected of me in relation to 
medication error reporting 
 
0.667 Knowledge 
I am aware of which medication errors should be 
reported 
 
0.654 Knowledge 
I am aware of my responsibilities for medication 
error reporting 
 
0.616 Knowledge 
I am aware of the definition of a medication error 
 
0.599 Knowledge 
I am aware of the distinction between a medication 
error and an adverse drug reaction 
 
0.518 Knowledge 
For me, submitting a medication error report is 
something I do automatically  
 
0.466 Nature of 
behaviour 
 
Fifteen items loaded onto component 1 and these originated largely from TDF 
domains of knowledge, skills and beliefs of capabilities. This component was 
therefore named ‘knowledge and skills related’. 
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Table 4.18: Component 2 items related to feedback and support (n=15) 
Component 2, feedback and support related 
 
Statements 
 
Matrix score Original TDF 
When I submit a medication error report, I am 
confident that I will receive feedback from the 
medication error reporting organisation 
 
0.801 Optimism 
When I submit a medication error report ,I am 
confident that I will receive rapid feedback from the 
medication error reporting organisation  
 
0.791 Optimism 
When I submit a medication error report I am 
confident that I will receive constructive feedback 
from the medication error reporting organisation 
 
0.791 Optimism 
When I submit a medication error report I am 
confident that I will receive feedback from the 
medication error reporting organisation which is 
appropriate to the severity of the error 
 
0.752 Optimism 
When I submit a medication error report I am 
confident that I will receive feedback from the 
medication error reporting organisation which 
focuses on the system and not the individual 
 
0.746 Optimism 
I feel that there is a positive safety culture in my 
organisation in relation to medication errors 
 
0.653 Environmental 
context and 
resources  
 
I receive sufficient encouragement and support 
from my multidisciplinary team to report 
medication errors 
 
0.652 Social influences  
I believe that each medication error report I submit 
will be appreciated by my multidisciplinary team 
 
0.647 Beliefs about 
consequences 
I feel that there is a ‘no blame’ culture in my 
organisation in relation to medication errors 
 
0.623 Environmental 
context and 
resources 
 
I receive sufficient encouragement and support 
from my peers to report medication errors 
 
0.620 Social influences 
I get professional reassurance from each 
medication error report that I submit 
 
0.585 Beliefs about 
consequences 
I believe that each medication error report I submit 
will be appreciated by my seniors  
 
0.579 Beliefs about 
consequences 
I believe that each medication error report I submit 
will be appreciated by my peers 
 
 
 
0.578 Beliefs about 
consequences 
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I receive sufficient encouragement and support 
from my seniors to report medication errors 
 
0.532 Social influences 
I receive sufficient encouragement and support 
from my organisation to report medication errors 
 
0.532 Environmental 
context and 
resources 
 
Fifteen items loaded onto component 2 and these originated largely from TDF 
domains of optimism, beliefs about consequences, social influences and 
environmental context and resources knowledge, skills and beliefs of 
capabilities. This component was therefore named ‘feedback and support 
related’. 
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Table 4.19: Component 3 items related to actions and impact (n=10) 
Component 3, actions and impact related  
 
Statements 
 
Matrix score Original TDF 
I believe that each medication error report I submit 
can make a significant contribution to my 
professional practice 
 
0.825 Beliefs about 
consequences 
I believe that each medication error report I submit 
can make a significant contribution to patient care  
 
0.824 Beliefs about 
consequences 
I believe that each medication error report I submit 
can make a significant contribution to patient 
safety   
 
0.820 Beliefs about 
consequences 
I believe that each medication error report I submit 
can make a significant contribution to the 
professional practice of others 
 
0.788 Beliefs about 
consequences 
I believe that each medication error report I submit 
can make a significant contribution to my 
organisation 
 
0.775 Beliefs about 
consequences 
I believe that it is my professional duty to report 
medication errors which I have made  
 
0.612 Social/professional 
role and identity 
I believe that it is my professional duty to report 
medication errors which others have made, 
irrespective of their professional background 
 
0.594 Social/professional 
role and identity 
I am confident that I will report medication errors 
even if others I work with do not 
 
0.493 Beliefs about 
capabilities 
I report medication errors even if there is very little 
time available 
 
0.475 Beliefs about 
capabilities 
I intend to report all medication errors 
 
0.440 Intentions  
 
Ten items loaded onto component 3 and these originated largely from TDF 
domains of beliefs about social/professional role and identity, and 
consequences. This component was therefore named ‘actions and impact 
related’.  
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Table 4.20: Component 4 items related to motivation (n=8) 
 
Component 4, motivation related 
 
Statements 
 
Matrix score Original TDF 
I need to be constantly reminded by others to 
submit a medication error report 
 
0.779 Memory, 
attention and 
decision 
processes 
 
I am too busy to report medication errors 
 
0.739 Motivation 
and goals 
 
For me, reporting medication errors is low priority 
compared to other professional duties 
 
0.579 Motivation 
and goals 
Others I work with will think less of me if I submit 
a report for a medication error I have made 
 
0.527 Social 
influences  
It is sometimes difficult for me to accept that I 
have made a medication error 
 
0.467 Beliefs about 
capabilities 
Others I work with will think less of me if I submit 
a report for a medication error they have made 
 
0.454 Social 
influences  
Reporting medication errors is something I 
seldom forget 
 
0.449 Memory, 
attention and 
decision 
processes 
 
I prioritise reporting those medication errors 
which I consider to be more serious 
 
0.342 Motivation 
and goals 
 
Eight items loaded onto component 4 and these originated largely from TDF 
domains of motivation and goals, and memory, attention and decision 
processes. This component was therefore named ‘motivation related’.  
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Table 4.21: Component 5 items related to effort (n=5) 
Component 5, effort related 
 
Statements 
 
Matrix 
score 
Original TDF 
Reporting medication errors is compatible with my 
daily practice  
 
0.596 Environmental 
context and 
resources  
 
For me, reporting medication errors takes very 
little time  
 
0.579 Environmental 
context and 
resources  
 
For me, reporting medication errors takes very 
little effort 
 
0.537 Environmental 
context and 
resources  
 
I am likely to report medication errors even if my 
peers do not 
 
0.491 Social 
influences 
I am likely to report medication errors even if my 
seniors do not 
 
0.475 Social 
influences 
 
Five items loaded onto component 5 and these originated largely from TDF 
domains of environmental context and resources, and social influences. This 
component was therefore named ‘effort related’.  
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Table 4.22: Component 6 items related to emotions (n=6) 
Component 6, emotions 
 
Statement Matrix score Original TDF 
 
I am concerned about any potential reprimand 
following submission of a medication error 
report  
 
0.837 Emotion 
regulation 
I am concerned about the potential impact on 
my career following submission of a medication 
error report  
 
0.827 Emotion 
regulation 
I am concerned about patient confidentiality by 
having to include the patient name on a 
medication error report  
 
0.769 Emotion 
regulation 
I am concerned about the potential 
consequences of having to include the name of 
the professional on a medication error report  
 
0.705 Emotion 
regulation 
I feel uncomfortable about submitting a 
medication error report for an error I have 
made 
 
0.504 Emotion 
regulation 
I feel uncomfortable about submitting a 
medication error report for an error others have 
made 
 
0.368 Emotion 
regulation 
 
Six items loaded onto component 6 and these all originated from the TDF 
domain of emotion regulation and was therefore named ‘emotions’.  
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Internal consistency values (Cronbach's alpha) were calculated for each of the 
six components, aiming for values over 0.7, with all negatively worded items 
reversed. Tables 4.23-4.28 give the item responses and Cronbach's alpha 
values for each component along with median and IQR values.  
 
Table 4.23: Component 1, knowledge and skills related item responses 
(N=294) 
Component 1, knowledge and skills related 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I am aware of the 
policy relating to 
medication error 
reporting in Abu 
Dhabi hospitals  
 
33.7 
(99) 
43.5 
(128) 
17.7 
(52) 
3.1 
(9) 
0.7 
(2) 
1.4 
(4) 
I have a clear plan 
of how to submit a 
medication error 
report 
 
32.7 
(96) 
49.3 
(145) 
12.9 
(38) 
2.4 
(7) 
1.0 
(3) 
1.7 
(5) 
I have a clear plan 
of under what 
circumstances I 
should submit a 
medication error 
report 
 
31.6 
(93) 
50.3 
(148) 
12.9 
(38) 
2.0 
(6) 
0.7 
(2) 
2.4 
(7) 
I find the policy 
straightforward to 
interpret  
 
26.5 
(78) 
50.7 
(149) 
17.7 
(52) 
2.4 
(7) 
0.7 
(2) 
2.0 
(6) 
 
I have the ability 
to report 
medication errors 
 
36.1 
(106) 
50.7 
(149) 
7.5 
(22) 
2.7 
(8) 
0.7 
(2) 
2.4 
(7) 
I am confident in 
my ability to 
recognise all 
medication errors 
 
42.2 
(124) 
48.3 
(142) 
8.2 
(24) 
0.3 
(1) 
0 1.0 
(3) 
I have received 
sufficient training 
in medication error 
reporting 
 
22.1 
(65) 
43.9 
(129) 
13.6 
(40) 
16.3 
(48) 
1.4 
(4) 
2.7 
(8) 
I find the policy 
straightforward to 
apply in practice  
 
27.9 
(82) 
45.9 
(135) 
22.1 
(65) 
2.4 
(7) 
0.3 
(1) 
1.4 
(4) 
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I have the 
necessary 
experience to 
report medication 
errors 
 
29.6 
(87) 
50.7 
(149) 
10.5 
(31) 
5.4 
(16) 
0.3 
(1) 
3.4 
(10) 
I am aware of 
what is expected of 
me in relation to 
medication error 
reporting 
 
38.4 
(113) 
47.6 
(140) 
10.2 
(30) 
0.7 
(2) 
0.7 
(2) 
2.4 
(7) 
I am aware of 
which medication 
errors should be 
reported 
 
34.4 
(101) 
45.9 
(135) 
11.9 
(35) 
3.7 
(11) 
2.4 
(7) 
1.7 
(5) 
I am aware of my 
responsibilities for 
medication error 
reporting 
 
43.9 
(129) 
48.3 
(142) 
3.7 
(11) 
0.3 
(1) 
0.7 
(2) 
3.4 
(9) 
I am aware of the 
definition of a 
medication error 
 
63.6 
(187) 
33.0 
(97) 
2.0 
(6) 
0 0 1.4 
(4) 
I am aware of the 
distinction between 
a medication error 
and an adverse 
drug reaction 
 
66.0 
(194) 
30.6 
(90) 
2.0 
(6) 
0 0 1.4 
(4) 
For me, submitting 
a medication error 
report is something 
I do automatically  
 
31.3 
(92) 
45.6 
(134) 
11.9 
(35) 
8.8 
(26) 
0.3 
(1) 
2.0 
(6) 
Cronbach's alpha 
score 
 0.934     
Median   28     
Interquartile 
range 
 21-32     
 
 
The Cronbach’s alpha value at 0.934 is in excess of 0.7 hence the scale is 
considered to be reliable. The minimum possible value for the scale is 15 
(representing most positive responses) and the maximum possible value for 
the scale is 75 (representing least positive responses) and a midscale point of 
45. With a median value of 28 and IQR of 21-32, respondents generally gave 
positive responses.  
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Table 4.24: Component 2, feedback and support related item responses 
(N=294) 
 
Component 2, feedback and support related 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
When I submit a 
medication error 
report, I am 
confident that that 
I will receive 
feedback from the 
medication error 
reporting 
organisation 
 
10.5 
(30) 
 
53.1 
(152) 
 
23.8 
(68) 
 
8.4 
(24 
 
4.2 
12 
2.7 
(8) 
When I submit a 
medication error 
report ,I am 
confident that I will 
receive rapid 
feedback from the 
medication error 
reporting 
organisation  
 
9.4 
(27) 
43.7 
(125) 
30.1 
(86) 
12.6 
(36) 
4.2 
(12) 
2.7 
(8) 
When I submit a 
medication error 
report I am 
confident that I will 
receive 
constructive 
feedback from the 
medication error 
reporting 
organisation 
 
7.7 
(22) 
46.1 
(131) 
31.3 
(89) 
10.9 
(31) 
3.9 
(11) 
2.7 
(8) 
When I submit a 
medication error 
report I am 
confident that I will 
feedback from the 
medication error 
reporting 
organisation which 
is appropriate to 
the severity of the 
error 
 
8.5 
(24) 
 
55.6 
(158) 
 
28.5 
(81) 
 
4.9 
(14) 
 
2.5 
(7) 
3.4 
(10) 
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When I submit a 
medication error 
report I am 
confident that I will 
feedback from the 
medication error 
reporting 
organisation which 
focuses on the 
system and not the 
individual 
 
 
11.2 
(32) 
 
 
43.4 
(124) 
 
 
31.5 
(90) 
 
 
9.1 
(26) 
 
 
4.9 
(14) 
 
3.4 
(10) 
I feel that there is 
a positive safety 
culture in my 
organisation in 
relation to 
medication errors 
 
18.9 
(54) 
47.0 
(134) 
23.2 
(66) 
6.0 
(17) 
4.9 
(14) 
3.1 
(9) 
I receive sufficient 
encouragement 
and support from 
my 
multidisciplinary 
team to report 
medication errors 
 
10.6 
(30) 
45.4 
(129) 
30.6 
(87) 
9.2 
(26) 
4.2 
(12) 
3.4 
(10) 
I believe that each 
medication error 
report I submit will 
be appreciated by 
my 
multidisciplinary 
team 
 
19.0 
(56) 
35.7 
(105) 
29.3 
(86) 
11.2 
(33) 
2.0 
(6) 
2.4 
(7) 
I feel that there is 
a ‘no blame’ 
culture in my 
organisation in 
relation to 
medication errors 
 
11.1 
(32) 
32.8 
(94) 
30.7 
(88) 
18.5 
(53) 
7.0 
(20) 
2.4 
(7) 
I receive sufficient 
encouragement 
and support from 
my peers to report 
medication errors 
 
20.0 
(57) 
 
60.7 
(173) 
 
15.1 
(43) 
 
3.9 
(11) 
 
0.4 
(1) 
3.1 
(9) 
I get professional 
reassurance from 
each medication 
error report that I 
submit 
 
 
16.3 
(48) 
36.1 
(106) 
34.4 
(101) 
8.2 
(24) 
2.0 
(6) 
2.4 
(7) 
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I believe that each 
medication error 
report I submit will 
be appreciated by 
my seniors  
 
22.4 
(66) 
40.8 
(120) 
26.5 
(78) 
5.1 
(15) 
2.7 
(8) 
2.7 
(8) 
I believe that each 
medication error 
report I submit will 
be appreciated by 
my peers 
 
47.3 
(139) 
43.9 
(129) 
6.1 
(18) 
0.3 
(1) 
0 2.7 
(8) 
I receive sufficient 
encouragement 
and support from 
my seniors to 
report medication 
errors 
 
15.1 
(43) 
51.6 
(147) 
19.6 
(56) 
9.8 
(28) 
3.9 
(11) 
3.1 
(9) 
I receive sufficient 
encouragement 
and support from 
my organisation to 
report medication 
errors 
 
14.3 
(41) 
48.1 
(138) 
25.8 
(74) 
9.4 
(27) 
2.4 
(7) 
2.4 
(7) 
Cronbach's Alpha 0.934      
Median  35      
Inter-quartile 
rate 
30-42      
  
The Cronbach’s alpha value at 0.934 is in excess of 0.7 hence the scale is 
considered to be reliable. The minimum possible value for the scale is 15 
(representing most positive responses) and the maximum possible value for 
the scale is 75 (representing least positive responses) and a midscale point of 
45. With a median value of 35 and IQR of 30-42, respondents generally gave 
positive responses. 
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Table 4.25: Component 3, action and impact related item responses (N=294) 
 
Component 3, actions and impact related  
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to my 
professional 
practice 
 
56.1 
(165) 
38.8 
(114) 
3.1 
(9) 
0 0 2.4 
(7) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to 
patient care  
 
47.3 
(139) 
43.9 
(129) 
 
6.1 
(18) 
 
0.3 
(1) 
0 2.4 
(7) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to 
patient safety   
 
55.4 
(163) 
 
37.8 
(111) 
 
3.7 
(11) 
 
0.7 
(2) 
0 2.4 
(7) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to the 
professional 
practice of others 
 
48.3 
(142) 
40.5 
(119) 
7.5 
(22) 
1.0 
(3) 
0 2.0 
(6) 
I believe that each 
medication error 
report I submit can 
make a significant 
contribution to my 
organisation 
 
48.3 
(142) 
41.2 
(121) 
7.1 
(21) 
0.7 
(2) 
0 2.7 
(8) 
I believe that it is 
my professional 
duty to report 
medication errors 
which I have 
made  
 
47.6 
(140) 
46.6 
(137) 
2.7 
(8) 
0.3 
(1) 
0 2.7 
(8) 
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I believe that it is 
my professional 
duty to report 
medication errors 
which others have 
made, irrespective 
of their 
professional 
background 
 
38.4 
(113) 
48.6 
(143) 
8.5 
(25) 
2. 0 
(6) 
0 2.4 
(7) 
I am confident that 
I will report 
medication errors 
even if others I 
work with do not 
 
35.8 
102 
 
50.5 
144 
 
11.6 
33 
 
2.1 
6 
 
0 3.1 
(9) 
I report medication 
errors even if there 
is very little time 
available 
 
32.3 
(95) 
48.0 
(141) 
12.2 
(36) 
3.4 
(10) 
1.4 
(4) 
2.7 
(8) 
I intend to report 
all medication 
errors 
 
42.5 
(125) 
43.5 
(128) 
9.5 
(28) 
2.7 
(8) 
0 1.7 
(5) 
Cronbach's Alpha 0.910      
Median  
 
17      
Interquartile 
rate 
12-20      
 
The Cronbach’s alpha value at 0.910 is in excess of 0.7 hence the scale is 
considered to be reliable. The minimum possible value for the scale is 10 
(representing most positive responses) and the maximum possible value for 
the scale is 50 (representing least positive responses) and a midscale point of 
30. With a median value of 17 and IQR of 12-20, respondents generally gave 
positive responses.  
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Table 4.26: Component 4, motivation related item responses (N=294) 
 
Component 4, motivation related 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
*I need to be 
constantly 
reminded by 
others to submit a 
medication error 
report 
 
5.4 
(16) 
15.3 
(45) 
10.9 
(32) 
46.6 
(137) 
18.0 
(53) 
3.7 
(11) 
*I am too busy to 
report medication 
errors 
 
3.7 
(11) 
13.9 
(41) 
9.9 
(29) 
51.4 
(151) 
18.4 
(54) 
2.7 
(8) 
*For me, reporting 
medication errors 
is low priority 
compared to other 
professional duties 
 
1.4 
(4) 
11.2 
(32) 
8.4 
(24) 
61.8 
(176) 
17.2 
(49) 
3.1 
(9) 
*Others I work 
with will think less 
of me if I submit a 
report for a 
medication error I 
have made 
 
7.6 
(22) 
34.0 
(98) 
29.9 
(86) 
22.9 
(66) 
5.6 
(16) 
2.4 
(7) 
*It is sometimes 
difficult for me to 
accept that I have 
made a medication 
error 
 
10.9 
(32) 
31.0 
(91) 
9.5 
(28) 
35.4 
(104) 
11.6 
(34) 
1.7 
(5) 
*Others I work 
with will think less 
of me if I submit a 
report for a 
medication error 
they have made 
 
7.6 
(22) 
34.0 
(98) 
29.9 
(86) 
22.9 
(66) 
5.6 
(16) 
2.0 
(6) 
Reporting 
medication errors 
is something I 
seldom forget 
 
 
12.6 
(37) 
35.7 
(105) 
14.3 
(42) 
24.1 
(71) 
8.5 
(25) 
4.8 
(14) 
I prioritise 
reporting those 
medication errors 
which I consider to 
be more serious 
 
25.9 
(76) 
51.4 
(151) 
6.5 
(19) 
9.9 
(29) 
3.1 
(9) 
3.4 
(10) 
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Cronbach's Alpha 0.560      
Median  21 (6 items reverse scored*)  
Interquartile 
rate 
18-23      
 
The Cronbach’s alpha value at 0.560 is lower than 0.7 hence the scale may 
lack reliability. The minimum possible value for the scale 8 (representing most 
positive responses) and the maximum possible value for the scale is 40 
(representing least positive responses) and a midscale point of 24. With a 
median value of 21 and IQR of 18-23, respondents gave more neutral 
responses.  
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Table 4.27: Component 5, effort related item responses (N=294) 
 
Component 5, effort related 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
Reporting 
medication errors 
is compatible with 
my daily practice  
 
13.0 
(37) 
61.8 
(176) 
17.5 
(50) 
7.4 
(21) 
0.4 
(1) 
3.1 
(9) 
For me, reporting 
medication errors 
takes very little 
time  
 
9.5 
(28) 
44.2 
(130) 
21.4 
(63) 
20.4 
(60) 
1.7 
(5) 
2.7 
(8) 
For me, reporting 
medication errors 
takes very little 
effort 
 
8.8 
(26) 
44.2 
(130) 
21.8 
(64) 
21.1 
(62) 
1.4 
(4) 
2.7 
(8) 
I am likely to 
report medication 
errors even if my 
peers do not 
 
20.0 
(57) 
60.7 
(173) 
15.1 
(43) 
3.9 
(11) 
0.4 
(1) 
3.1 
(9) 
I am likely to 
report medication 
errors even if my 
seniors do not 
 
18.8 
(54) 
61.3 
(176) 
15.0 
(43) 
4.2 
(12) 
0.7 
(2) 
2.4 
(7) 
Cronbach's Alpha 0.751      
Median  
 
11.5      
Interquartile 
rate 
10-14      
 
The Cronbach’s alpha value at 0.751 is higher than 0.7 hence the scale is 
reliable. The minimum possible value for the scale 5 (representing most 
positive responses) and the maximum possible value for the scale is 25 
(representing least positive responses) and a midscale point of 15. With a 
median value of 11.5 and IQR of 10-14, respondents generally gave positive 
responses.  
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Table 4.28: Component 6, emotions item responses (N=294) 
 
Component 6, emotions 
Statements Strongly 
Agree 
% (n) 
Agree 
 
% (n) 
Unsure 
 
% (n) 
Disagree 
 
% (n) 
Strongly 
Disagree 
% (n) 
Missing 
 
% (n) 
 
*I am concerned 
about any potential 
reprimand 
following 
submission of a 
medication error 
report  
 
11.2 
(32) 
44.4 
(127) 
15.4 
(44) 
26.2 
(75) 
2. 8 
(8) 
3.4 
(10) 
*I am concerned 
about the potential 
impact on my 
career following 
submission of a 
medication error 
report  
 
10.5 
(30) 
39.2 
(112) 
16.1 
(46) 
29.0 
(83) 
5.2 
(15) 
2.7 
(8) 
*I am concerned 
about patient 
confidentiality by 
having to include 
the patient name 
on a medication 
error report  
 
15.5 
(44) 
43.5 
(123) 
17.0 
(48) 
21.2 
(60) 
2.8 
(8) 
3.7 
(11) 
*I am concerned 
about the potential 
consequences of 
having to include 
the name of the 
professional on a 
medication error 
report  
 
10.9 
(31) 
 
44.0 
(125) 
 
23.2 
(66) 
 
19.0 
(54) 
 
2.8 
(8) 
3.4 
(10) 
*I feel 
uncomfortable 
about submitting a 
medication error 
report for an error 
I have made 
 
6.3 
(18) 
29.1 
(83) 
13.3 
(38) 
40.7 
(116) 
10.5 
(30) 
2.0 
(6) 
*I feel 
uncomfortable 
about submitting a 
medication error 
report for an error 
others have made 
 
 
7.3 
(21) 
30.9 
(89) 
20.1 
(58) 
32.6 
(94) 
9.0 
(26) 
3.1 
(9) 
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Cronbach's Alpha 0.820      
Median  
 
20 (All items reverse scored*) 
Interquartile 
rate 
16-23      
 
All the statements in component 6 were reversed in score therefore, the 
minimum score (6) represent the disagreement of participants to all statement 
and the maximum score (30) present the agreement of all participant in the 
study for all statement in component 6 
The Cronbach’s alpha value at 0.820 is higher than 0.7 hence the scale is 
reliabile. The minimum possible value for the scale 6 (representing most 
positive responses) and the maximum possible value for the scale is 30 
(representing least positive responses) and a midscale point of 18. With a 
median value of 20 and IQR of 16-23, respondents generally gave negative 
responses. 
 120 
 
4.3.4 Exploring relationships between demographic variables and 
component scores 
Mann-Whitney U test was used to compare the component scores for the 
demographic variables 
 the null hypotheses were that there were no differences in scores 
 the alternative hypotheses were that there were differences in scores. 
 
Health profession 
Table 4.29: Comparison of component scores for different health professions 
(N=294) 
 
Component Profession  Median  IQR P-value Decision  
1, 
knowledge 
and skills 
related 
Doctors 34 28-39 <0.001 
 
Reject the 
null 
hypothesis; 
the nurses 
were most 
positive and 
the doctors 
the least 
Nurses  24 18-30 
Pharmacists 29 23-32 
     
2, feedback 
and support 
related 
Doctors 39 32-44 0.001 Reject the 
null 
hypothesis; 
the nurses 
were most 
positive and 
the doctors 
the least 
 
Nurses  34 30-39 
Pharmacists 37.5 32-49 
   
3, action 
and impact 
related 
Doctors 18 13.25-21 <0.001 Reject the 
null 
hypothesis; 
the nurses 
were most 
positive and 
the 
pharmacists 
the least 
 
Nurses  14 10.75-20 
Pharmacists 20 15.75-22 
   
4, 
motivation 
related 
Doctors 21 18-24 0.003 Reject the 
null 
hypothesis; 
the nurses 
were most 
positive and 
the 
pharmacists 
the least 
Nurses  20 17-22.25 
Pharmacists 22 19.25-
25.75 
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5, effort 
related 
Doctors 12 10-15 0.004 Reject the 
null 
hypothesis; 
the nurses 
were most 
positive and 
the doctors 
the least 
 
Nurses  11 10-13 
Pharmacists 12 10-14 
   
6, emotions Doctors 19 15-22 0.129 Retain the 
null 
hypothesis 
of no 
difference 
 
Nurses  20 16-23 
Pharmacists 20.5 17-23 
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Gender 
Table 4.30: Comparison of component scores for different genders (N=294) 
 
Components Gender  Median  IQR P-value Decision  
1, knowledge 
and skills 
related 
Male 31 24-35 <0.001 Reject the 
null 
hypothesis; 
the females  
were most 
positive 
and the 
males least 
 
Female  26.50 19-30 
   
2, feedback 
and support 
related 
Male 31 24-35 0.028 Reject the 
null 
hypothesis; 
the females  
were most 
positive 
and the 
males least 
 
Female  26.50 19-30 
   
   
3, action and 
impact 
related 
Male 31 24-35 0.007 Reject the 
null 
hypothesis; 
the females  
were most 
positive 
and the 
males least 
 
Female  26.50 19-30 
   
4, motivation 
related 
Male 31 24-35 0.026 Reject the 
null 
hypothesis; 
the females  
were most 
positive 
and the 
males least 
 
Female  26.50 19-30 
   
5, effort 
related 
Male 31 24-35 0.017 Reject the 
null 
hypothesis; 
the females  
were most 
positive 
and the 
males least 
 
Female  26.50 19-30 
   
6, emotions Male 31 24-35 0.342 Retain the 
null 
hypothesis 
of no 
difference 
Female  26.50 19-30 
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Years registered as a health professional 
Table 4.31 Comparison of component scores for different years of registration 
as health professionals (N=294) 
 
Components Years 
registered as 
health 
professional 
Median  IQR P-
value 
Decision  
1, knowledge 
and skills 
related 
< 6 years 31.50 24-37.25 0.003 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive  
6-10 years 28 21-32 
11-15 years 29 23-34 
16-20 years 27 20.50-
29.75 
> 20 years 24 16-30.50 
   
2, feedback 
and support 
related 
< 6 years 41 33-43 0.019 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive 
6-10 years 35 31-41.75 
11-15 years 39 31-47 
16-20 years 35 30-39 
> 20 years  33 30-40 
   
3, action and 
impact 
related 
< 6 years 20 16.25-21 <0.001 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive 
6-10 years 18 12-20.75 
11-15 years 17 13-21 
16-20 years 16 11.75-20 
> 20 years 13 10-18 
    
4, motivation 
related 
< 6 years 21 19-23.5 0.002 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive 
 
6-10 years 21 19-25 
11-15 years 22 18.75-24 
16-20 years 19 17-22.5 
> 20 years 19 15.5-22 
   
5, effort 
related 
< 6 years 12.5 11.75-14 <0.001 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive 
 
6-10 years 12 10-14 
11-15 years 12.5 10-15 
16-20 years 11 10-12 
> 20 years 10 8-13 
   
6, emotions < 6 years 21 18-23 0.002 Reject the 
null 
hypothesis; 
those 
registered the 
longest were 
most positive 
 
6-10 years 21.5 17.25-24 
11-15 years 20 18-22 
16-20 years 18 14-22 
> 20 years 19 13-21.5 
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Age  
Table 4.32 Comparison of component scores for different age of health 
professionals (N=294) 
 
Components Age, 
years 
Median  IQR P-
value  
Decision  
1, knowledge 
and skills 
related 
<25  28.5 25-28.5 0.090 Retain the null 
hypothesis of no 
difference 
25-34 30 23-34 
35-44 28 22.75-33 
45-54  26 19.5-30 
>54  23 16-31 
   
2, feedback 
and support 
related  
<25  47.5 29-47.5 0.199 Retain the null 
hypothesis of no 
difference 
25-34 36 31.75-43 
35-44 34 30-43 
45-54  36 31-40 
>54  30.5 27-39.25 
   
3, action and 
impact 
related 
<25  15 13-15 <0.001 Reject the null 
hypothesis; those 
older were most 
positive 
25-34 20 13-21 
35-44 17 12-20 
45-54  14 11-20 
>54  11 10-17.75 
   
4, motivation 
related 
<25  25 17-25 0.004 Reject the null 
hypothesis; those 
older were most 
positive 
25-34 21 20-25 
35-44 21 18-23 
45-54  19.5 18-23 
>54  18.5 15-22 
   
5, effort 
related 
<25  8 7-8 0.012 Reject the null 
hypothesis; the 
youngest were most 
positive 
 
25-34 12 10-14 
35-44 11 10-14 
45-54  11 9-14 
>54  10 8-12 
   
6, emotions <25  22.5 
 
22-22 <0.001 Reject the null 
hypothesis; those 
older were most 
positive 
25-34 21 18-24 
35-44 20 16-23 
45-54  18 14-20 
>54  19 12.5-
21.5 
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4.3.5 Analysis of textual responses to open questions  
A content analysis approach was used to analyse the textual responses given 
in response to the open questions. The goal of content analysis is ‘to provide 
knowledge and understanding of the phenomenon under study’.122 Comments 
were received from 25 out of the 294 respondents; these given responses were 
mapped to the six components as shown in table 4.33. 
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Table 4.33 Respondents illustrative quotes mapped to the six PCA components 
Components Illustrative quotes  
1. Knowledge and skills related “…not aware of written policy. I haven’t been given any training or orientation” (physician) 
“…and offer training and awareness to other healthcare professional about medications error 
reporting types” (physician) 
2. Feedback and support 
related  
“Lack of feedback reduces the importance of medication error reporting as well as lack of a 
constructive response for the upgrading the quality of the whole hospital system” (physician) 
3. Action and impact related “We do not have the culture of constructive medication error reporting at all” (pharmacist) 
“There is a hostile culture against reporting as if I am reporting to intelligence not quality 
department” (physician) 
“Still the mentality in our culture/Institutions is to not accept any error in medicine, very hard and 
serious when it comes to taking action against whoever commits the error” (nurse) 
4. Motivation related ” there is every possibility that patient safety will be enhanced by prompt reporting, so we should 
encourage the reporting and feedback to the reporters is a must” (pharmacist) 
“I think medication error reporting is one of the indicators of the level of culture of safety which is 
required the support from both the regulatory body and the decision makers as well as the leaders 
of the organizations” (physician) 
5. Effort related “…this will need sufficient time with constant effort to show the support for the health care providers 
and build the trust” (nurse) 
“…it is improving but it will take time...” (pharmacist) 
6. Emotions “… the fear of blame and job security are the main reason of not reporting medication errors (the 
culture)” (physician) 
 “…there is always a fear of what to do and what will happen if something ever goes wrong” (nurse) 
 “I am very concerned about the perception and acceptance of this organisation, my department 
peers and other colleagues in my clinical work area as when I have done a drug error” (pharmacist) 
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4.4 DISCUSSION 
4.4.1 Statement of main findings 
The aim of this study was to quantify the behavioural determinants of health 
professional reporting of medication errors in Abu Dhabi, the UAE. 
A cross-sectional survey approach was used with responses from 294 health 
professionals. PCA identified six components, the scales of which were found 
to have high internal consistency. These six components were: knowledge and 
skills related; feedback and support related; action and impact related; 
motivation related; effort related; and emotions.  
Respondents generally gave positive responses in terms of knowledge and 
skills, feedback and support, action and impact related components. Responses 
were more neutral for the motivation related component and the effort related 
component, while respondents generally gave negative responses for the 
emotions component.   
Comparison of component scores across professions, genders, years of 
professional experience and age identified that, in general, nurses, females, 
those with greater experience and being older were more likely to be positive 
in their responses. In terms of emotions, the component with the lower scores 
those older respondents with greater experience gave more positive response.   
 
4.4.2 Strengths and weaknesses  
Prior to considering and interpreting the quantitative findings, it is important 
to reflect on the key strengths and weaknesses of the research.  
There are a number of strengths to this research. As noted earlier the 
questionnaires were developed from evidence generated through the previous 
systematic review research phase. Furthermore, the questionnaires questions 
were mapped to the domains of the TDF hence the questionnaire items were 
grounded in behavioural theories. The questionnaire was subjected to 
extensive pretesting and review prior to the full study.  
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Furthermore, the systematic review identified a limited number of cross-
sectional survey, none of which were grounded in theory hence this study is 
an original contribution to knowledge.  
There are, however, several weaknesses	 and hence the results should be 
interpreted with caution. The study was carried out in three tertiary hospitals 
in Abu Dhabi hence the findings may not be generalisable to the UAE, the 
Middle East or beyond. Despite the number of measures taken to maximize the 
response rate, the number of questionnaires submitted was low and a precise 
response rate could not be determined. There are a number of factors which 
may have contributed to the low response rate. The email invitation was not 
sent from the principal researcher, who was unable to confirm that that the 
email had been sent to all doctors, nurses and pharmacists. Furthermore, 
medication error reporting is a sensitive area hence the nature of the study 
may have deterred participation. This may be reflected in the survey results 
which identified issues around emotions to be important in deterring error 
reporting. Biases around recruitment and response may therefore have 
impacted the findings. Ideally the demographics of the respondents and non-
respondents would have been compared but this was not possible due to the 
absence of information on the non-respondents. The online method of 
questionnaire completion meant that a test-retest reliability check could not be 
completed. In addition, the findings are all based on self-reported data which 
could not be validated.  
These weaknesses and biases are potential threats to internal validity and limit 
the degree of generalisability (external validity) of the findings.		
 
4.4.3 Interpretation of findings 
Principal component analysis identified that the responses to the 14 
behavioural determinants of TDF formed six components, with collapsing of 
some TDF domains such as knowledge and skills. These six components were: 
knowledge and skills related; feedback and support related; action and impact 
related; motivation related; effort related; and emotions.  
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The findings relating to each of these will be discussed in turn, and compared 
to the cross-sectional surveys described in the systematic review. 
 
Knowledge and skills related 
While the scores for this component were generally low, indicating positive 
responses, there were significant differences in terms of profession (nurses 
most positive), gender (females most positive), and years of experience 
(greater experience most positive). Several studies identified in the systematic 
review also reported issues related to knowledge. Wild and Bradley (2005) 
noted that fewer doctors than nurses knew of and had used the reporting 
system;93 and Evans et al (2006) that most nurses and doctors were aware of 
the reporting system.94  
 
Feedback and support related 
Similar to knowledge and skills, the scores for issues of feedback and support 
were also low, indicating positive responses. There were significant differences 
in terms of profession the (nurses most positive), gender (females most 
positive) and years of experience (greater experience most positive). Notably, 
responses to the individual items within this component identified that around 
one third of respondents were unsure/disagreed/strongly disagreed with items 
relating to feedback following submitting a report to be given at all, that it was 
constructive, appropriate and rapid.  
These findings around feedback are similar to those of McArdle et al (2003)98 
Sanghera et al (2007),100 and Hartnell et al (2012).101  
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Action and impact related 
The responses to items within this component were similar to the previous two 
with generally positive responses and also significant differences in terms of 
profession the (nurses most positive), gender (females most positive) years of 
experience (greater experience most positive) and age (older most positive). 
Almost all respondents strongly agreed or agreed with all statements. None of 
the cross-sectional studies in the systematic review placed emphasis on these 
aspects.  
 
Motivation related 
In comparison to the previous three components, the responses relating to the 
motivation component were more neutral. These higher scores were derived 
largely through responses to items relating to others thinking less of those 
reporting errors. There were significant differences scores in terms of 
profession (nurses most positive), gender (females most positive), years of 
experience (greater experience most positive) and age (older most positive). 
Patrician & Brosch (2009) also identified that peers would consider the reporter 
incompetent and that this was a barrier to reporting.95  
 
Effort related 
As with motivation related, the scores for the effort related component were 
also neutral, with significant differences in terms of profession (nurses most 
positive), gender (females most positive) and years of experience (greater 
experience most positive). Interestingly, however, the younger health 
professionals were found to be the most positive which appears to be at odds 
with the findings for years of registration.  These more neutral scores were 
derived largely from items around the time and effort to report.  
While this is surprising given the relative ease of submitting an error report, 
similar findings were reported by Wakefield et al (1996),103 and Chiang et al 
(2010).97  
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Emotions 
The scores for the emotion component were the highest of all six components, 
indicating that respondents generally gave much more negative responses. 
Respondents were concerned over submitting reports for errors committed by 
themselves or others, with worries over potential reprimand and implications 
for their careers. Interestingly, the only significant differences were in terms 
of years of registration (greater experience most positive) and age (older most 
positive) but with no differences in terms of profession or gender. Fear of 
reporting for various reasons was also identified by Wakefield et al (1996),90 
Stratton et al (2004),92 Patrician & Brosch (2009),95 and Bahadori et al 
(2013).103 
 
Intervention development 
The most negative responses were given in relation to the items within the 
emotions component, with particularly negative responses given in relation to 
the potential impact of error reporting on reprimand, career progression. While 
several others have also noted fear of reporting for various reasons (Wakefield 
et al (1996),90 Stratton et al (2004),92 Patrician & Brosch (2009),95 and 
Bahadori et al (2013).103), this is the first study which has used behaviour 
theories and also quantified scores.  
Based on these quantitative findings, interventions to modify emotions should 
be prioritised in an effort to enhance reporting and be targeted at all 
professions, particularly the younger and less experienced. While component 
scores within the components of motivation and effort were generally neutral, 
there were negative responses to items relating to colleagues and peers 
thinking less of those reporting errors and also the time and effort to complete 
and submit a report. The responses for the three remaining components of 
knowledge and skills, feedback and support and action and impact were 
generally positive.  
It therefore appears that the key barrier to medication error reporting identified 
in this phase of the study relates to the behavioural determinant of emotions.  
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Multimodal interventions may be required to promote behavioural change, 
particularly in areas such as emotions, a complex process that takes place over 
time at individual, population and organisational levels.  
Any intervention developed and implemented with the aim of enhancing 
medication error reporting would be classed as a ‘complex intervention’. These 
are defined by the UK MRC as ‘interventions with several interacting 
components’.29 Behaviour change interventions, can be defined as ‘co-
ordinated sets of activities designed to change specified behaviour patterns’. 
These are often complex, consisting of many interacting components known as 
‘behaviour change techniques’ (BCTs), ‘observable and replicable components 
designed to change behaviour’.123  
Michie et al (2013) carried out a Delphi type consensus exercise to develop a 
cross-disciplinary taxonomy of BCTs.124 Further research carried out by the 
same group developed and tested a methodology for linking BCTs to TDF 
domains.125 
As discussed earlier, one of the benefits of applying TDF to the survey and 
interview research phases is that the behavioural determinants could be 
mapped to specific BCTs as part of the development of interventions.  
Those BCTs mapped to emotions are: 
 Reduce negative emotions, for example by  advising on ways of reducing 
negative emotions to facilitate performance of the behaviour 
 Emotional consequences, for example by providing information (e.g. 
written, verbal, visual) about emotional consequences of performing the 
behaviour 
 Social support (emotional), for example by advising on, arranging or 
providing emotional social support (e.g. colleagues, ‘buddies’ or staff) 
for performance of the behaviour 
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4.5 CONCLUSION 
The quantitative data from this cross-sectional study has highlighted specific 
behavioural determinants which may be impacting medication error reporting 
practices. Furthermore, significant differences were identified in terms of 
health professions, gender, age and experiences of respondents. Findings of 
this study would indicate that interventions to enhance medication error 
reporting should be directed to all health professionals, the priorities being to 
target doctors and pharmacists rather than nurses, and those less experienced 
health professionals. In terms of the behavioural determinants, interventions 
which address determinants of emotional related aspects should also be 
prioritised. Development of interventions will be considered in the final chapter. 
 
4.6 REFLECTIONS AND FUTURE DIRECTION 
As part of the mixed methods approach, qualitative research employing a 
phenomenological methodology will therefore be conducted on a sample of 
survey respondents to provide greater depth and an explanation of the findings 
prior to intervention development.  
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CHAPTER 5: QUALITATIVE INTERVIEWS WITH HEALTH 
PROFESSIONALS IN THE UNITED ARAB EMIRATES 
 
5.1 INTRODUCTION 
As noted in the systematic review presented in chapter 3, few qualitative 
studies (employing methods of semi-structured interviews and focus groups) 
have explored reporting of medication errors by health professionals. One key 
limitation is that none of these made any reference to behavioural theories 
throughout the processes of research data collection and generation, analysis 
or interpretation.  
This chapter follows on from the quantitative cross-sectional survey study 
presented in chapter 4. This mixed methods approach of quantitative data 
collection and analysis followed up with qualitative data generation and 
analysis is referred to as an explanatory sequential design.34 The purposes of 
the qualitative element are to provide further depth and interpretation to the 
quantitative data.  
 
5.1.1 Study aim and research questions 
The aim of this study was to provide more depth to and explain the quantitative 
findings. In particular, this phase aimed to describe and understand the 
behavioural determinants of health professional reporting of medication errors 
in the Abu Dhabi, the UAE.  
The detailed research questions were:  
 How do specific behavioural determinants impact error reporting? 
 Why do specific behavioural determinants impact error reporting? 
 Are there any differences between health professions? 
 How could error reporting be improved and optimised? 
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5.2 METHOD 
5.2.1 Design 
A qualitative interpretative phenomenological methodology of face-to-face 
semi-structured interviews was employed in this phase of the study to achieve 
the study objectives. As described in chapter 2, phenomenological studies 
examine human experiences through the descriptions provided by the people 
involved.126 The phenomenon in question was health professional reporting of 
medication errors. Streubert and Carpenter propose that the phenomenological 
methodology is rigorous, critical, and systematic.127 Describing and 
understanding perspectives on error reporting would provide an opportunity to 
generate novel data.  This could inform the development of an intervention to 
impact the effectiveness and efficiency of the medication error reporting 
systems and processes.  
Face-to-face interviews were considered more appropriate than other forms of 
data generation. Use of methods such as focus groups may have inhibited some 
individuals, particularly those with less experience or those with negative 
experiences, from expressing their views, with implications for data credibility 
and research trustworthiness.  
 
5.2.2 Governance  
The study was approved, as described in chapter 4. Signed informed consent 
(Appendix 5.1) was received from each participant prior to the interview taking 
place. All consent forms, transcripts and reports were stored in secured areas 
in accordance with the standard operating procedure of the School of Pharmacy 
and Life Sciences, Robert Gordon University. 
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5.2.3 Setting  
The research setting was described in chapter 4. 
 
5.2.4 Inclusion and exclusion criteria 
Those health professionals (doctors, nurses and pharmacists) who completed 
the survey phase of the research and declared an interest in participating in 
the interview phase were included. Those participating in the pilot interviews 
were excluded from the full study.  
 
5.2.5 Sampling and recruitment 
Those health professionals declaring an interest were requested to complete 
an online sampling survey providing demographic information (Appendix 5.2) 
which was submitted at the same time as the online questionnaire. A sampling 
approach was employed with strata of profession and years of experience. 
Those sampled for interview were contacted individually via telephone to 
organise the date, time and location of the interview.  
 
5.2.6 Sample size 
The approach to determining the sample size in qualitative research differs 
from that employed in quantitative research in many respects. While sample 
sizes for qualitative research are generally much smaller than those used in 
quantitative studies, there is no one specific scientific calculation which can be 
applied. Sampling and data generation were continued to the point of data 
saturation. The approach to determining the point of saturation recommended 
by Francis et al,60 as described in chapter 2, was employed. The initial analysis 
sample was five from each profession, with interviews progressing until no new 
themes were identified from three further consecutive interviews.  
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5.2.7 Interview schedule development 
A draft interview schedule was developed as a guide for the principal researcher 
to use when conducting the interview to ensure a consistent and systematic 
approach, while allowing the opportunity to probe further. The schedule was 
developed in relation to the research aim and objectives, the literature 
presented in the systematic review in chapter 3 and the main findings of the 
survey phase. Questions focused on medication error reporting, facilitators, 
barriers, experiences and suggestions for improving effectiveness and 
efficiency. The schedule was reviewed for credibility by four individuals in the 
UK with expertise in patient safety and qualitative research, with minor 
modifications to the wording of some questions. Three pilot interviews were 
then conducted (one nurse, pharmacist and physician) to determine participant 
understanding of questions, to provide an estimate of interview duration and 
to build researcher confidence.128 The final interview schedule is given in 
Appendix 5.3.  
 
5.2.8 Data generation 
Interviews were conducted in English by the principal researcher who had 
extensive work experience in hospital settings in the UAE and training in 
qualitative interviewing. The interviews took place between July and 
September 2014, with each lasting around 45 minutes.  
The interviews were audio-recorded (with permission) and transcribed in full, 
using a naturalistic approach in which every utterance is transcribed in as much 
detail as possible.129 Schegloff states that with a naturalized approach, 
language represents the real world.130 All interviewees were afforded the 
opportunity to review their transcripts prior to analysis. DS reviewed the first 
five audio-recordings to ensure high quality interviewing skills and thus 
promote data credibility, and checked the reliability of transcribing of each 
interview. Furthermore, a very clear audit trail was maintained with 
documented details of data gathering to promote dependability. 
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5.2.9 Data analysis 
Analysis was carried out using the framework approach, as described in chapter 
2. NVivo Version 10 software was used as a data management tool. The six 
phases were applied as follows:  
Phase 1: data familiarization, which involved listening repeatedly to all or parts 
of the audio-recordings and reading repeatedly the transcripts to promote 
researcher immersion in the data. 
Phase 2: generating initial codes, using the TDF domains as headings, which 
was carried out independently by the principal researcher and DS. These codes 
were subsequently discussed and agreed.  
Phase 3: identification of themes within each of the TDF domains. Again, this 
was conducted independently by the principal researcher and DS.  
Phase 4: reviewing themes, which involved discussion between the principal 
researcher and DS.  
Phase 5: defining, naming and mapping themes.  
Phase 6: producing the report, which involved producing the narrative analysis 
of the data. Quotes were selected which best represented each of the themes, 
labeling each by profession to protect anonymity.   
 
5.2.10 Promoting quality in research: trustworthiness  
Throughout research planning and conduct, many steps were taken to enhance 
rigour and hence the trustworthiness of the findings.  
According to Lincoln and Guba, trustworthiness refers to the “truth value” of 
the study’s findings or how accurately the investigator interpreted the 
participant’s experiences.37,77 Generally, rigour in qualitative research is 
established through the study’s credibility, transferability, dependability and 
confirmability.  
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The following steps were taken to promote trustworthiness: 
 
1. the principal researcher was trained in qualitative interviewing and data 
analysis by attending qualitative interview data analysis and research 
ethics courses, promoting credibility; 
2. the principal researcher’s position and stance (as a pharmacist in the 
UAE interested in medication error reporting) was described clearly to 
promote  dependability; 
3. the research setting and participants were described to promote 
consideration of transferability; 
4. the interview schedule developed based on the research objectives and 
main findings of survey, followed by expert panel review to promote 
credibility; 
5. a clearly described sampling strategy was adopted to enhance 
credibility;  
6. interviewees were given the opportunity to review and comment on the 
transcripts (member checking) to enhance credibility; 
7. all analysis was undertaken independently by two researchers to 
promote credibility and dependability; and 
8. there was constant reflection and reflexivity to promote credibility and 
dependability.  
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A summary of the methodological steps is provided in Figure 5.1 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
To explore behavioural 
determinants relating to health 
professional reporting of 
medication errors using the 
Theoretical Domains Framework 
Use of qualitative methods 
Answer “why” 
rather than 
“what” is 
happening 
around ME 
Use of in-depth interviews rather 
than focus group 
To allow generation of in-
depth, rich data to 
understand participants 
experiences of the 
phenomenon of ME 
reporting. The topic is 
highly sensitive; the 
participants may feel 
more secure 
Sampling and recruitment to 
ensure strata of profession, obtain 
ethics approval 
Planning and conducting 
interviews which were audio-
recorded and transcribed 
Choice of participants; 
HCP who completed the 
online survey in phase 1 
declaring interests to be 
interviewed were 
requested to complete 
online form providing 
demographic information, 
those sampled for 
interview were contacted 
and organize time and 
date. Sampling were 
continued to the point of 
data saturation  
Choice of 
location: three 
main tertiary 
hospitals in 
Abu- Dhabi   
Interview 
schedule 
development as 
a guide t 
ensure 
Analysis using “Framework” 
approach 
Identify themes 
through reading of 
transcripts 
Input into NVIVO10 
Develop a descriptive 
account for each 
participant, Perform 
content analysis 
Figure 5.1 Summary of all methodological steps in qualitative phase 
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5.3 FINDINGS 
Forty-three health professionals agreed to be interviewed, with data saturation 
being achieved after interviewing ten nurses, ten pharmacists and nine 
physicians. The demographics of the 29 interviewees are given in Table 5.1.  
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Table 5.1 Interviewee identifier codes and demographics  
Interviewee Code Profession Years of practice 
1 K5 Physician 11-15  
2 S2 Physician 11-15  
3 T2 Physician > 20  
4 T5 Physician 11-15  
5 M5 Physician < 6  
6 Y2 Physician > 20  
7 F1 Physician 11-15  
8 H2 Physician 16-20  
9 B4 Physician < 6  
10 S2 Nurse 11-15  
11 B2 Nurse 16-20  
12 P2 Nurse 6-10  
13 K2 Nurse 11-15  
14 J2 Nurse 6-10  
15 K5 Nurse 16-20  
16 M2 Nurse > 20  
17 R5 Nurse < 6  
18 P7 Nurse 16-20  
19 U2 Nurse >20 
20 H2 Pharmacist 11-15  
21 A5 Pharmacist 11-15  
22 L5 Pharmacist 6-10  
23 F1 Pharmacist 11-15  
24 B1 Pharmacist 11-15  
25 S2 Pharmacist 16-20  
26 C1 Pharmacist 11-15 
27 A2 Pharmacist 16-20  
28 G5 Pharmacist 11-15  
29 N8 Pharmacist 11-15  
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5.3.1 Thematic analysis 
Key themes identified from the analysis of the transcripts of the semi-structure 
face-to-face interviews were mapped to TDF domains.  
 
DOMAIN 1 – Goals  
(Mental representations of outcomes or end states that an individual wants to 
achieve) 
 
At the outset of the interview, all interviewees were asked to describe their 
thoughts on the aim and purpose of the medication error reporting system 
which operated within their hospitals. The two main themes which emerged 
were patient safety and developing and improving the healthcare system and 
practices.   
 
a. Patient safety 
Physicians, nurses and pharmacists all commented on the improvement in 
patient safety which could be achieved through reporting medication errors,  
 
“That is the fact for the patient’s safety. Because you are losing a lot of 
opportunities and areas for improvement.”   
[Physician K5] 
 
“Yeah, the good point of having reporting system is that it lessens the number 
of errors and improves the quality of patient care.” 
[Physician S2] 
 
“The purpose of the reporting system, in general, is to decrease the recurrence 
of making mistakes and to increase the safety of the patient which will 
ultimately  improve the quality of the health system in the hospital.” 
 
[Nurse S2] 
 144 
 
Some interviewees noted that the patient benefit of reporting outweighed the 
negative implications of reporting the practices of colleagues,  
 
“I am not doing it to be nasty to have an outcome on that level. I am doing it 
for the benefit of the patient.”  
[Nurse B2] 
 
One pharmacist voiced the professional prestige of the authority to report 
medication errors but that the overriding aim was focused on safety, 
 
“It is not only for the prestige that we are acquiring. It is for the safety of the 
patient, of course.” 
[Pharmacist H2] 
 
b. Developing and improving healthcare systems and practices 
Physicians, nurses and pharmacists described additional aims of reporting 
medication errors around highlighting issues or flaws in either professional 
practice, systems or processes. Once these had been identified, corrective 
action could be implemented which would result in improvement and 
prevention of further error,  
 
“The aim is to just whenever we identify a problem it just will be more easy to 
solve it  and it is about development of system just to see what errors the 
system has and just to fill the gaps.” 
[Physician T2] 
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“You want to see where are the gaps that are hidden maybe and then try to 
improve our processes, our system, our polices, through investigating and 
checking what was the reason behind these incidents. So the main purpose is 
to improve, of course.”  
[Pharmacist A5] 
 
“Well, I know that the main purpose is to initiate action regarding these errors 
to develop the area. You want to see where are the gaps that are hidden maybe 
and then try to improve our processes, system, polices, through investigating 
and checking what was the reason behind these incidents.” 
[Pharmacist L5] 
 
“The goal of reporting system is to improve the quality of service. That means, 
you are providing good service to the patients and their safety will become 
your priority.” 
[Physician T5] 
 
One physician explained further that such improvement could lead to raising 
practice to be at international standards of excellence,  
 
“I think that is the main goal of reporting errors that I do not need this error 
to occur later, not to blame, not to shame. It is just for improving a practice, 
so that we have a safer or we excel with whatever we are doing, we get in line 
with international standards.” 
[Physician M5] 
 
One nurse noted, while reporting should lead to the overall goal of improving 
efficiency and reducing errors, this did not occur in practice,  
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“we should see improvement in the overall reporting process which means we 
don’t see the error happening over and over again despite me reporting it two, 
three, four times, this is disappointing. I will not report it anymore assuming 
that they already knows about it and no action was taken. It is a non-efficient 
system”. 
[Nurse P2]  
DOMAIN 2 – Knowledge  
(An awareness of the existence of something) 
Two key subthemes emerged which related to the domain of knowledge. 
 
a. General lack of knowledge of medication error reporting policy and 
systems 
Interviewees were generally unaware of the medication error reporting policies 
and systems in their hospitals. While this lack of awareness was widespread 
amongst all health professions, it appeared to be more marked in relation to 
physicians, 
 
“Am not aware of that policy which explains the reporting process, frankly no.” 
 
[Physician Y2] 
 
“No, to be honest I did not, have not seen policy in this hospital clarifying what 
to report. I have not seen any reporting form or tools yet.”  
[Physician S2] 
 
One physician, who was aware of the existence of the policy, was aware of his 
lack of understanding and implementation of the policy in terms of the types 
of errors to report,  
 
“In regards to what to report and not to report in the policy, it is not very well 
explained yet. The near miss, but I am trying to update myself.” 
[Physician H2] 
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This lack of awareness was also apparent in the other health professions,  
 
“I had never attended an education session in 15 years on error reporting, on 
how it should be, how it should be written. So, you know, that needs to be 
follow through.” 
 
[Nurse K2] 
 
Several were adamant that there was no system or policy around self reporting 
medication errors, 
 
“Well usually, if I discovered my mistake I will verbally solve it. I have made 
an error and here is the correction, but there is no self-reporting system.” 
[Pharmacist F1] 
 
“I have an error. I need to report it. Can you give me guidelines on doing it?”  
[Nurse K2] 
 
In contrast, very few interviewees were aware of the policies and systems, 
 
“First of all, like our policy in the hospital here, If you will see any kind of 
medication error, you will write incident report, which is going to be supplied 
to the head nurse, from the head nurse to the in-charge, the supervisor, then 
they will send, I think, to the quality…” 
[Nurse J2] 
 
“We became acquainted with the policy before that because there was like a 
meeting for the dissemination of information.” 
[Pharmacist G5] 
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b. Need for education and training to improve knowledge  
Interviewees across all of the health professions, and at all levels of seniority, 
highlighted the need for enhanced education and training as one step in 
improving medication error reporting,  
 
“To create a workshop or teaching people how to deal with reports, how to 
report things, or how do we do with outcomes, and problem solving. This would 
really help.” 
[Nurse M2] 
 
“Education needed about how to report and what about next after reporting, 
because anyone of us, I am in supervisory level, I know what is going on, but 
if you ask anybody else, they don’t know after reporting what will happen.” 
 
[Pharmacist B1] 
 
 “I believe there is lack of communication and awareness in the implementation 
policy of medication management and use especially the part related to the 
reporting error process. There is definitely problem with education to 
implement such a practice.” 
[Pharmacist S2] 
 
“For successful implementation and results of reporting system or other system 
awareness is a must. You have to tell the people when to do it, how to do it, 
why to do it, and what to do it”. 
[Pharmacist C1] 
 
 
 
Several interviewees, however, had contrasting views and experiences of the 
education and training providing around reporting policy, systems and practice,  
 
 
“It is part of the staff orientation programme, the quality and patient’s safety 
and I think, everyone when they are recruited are trained how to use the PSN 
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[Provider Service Network established and organized by healthcare provider] 
and how to report.”  
[Physician S2] 
 
 
“As I am talking about the nursing, the quality department are doing very good 
job with them, by giving lectures, courses as part of nursing skills development. 
we have very clear form to be fill it up in case of error happened.” 
[Nurse J2] 
 
“We acquainted with the policy before that because there was like a meeting 
in the dissemination of information. So when I get into the incident, I asked 
for a form.” 
 
[Pharmacist A2] 
 
DOMAIN 3 - Social Professional and Role Identity  
(Those interpersonal processes that can cause individuals to change their 
thoughts, feelings, or behaviours) 
 
a. Professional obligation 
Many interviewees considered that it was their professional obligation to report 
medication errors,  
 
“the existence of the reporting system is to incorporate our facility with a 
system of discovering errors in order to improve overall services that we have, 
any error happen while prescribing, dispensing and administrating it has a 
serious consequences and it needs to be reported so that doctors are more 
aware of their mistakes, without reporting it the error will just pass and no 
benefit will be taken out of the incidence” 
 
[Physician B4] 
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“I think who is responsible and like concerning about the patients’ safety they 
will do it, just they will go for it , like there is any kind of error they will come 
across, they will report it and the big motivator behind that is the patient’s 
safety. Like, we need to do that, because we need to care about the patient’s 
safety.” 
[Nurse K5] 
 
“Reporting should be a multi-departmental. When you report error, the same 
error could be repeated anywhere across the hospital and it could be anybody. 
So as professional, has to be nursing in combination with nurses, pharmacist 
and doctors, reporting has to be across all departments…” 
[Nurse M2] 
 
One of the pharmacists commented that, in his experience, physicians never 
reported medication errors,  
 
“Usually, the reporting comes from nurses and pharmacists. I never saw a 
physician reporting anything.” 
[Pharmacist H2] 
 
 
DOMAIN 4 - Intentions  
(A conscious decision to perform a behaviour or a resolve to act in a certain 
way) 
 
a. Selectivity of errors reported  
Several interviewees explained that they were more likely to report certain 
types of medication errors or errors committed by certain individuals.  
 
  
 151 
 
Pharmacists and nurses highlighted the tendency to report only the more 
serious errors and not those considered to be near misses, 
 
“I think they will report any serious incidents, but they don’t really see that 
near misses are more important or errors that about to be happened are more 
important.” 
[Pharmacist A2] 
 
“Yeah, but sometimes due to familiarity There are some errors that ‘no need’, 
to report but there are errors that can push you hard like ‘you have to report’”.   
[Nurse R5] 
 
Others highlighted their intentions or observed intentions of others to report 
only those errors were blame could not be attributed to an individual,  
 
“Nurses can report an incident where there is nobody to blame. But if there is 
a clear error from a specific person, they don’t report these things.  No. usually, 
they don’t….” 
[Pharmacist L5] 
 
DOMAIN 5 - Belief of Consequences  
(Acceptance of the truth, reality, or validity about outcomes of a behaviour in 
a given situation) 
 
a. Lack of feedback following reporting 
One key recurring theme in relation to the beliefs of consequences was the lack 
of any feedback following submitting a medication error report. This was a 
major barrier to reporting further medication errors. This lack of feedback was 
apparent throughout the different health professions,  
 
“I have found that my expectation has not been made. It has not been made. 
In that, I have written a report. It is gone to Quality and I have not heard 
anything about it.”   
[Nurse P2] 
 152 
 
 
 
“…and also someone to follow up the error and to do something about the 
errors. They have to try to improve the system.” 
[Physician S2] 
 
“He expects that incident will go back to this particular person who will 
investigate the incident and then you will give him a feedback on what action 
and what contributing factors.” 
[Pharmacist G5] 
  
 
One of the pharmacists described experiences of receiving informal, verbal 
feedback from the quality department in regards to the submission of the 
incident report. 
 
“Usually, the feedback you get it like verbal or just through meeting or talk. 
You don’t get a formal feedback about what you have reported.” 
[Pharmacist F1] 
 
While unable to provide specific examples and details, a few of the physicians 
described feedback provided to those reporting medication errors,  
 
“Yeah, it is usually…They are giving the feedback, the quality control actually 
that I think to the people who are involved in that process, usually they 
interview.” 
[Physician B4] 
 
“Even if there is such a thing [feedback], they will have a meeting with the 
nurse, the in-charge, even with the consultants, and it should be pointed out, 
so that nothing happens, so even nurse or doctor is more confident because of 
this system.”  
[Physician Y2] 
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In terms of the feedback, one physician highlighted that positive, encouraging; 
no-blame feedback should be provided, 
 
“The more the staff is encouraged in a positive way and if the hospital has 
adapted a ‘no-blame’ culture and anonymous reporting and… that will help, so 
that the staff feels that I am reporting anonymously.”  
[Physician S2] 
 
Avoiding any negative feedback following reporting was also described by one 
pharmacist,  
 
“It has to be that at least the reporting person should not get a negative 
feedback.”  
[Pharmacist A5] 
 
 
b. Impacting professional reputation 
Many interviewees were concerned over the impact of reporting medication 
errors on their professional reputations.  This concern was heightened by the 
lack of anonymity in the reporting process and hence colleagues would get to 
know of their errors,  
 
“All people make mistakes, but some old people are concerned about the 
reaction what will happen if I report myself or anybody reports me, yes, the 
outcome of the report and what will happen next is the only point of concern.” 
[Physician T5] 
 
“If you report it that somebody made a mistake, anybody can know who 
reported, whom the report was referred to, and who is the person did the 
mistake, and what happened everybody will come to know.” 
[Nurse P7] 
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“They will not think actually what happened, how they can improve. Instead of 
that, in a meeting, in the ward meeting, they are telling it to all, you feel shame 
sometimes. They may publish it like that.”  
[Physician Y2] 
 
 
c. Impacting professional relationships 
As well as impacting their professional reputation, another recurring theme was 
how reporting medication errors could impact professional working 
relationships. Many described their reluctance to report medication errors 
committed by their colleagues and friends. These concerns existed at both 
interprofessional and intraprofessional levels,  
 
“Yes, I am concerned. Because, if you report error. We are reporting names or 
caring person. So he may be thinking that he is being targeted …which is a bit 
uncomfortable as it limits your relationship with colleagues, if it is a nurse or 
my colleague I always reassure them by saying “this is not something to harm 
or blame you, it helps to improve the system and patient safety” and I have 
experienced such a thing, this makes him feel like that he is not doing good, 
that is why he's been reported.” 
[Physician S2] 
 
“If it is like a physician, it could at least get negative comments, maybe harsh 
interaction, and maybe uncooperative interaction in the future, maybe just 
waiting for them to make a mistake in order to really get back to them.” 
[Pharmacist A5] 
 
“It is a tendency of blame. People are feeling that they don’t want to report 
the error because then the person that you are basically accusing of the error 
is going to get back to you and they in turn is going to be retaliative.”   
[Nurse K2]  
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“But it is there, abrasive, repercussion in that ‘why did you report, you know? 
You did not have to report me. You could have come in and just told me, you 
know. You don’t have to put on a piece of paper. Now it is going to another 
department.’ So I think that is the….So it is abrasive.” 
[Nurse J2] 
 
 
One nurse also added that there were cultural issues of nurses from different 
ethnic backgrounds which was an extreme barrier to them reporting medication 
errors committed by physicians,  
 
“Again, we go back to a culture thing. The Indian nurse will never confront the 
doctors.  But me, oh, yes, I will, because I am professional about it. They 
respect me. They respect me for my knowledge, for my experience, for who I 
am. I have a presence whereas the little Indian nurse and the little Filipino 
nurse, they are not going to listen [to him/her].”  
[Nurse M2] 
 
d. Impacting career progression   
Many interviewees discussed their concerns over how reporting medication 
errors could impact their career and indeed, in some instances, their job 
security,  
 
“…I have heard other people talking, I reported this and now I am battling, you 
know. I have been transferred else and …” 
[Nurse K2] 
 
“Only they will concentrate about this first one incident only and he will lose 
the job. That is why, maybe, they are not reporting.” 
[Physician F1] 
 
“There are always consequences. Maybe minor, maybe major. One of the 
drawbacks that everybody knows everything happened is that it becomes a 
kind of public opinion or public issue that everybody.” 
[Pharmacist C1] 
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“Whenever we report, the first thing, we are getting some performance focus 
like or we are worried whether our appraisal will be affected.” 
[Physician T2] 
 
 
One physician offered an alternative view that, as errors were largely due to 
human error, that there was an no-blame culture, 
 
“I think it is safe to report errors. As we have, like in our hospital, incident 
report, if thing like this happens and it is not like something threatening the 
individual or who is dealing who had made the mistake because those are 
human errors, but just to make it highlighted, that is why it does not happen 
again. It should be applied to improve the services.” 
[Physician K5] 
 
DOMAIN 6 – Emotion  
(A complex reaction pattern, involving experiential, behavioural and 
physiological elements, by which the individual attempts to deal with a 
personally significant matter or event) 
 
a. Fear and worry  
The behavioural determinant domain of ‘emotions’ emerged as a key theme in 
relation to reporting medication errors and was described by physicians, nurses 
and pharmacists as generating fear and worry. Furthermore, different aspects 
of fear emerged within this domain from the perspectives of health care 
professionals and management, 
 
”…because, I was shocked and I was afraid and I was afraid she will inform the 
unit manager and everybody.  
[Pharmacist B1] 
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“That goes back to trust. Fear of losing job. Fear of ‘no performance’”. 
[Physician M5] 
 
“They are afraid because I heard, usually mostly nurses tell, ‘you tell’. For 
example, the ratio between the nurse and the patient is not enough, then they 
cannot even nibble their food, then I said, ‘you just tell your in-charge to report’ 
and then they said ‘it might go back to us’.  It is just like more punishment. 
They are afraid.  
[Nurse J2] 
 
“Fear is always there. It is a part of our personality. There is always fear, and 
nobody like to have this, to be blamed.”  
[Pharmacist S2] 
 
Several interviewees indicated that while they tried to reassure their colleagues 
of the overall aim of improving medication safety, there was still an over-riding 
fear,  
 
“Yes, I am concerned. Because, if you report error, we are reporting names or 
caring person. So he may be thinking that he is being targeted or…So this is 
the thing, which is a bit uncomfortable as it limits your relationship with 
colleagues, if it is a nurse or my colleague i always reassure them by saying 
“this is not something to harm or blame you, it helps to improve the system 
and patient safety and I have experience such a thing, this make him feels like 
that he is not doing good, that is why he's been reported.”   
[Physician F1] 
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One pharmacist described at length the negative impact of an organizational 
change in relation to the blame free culture,  
 
“In the beginning, they were called blame-free error reporting. So nobody was 
blamed, but just two-three months back, they said, healthcare system cannot 
afford to be blame free. If you made an error, you will be accountable for it. 
So they did not clarify that much. They try to make it as soft as possible, but… 
people took this into account”.   
[Pharmacist L5] 
 
 
DOMAIN 7 - Environmental Context and Resources  
(Any circumstance of a person's situation or environment that discourages or 
encourages the development of skills and abilities, independence, social 
competence, and adaptive behaviour) 
 
 
Several subthemes emerged relating to the environment in which they were 
practising and the resources available to them.  
 
a. Time commitment 
Many interviews described a lack of time to report medication errors and many 
other competing priorities, 
 
“But sometimes I have the reason to not to report, just like one afternoon I 
am alone, I will do the IV. I have incidents to report, but no time. I will just 
take my snack instead of reporting. So that is time limit and I am alone.” 
[Nurse M2] 
 
“No time to report if I would leave the patient to report an incident, I will be 
asked to come back and report later which usually you tend to forget or its 
already too late you have to go home.” 
[Pharmacist H2] 
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Some also linked the time take to report to the paper based reporting system 
and issues around access to the reporting forms,  
 
“Basically, we are paper-base system. So it is time consuming definitely.” 
[Nurse P2] 
 
“…reporting error takes a lot of time and consumption. There are no forms that 
are readily available for everybody.”   
[Physician Y2] 
 
 
Some interviewees, however, expressed contrary views in relation to the time 
commitment,  
 
“It is not time consuming. If we are used to it is not consuming. If we are doing 
first time or like that, you will feel, you know, it is time consuming. For me, it 
is ok”. 
[Pharmacist N8] 
 
One nurse explained that while the reporting form was simple, there was some 
ambiguity in terms of the actual detail to be recorded and the categorization 
of the events,  
 
“Here in the hospital, the documentation is very simple. It is very basic; the 
questions are asked and the document is filled in. It is very vague…There are 
no directions or categorization for the events.” 
[Nurse P2] 
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b. Electronic system  
Several interviewees commented on the lack of electronic reporting systems in 
their hospitals and that the paper based system was a major deterrent to 
reporting,  
 
“Again, the lack of the electronic system is one of our big challenges that we 
haven’t in our hospital. So in order for us to do a reporting, we have to go 
through many steps of getting the paperwork, manually reporting the system 
and waiting for the results and implementing and how do you advertise 
everybody in your hospital that this error did happen, lack of internal 
communication - we do not have an email.  It is the lack of education, 
awareness, and general communication that we do struggle in our hospital 
results in under-reporting errors in our hospital.” 
[Pharmacist C1] 
 
Many others noted that implementing such an electronic system would 
facilitate medication error reporting,  
 
“… electronic system, simple reporting from,  not time consuming,  easy to the 
point, post the results for everybody that will encourage everybody to report.” 
[Physician T2] 
 
 “So the lack of having an electronic system and make it easy just to report it 
right there on a computer where no papers involve, it is a lot easier”. 
 
[Nurse B2] 
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One nurse summarized that whatever the system is, it must be accessible and 
easy,  
 
“This is it, whatever is easy, people will do. If it is an easy paper and it is a 
hard site, they will do the paper. If it is an easy paper and easy site, they will 
do whatever is accessible, maybe they don’t have the net access, maybe they 
don’t have whatever. Or if they have internet access, but they don’t have a 
copier machine, they will do the internet. So it depends on the availability of 
the resources and the reporting and the actions should be communicated.” 
 
[Nurse R5] 
 
 
DOMAIN 8 - Social influences  
(Those interpersonal processes that can cause individuals to change their 
thoughts, feelings, or behaviours) 
 
Many interviewees described their thoughts on the influences of others on their 
likelihood of reporting medication errors.  
 
a. Professional hierarchy 
The perceived professional hierarchy and power of physicians was a major 
issue, as described by nurses and pharmacists,  
 
“Especially, when you report physicians in the higher hierarchy and they know 
who reported. Then they come back to you “why did you report that? You did 
not have to. You should have talked to me. This is small thing…”. Then you are 
in a poor situation what the correct action of plan is actually.  Should I report, 
should I go back to him and try to solve it on a friendly basis or unofficial, at 
least unofficial basis.  I don’t know.” 
[Pharmacist A5] 
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“So I think it is a big [issue], which I think is, also could be a reason why not 
to apply and practice reporting what needs to be reported, the encouragement 
from superior staff.” 
[Nurse P7] 
 
“I did report do not use abbreviation in one of our physicians and I did complete 
the report, sent it out to that Quality Control, the physician did receive it, and 
I think it was a week after he is like ‘oh, you are the one reported. You know 
me?’ and I am like…you know, ‘yes, I did’ and he again took that negative teeth 
from me and to be honest with you was more of a clash in the beginning and….”  
[Pharmacist G5] 
 
Some physicians described the issue relating to the potential negative impact 
of reporting their colleagues,  
 
“…if you report error, we are reporting names or caring person. So he may be 
thinking that he is being targeted which is a bit uncomfortable for the reporter 
to report and pressure as it limits your relationship with colleagues. if it is a 
nurse or my colleague I always reassure them by saying ‘this is not something 
to harm or blame you, it helps to improve the system and patient safety’ and 
I have experience such a thing, this make him feels like that he is not doing 
good, that is why he's been reported”.  
[Physician H2] 
 
“He feels like it is an insult, although may be she or he is very good in caring 
and so…” 
[Physician K5] 
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DOMAIN 9 – Reinforcement  
(Increasing the probability of a response by arranging a dependent 
relationship, or contingency, between the response and a given stimulus) 
 
Several of the more senior interviewees described various incentives which had 
been implemented to increase the likelihood of reporting medication errors.  
 
a. Incentives to report medication errors 
One senior physician described a scheme to reward the member of staff 
reporting the highest number of medication errors,  
 
“Another thing is that we are rewarding the highest reporter, so that we say 
that ‘he is the reporter of the month, not only on numbers, but he has catch-
up [identified] an incident that could have caused this and this’, so we try to 
somehow encourage them”. 
[Physician T5] 
 
However, this individual was not able to provide any information on the uptake 
or success of the scheme. A senior pharmacist discussed an approach to 
reinforcing  and encouraging medication error reporting by engaging the 
reporter on any action taken, particularly improvements made,  
 
“The way that we do it is that we thank the staff who reports following their 
report with an email saying “‘thank you for reporting” and we keep them 
engaged on the analysis, the contributing factors, and we report back to them 
what improvement have we done out of his report”. 
[Pharmacist L5] 
 
 
A similar approach was described by a senior nurse from the same hospital,  
 
“We have internally a patient recognition or employee recognition system, 
which is…you can send the employee ‘E–Thank You’ card for contributing and 
one of the elements is creating a patient safety environment”. 
[Nurse U2] 
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Table 5.2 provides a summary of the themes mapped to the TDF domains, 
highlighting each as either a facilitator and/or barrier.  
 
Table 5.2 Key themes mapped to TDF domains  
TDF domains  Themes  Facilitator or 
barrier to reporting 
Goals a) Patient safety 
b) Developing and improving healthcare 
system and practices 
Facilitator 
Facilitator 
Knowledge a) General lack of knowledge of 
medication error reporting policy and 
systems 
b) Need for education and training to 
improve knowledge 
Barrier 
 
 
Barrier 
Social professional 
and role identity  
a) Professional obligation Facilitator 
Intentions a) Selectivity of errors reported Barrier 
Belief of 
consequences 
a) Lack of feedback following reporting 
b) Impacting professional reputation 
c) Impacting professional relationships 
d) Impacting career progression   
Barrier 
Barrier 
Barrier 
Barrier 
Emotion a) Fear and worry Barrier 
Environmental 
context and 
resources 
a) Time commitment 
b) Electronic system 
Barrier 
Facilitator 
Social influences  a) Professional hierarchy  Barrier 
Reinforcement  a) Incentives to report medication errors Facilitator 
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The following TDF domains were not represented in the thematic analysis: 
skills; beliefs about capabilities; optimism; memory, attention and decision 
processes; and behavioral regulation.  
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5.4. DISCUSSION 
5.4.1 Statement of main findings 
The aim of this phase of the research was to provide more depth to and explain 
the quantitative findings. In particular, this phase aimed to describe and 
understand the behavioural determinants of health professional reporting of 
medication errors in the Abu Dhabi, the UAE. 
A qualitative approach was used to elucidate the key behavioural determinants 
around medication error reporting in a sample of 29 health professionals in the 
UAE. While it appeared that patient safety and organisational improvement 
goals, and intentions were determinants which facilitated reporting, there were 
key determinants which deterred reporting. These included the beliefs of the 
consequences of reporting, emotions, social influences and issues related to 
the environmental context.  
 
5.4.2 Strengths and weaknesses  
Prior to considering and interpreting the qualitative findings, it is important to 
reflect on the key strengths and weaknesses of the research. 
There are a number of strengths to this research. As noted earlier, only a few 
studies have used qualitative methodologies to study medication error 
reporting and none used a theoretical approach. This doctoral research has 
therefore provided original findings.  
The steps taken to promote research trustworthiness, particularly the elements 
of credibility and dependability and hence rigors are key strengths:61 
 the documented operational detail of data gathering and analysis; 
 member checking; and 
 ensuring a skilled interviewer.  
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Furthermore, it is likely that data saturation was achieved, using the process 
recommended by Francis et al.131  
However, there are several limitations and as such the findings should be 
interpreted with caution. The research was conducted within three major 
hospitals of the UAE and the findings may not necessarily be transferable to 
other settings in the UAE, and beyond. Nevertheless, it is likely that the findings 
will resonate widely, given the acknowledged and demonstrated scale of under-
reporting of medication errors.98-102 
Although there were attempts to promote the credibility (i.e. that the findings 
were congruent with reality), it is possible that some interviewees may not 
have described truly their perspectives and experiences. It is also possible that 
those agreeing to participate were not representative of all health 
professionals. Notably, only a small number of the survey respondents were 
willing to participate in a face-to-face interview. While the reasons for the low 
uptake of interviews are unknown, the sensitivity of the subject matter and the 
identification of interviewees may have been influencing factors.  
 
5.4.3 Interpretation of findings 
This research extends the knowledge base, particularly those findings 
highlighting those behavioural determinants which are facilitators and barriers 
to medication error reporting. While some of the barriers, such as selective 
reporting depending on perceived error severity, anxieties of reporting, and 
lack of feedback are similar to other qualitative studies, 99,101,102 this research 
has provided rich detail around specific TDF behavioural determinants which 
impacted reporting.  
Furthermore, this phase of the study was the quantitative element of a mixed 
methods (quantitative, qualitative) study and as such extends the knowledge 
base beyond the quantitative findings of emotional issues impacting reporting.  
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The qualitative findings have extended those of the quantitative phase in that 
there were three key behavioural determinants which acted as barriers to 
reporting. In addition to emotions, these were the health professionals’ beliefs 
of the consequences of reporting and social influences.  
Overall, there were few key differences identified between the professional 
groupings, other than perceived hierarchies.  
Many interviewees of all professions and years of experience reported their 
fears and worries of reporting. These in turn were linked to their beliefs of the 
consequences of reporting impacting their professional standing, inter and 
intraprofessional relationships and working, and their career progression. 
There appeared to be a hierarchical, social influence based upon the perceived 
power of certain physicians by nurses and pharmacists which deterred 
reporting of physician errors by these other professions. These issues are all 
complex and related to the culture within which the health professionals are 
working. Indeed, the entire field of safety culture is complex with an 
acknowledged lack of consistency in terms such as ‘culture’ and ‘climate’ and 
no standardised definitions. A recent literature review identified the most 
common definition of safety culture as, ‘the product of individual and group 
values, attitudes, competencies and patterns of behaviour that determine the 
commitment to, and the style and proficiency of, an organisation’s health and 
safety programmes. Organisations with a positive safety culture are 
characterised by communications founded on mutual trust, by shared 
perceptions of the importance of safety, and by confidence in the efficacy of 
preventive measure 132. Mutual trust and confidence are key within this 
definition and the findings of this study demonstrate that much work is required 
to promote a safety culture in relation to medication error reporting. Two 
systematic literature reviews have explored interventions to promote safety 
culture in hospitals and acute hospitals specifically 133,134. Both reviews noted 
that studies were generally of poor quality but that interventions may improve 
perceptions of safety culture.  
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However, none of the studies within these reviews had focus on perceptions of 
culture around medication error reporting.  
Barriers such as knowledge gaps around the reporting policies, specifically 
what to report, and issues relating to the environmental context and resources 
(time commitment, burden) have been described in quantitative 90-97 and 
qualitative studies 98-102  . Similarly, selective reporting of errors perceived by 
the health professional to be more serious has been highlighted previously. 
While this may be understandable to some extent, it is not congruent with the 
reporting policy in place in the Health Authority of Abu Dhabi which requires 
all errors and near misses to be reported 135. Reporting and learning from near 
misses may be particularly valuable in providing feedback at practitioner and 
organisation levels to develop safer systems of practice. However, one further 
key theme which emerged in this study was the lack of feedback following 
reporting which deterred further reports being submitted. 
As highlighted in Chapter 4, one of the many benefits of using TDF to identify 
key behavioural domains is that these can then be used as intervention targets, 
as suggested by the MRC 29. The BCTs mapped to emotion are as described in 
Chapter 4. Those relating to beliefs of consequences are: 
 Salience of consequences, such as using methods specifically designed 
to emphasise the consequences of performing the behaviour with the 
aim of making them more memorable (goes beyond informing about 
consequences); and  
 Anticipated regret, inducing or raising awareness of expectations of 
future regret about performance of the unwanted behaviour. 
Those relating to social influences are: 
 Social comparison, drawing attention to others’ performance to allow 
comparison with the person’s own performance;  
 Social support (emotional); advising on, arranging or providing 
emotional social support (e.g. from colleagues, ‘buddies’ or staff) for 
performance of the behaviour; and  
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 Vicarious reinforcement, prompting observation of the consequences 
(including rewards and punishments) for others when they perform the 
behaviour.  
 
5.5 CONCLUSION 
This qualitative study has identified key behavioral determinants of the beliefs 
of the consequences of reporting, emotions and issues related to the 
environmental context which all negatively impact medication error reporting. 
These determinants can be mapped to behavior change strategies facilitating 
the development of an intervention, centering on organizational safety and 
reporting culture, to enhance medication error reporting effectiveness and 
efficiency with implications for healthcare practice and patient safety. The final 
chapter discusses these findings in light of the systematic review and cross-
sectional survey. 
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CHAPTER 6: DISCUSSION 
 
6.1 AIMS AND KEY FINDINGS   
The overall aim of this research was to explore health professional reporting of 
medication errors reporting in Abu Dhabi, the UAE, as a preliminary step to the 
development of interventions to improve and optimise the effectiveness and 
efficiency of medication error reporting thus impacting patient safety. The 
research was conducted in three phases, each with specific aims and key 
findings as described below. 
Phase 1 aimed to critically appraise, synthesize and present the available 
evidence on health professionals’ beliefs, attitudes and experiences of 
medication error reporting. The JBI registered systematic review identified 13 
published papers, which highlighted a number of facilitators and barriers 
relating medication error reporting. However, none of the studies reviewed 
employed a mixed methods (quantitative, qualitative) approach and there was 
a notable absence of the use of theories of behaviour change in the data 
collection and generation tools, data analysis and interpretation. 
Since completing the systematic review, several primary research studies have 
been published which match this review inclusion criteria. Mostafaei et al 
(2012) conducted a cross-sectional survey of nursing staff in one hospital in 
Iran, aiming to determine the level of importance of factors in refusal to report 
medication errors.136 The response rate was 85% (85/100), with data 
indicating that the most important factors in refusal to report medication errors 
respectively were: lack of medication error recording and reporting system; 
lack of appropriate feedback; and lack of a clear definition for a medication 
error. 
Castel et al reported a cross-sectional survey of 2319 physicians and 386 
nurses (response rate not stated) in Canada, aiming to examine the influence 
of clinician demographics, organisation demographics and leadership factors 
on fear of repercussions following error reporting.  
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Results indicated absence of any association between these factors and fear, 
with the authors concluding the need for further research in this field.137  
These two additional studies do not alter the findings of the systematic review 
presented in Chapter 3.  
 
Phase 2 aimed to quantify the behavioural determinants of health professional 
reporting of medication errors in Abu Dhabi, the UAE. This was the first stage 
of an explanatory sequential mixed methods design, with behavioural theories 
(TDF) embedded throughout. A cross-sectional survey methodology conducted 
in Abu Dhabi elicited responses from 294 health professionals. PCA identified 
six components, the scales of which were found to have high internal 
consistency. These six components were: knowledge and skills related; 
feedback and support related; action and impact related; motivation related; 
effort related; and emotions. Respondents generally gave positive responses 
in terms of knowledge and skills, feedback and support, action and impact 
related components. Responses were more neutral for the motivation related 
component and the effort related component, while respondents generally 
gave negative responses for the emotions component.   
Comparison of component scores across professions, genders, years of 
professional experience and age identified that, in general, nurses, females, 
those with greater experience and being older were more likely to be positive 
in their responses. In terms of an emotion, which was the component with the 
lower scores, older respondents and those with greater experience gave more 
positive responses.   
 
Phase 3 aimed to provide more depth to and explain the quantitative findings. 
This qualitative, phenomenological phase explored further medication error 
reporting in a purposive sample of survey respondents.  
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In depth face to face interviews were undertaken with 29 health professionals 
in relation to the determinants of behaviour. The most dominant domains 
were: goals, intentions, beliefs of the consequences of reporting, emotions, 
social influences and issues related to the environmental context.  While it 
appeared that patient safety and organisational improvement goals, and 
intentions were determinants which facilitated reporting, there were also key 
determinants which deterred reporting. These included the beliefs of the 
consequences of reporting, emotions, social influences and issues related to 
the environmental context.  
 
6.2 ORIGINALITY OF THE RESEARCH 
These three phases of research have generated original findings which extend 
the knowledge base around medication error reporting and have potential to 
impact professional practice and patient care.  
The phase one systematic review protocol was registered with and published 
by JBI, which provides evidence of originality. Most of the studies reported in 
this review were conducted within Europe and the USA, with only one from the 
Middle East. Phases two and three, conducted in the Middle East, therefore 
generated original data in terms of the geographical setting. Furthermore, 
these phases employed a mixed methods approach and incorporated 
behavioural theory. The benefits of using theory were described in Chapter 2 
and also highlighted as part of the MRC Framework of the development of 
complex interventions. The use of TDF has allowed determination of the 
behavioural determinants of mediation error reporting (or not reporting) and 
will aid the development of interventions to enhance reporting (see later).  
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6.3 IMPLICATIONS OF RESEARCH  
Table 6.1 summarises the results of determinants of medication error 
reporting, highlighting these as barriers and facilitators derived from phases 
one to three. These are presented in relation to the TDF domains (and the PCA 
components) in phases two and three. It is clear that the behavioural 
determinants which are dominating as barriers are around the beliefs of 
consequences of reporting and emotions, with social influences also important. 
The quantitative data also indicate that those with less experience, males, 
doctors and pharmacists should be prioritised for intervention.  
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Table 6.1: Barriers and facilitators identified from the three research phases (some were both barriers and facilitators)
 PCA components from 
survey (TDF domains) 
TDF domains from 
interviews 
Systematic review 
Barriers 1.Motivation related 
component  
- Social influences 
- Memory, attention and 
decision processes 
- Goals 
- Beliefs about capabilities 
 
2. Effort related component  
- Social influences   
- Environmental context and 
resources 
 
3. Emotions component  
- Emotions 
1. Beliefs of the 
consequences of reporting 
 
2. Emotions 
 
3. Social influences  
 
4. Issues related to the 
environmental context 
Fear, reporting effort, lack of 
awareness and understanding 
of reporting policies, fear of 
disciplinary action, loss of 
peer respect and lack of 
feedback, complexity of the 
process, culture of blame, no 
value, reporter burden, 
professional identity, 
information gap and 
organisational factors 
Facilitators 1. Knowledge and skills 
related component 
- Knowledge 
- Skills 
- Behavioural regulation 
- Beliefs of capabilities 
 
2. Feedback and support 
related component  
- Optimism 
- Environmental context and 
resources 
- Social influences 
- Beliefs about consequences 
 
3. Action and impact related 
component 
- Beliefs about consequences 
- Social/professional role and 
identity 
- Intentions 
1. Goals (patient safety and 
organisational improvement) 
 
2. Intentions 
Safety culture, effective, 
timely system changes in 
response to error review and 
analysis, simplified reporting 
process, timely feedback to 
reporter, training on 
reporting medication error  
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6.3.1 Intervention development 
As described in the discussions of Chapters 4 and 5, multimodal interventions are 
required to promote behavioural change; a complex process that takes place over 
time at individual, population and organizational levels.  
Evans et al reported the evaluation of an intervention aimed at improving voluntary 
incident reporting in hospitals.94 The intervention was a package including intense 
education, a range of reporting options, changes in management and enhanced 
feedback. The study was conducted in Australia, with the design being a non-
randomised controlled trial in ten intervention and ten control units across four 
hospitals. Intervention development was based on the findings of focus group 
research with doctors and surveys of doctors and nurses. The outcome measures 
were the changes in the reporting rates. Results demonstrated significant 
improvement in reporting rates in certain hospital areas (e.g. emergency 
departments) but there was considerable variation. Key limitations of the study are 
the lack of attention to any behavioural change theories in the development of the 
intervention and the focus on the number of reports rather than quality of reports. 
In addition, there was no attempt to measure the sustainability of the intervention.  
In this doctoral research, many research participants of all professions and years of 
experience reported in the quantitative and qualitative phases their fears and worries 
of reporting. These in turn were linked to their beliefs of the consequences of 
reporting impacting their professional standing, inter and intraprofessional 
relationships and working, and their career progression. These issues are all complex 
and related to the culture within which the health professionals are working.  
As discussed earlier, any intervention developed and implemented with the aim of 
enhancing medication error reporting would be classed as a ‘complex intervention’ as 
defined by the MRC.29  
While the BCTs linked to the specific behavioural determinants were highlighted in 
Chapters 4 and 5, these are summarised in Table 6.2.  
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Table 6.2: BCTs mapped to TDF domains relating to medication error reporting123 
TDF 
determinants 
BCTs Description of each BCT 
Emotion Reduce negative emotions  
 
 
Emotional consequences 
 
 
Social support (emotional) 
Advise on ways of reducing negative emotions to facilitate performance 
of the behaviour  
 
Provide information (e.g. written, verbal, visual) about emotional 
consequences of performing the behaviour  
 
Advise on, arrange or provide emotional social support (e.g. colleagues, 
‘buddies’ or staff) for performance of the behaviour” 
 
Belief of 
consequences 
Salience of consequences  
 
 
 
 
Anticipated regret  
 
Use methods specifically designed to emphasise the consequences of 
performing the behaviour with the aim of making them more memorable 
(goes beyond informing about consequences) 
 
 
Induce or raise awareness of expectations of future regret about 
performance of the unwanted behaviour 
 
Social 
influences  
Social comparison 
 
 
Social support (emotional)  
 
 
 
Vicarious reinforcement 
Draw attention to others’ performance to allow comparison with the 
person’s own performance 
 
Advise on, arrange or provide emotional social support (e.g. from 
colleagues, ‘buddies’ or staff) for performance of the behaviour 
 
 
Prompt observation of the consequences (including rewards and 
punishments) for others when they perform the behaviour 
 
 

 175 
 
The ideal intervention relating to medication error reporting should align to these BCTs, 
with elements of:  
 reducing the emotions and beliefs of consequences by providing reassurance 
(written, verbal, visual) to health professionals that reporting is confidential and 
anonymous; 
 highlighting that a ‘fair blame’ culture is operating at all levels of the 
organisation; 
 providing emotional support and reassurance around reporting;  
 highlighting key memorable patient cases of the benefits of reporting in terms of 
patient safety, health professional practice and the organisation; 
 highlighting the missed opportunities to improve patient safety if reports are not 
submitted; 
 highlighting the reporting behaviours of peers, seniors etc (anonymized);  
 considering rewards for reporting (e.g. continuing professional development 
credits); and 
 providing appropriate feedback to the reporter. 
 
6.4 FURTHER RESEARCH  
There are many potential future research studies which have emerged from this 
doctoral research. Further work now should focus on key priority areas which can lead 
to optimizing medication error reporting, impacting health professional practice and 
patient care. The following outlines key, prioritised research studies aligned to the MRC 
framework phases of feasibility and piloting interventions based on specific BCTs.  
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Study 1, Intervention development 
Findings of the doctoral research in terms of the BCTs, should now be used to design 
and develop the intervention. This is a crucial phase in translating the findings into 
practice. One key factor is to ensure that the key stakeholders are represented in this, 
and indeed, all future stages. The key stakeholders will include representation from 
policy makers (in this case HAAD) and health profession leaders. It is, however, 
important to include practitioners at all levels of experience and patients. Other key 
stakeholder groups could include educators, academics and student health 
professionals. Those involved in managing the reporting system must also be involved 
as the intervention may involve in developing aspects such as reporting feedback. A 
snowball sampling approach could be utilised to identify the most appropriate 
individuals and all must consent to take part and commit to the design and development 
phases. An appropriately qualified individual should lead the design and development 
phases and while there are no specific research outcome measures, the approach 
should be as robust and rigorous as possible. This phase should be completed within a 
maximum of three months. 
 
Study 2, feasibility testing 
Following the design and development phase, the next is testing the feasibility of the 
intervention.  
The aim of this stage is to explore health professionals’ views of the intervention 
targeting the improvement of medication error reporting behaviours in UAE hospitals. 
A constructivist approach is the most appropriate, based on a qualitative, 
phenomenological methodology. While several different methods would be appropriate, 
the most appropriate is likely to be focus groups of to provide rich and in-depth 
discussion. Ideally the focus groups will be multidisciplinary with purposively sampled 
participants (i.e. those who are likely contribute most to data generation). It is 
important that those involved in phase 1 are excluded from participating in this phase. 
Focus group sampling and recruitment will continue to the point of data saturation.  
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Following transcribing and data analysis using the Framework Approach, in-depth views 
of the likely feasibility, practicability, benefits and drawbacks of the intervention will be 
described. These can then be used by intervention design and development group to 
reflect on the intervention, and improve if necessary.  
 
Study 3, pilot testing 
Prior to launching the intervention widely, it is essential to conduct a pilot study in 
selected clinical areas of medicine and surgery. This phase aims to test the effectiveness 
of the intervention on a small scale prior to wide scale implementation, while at the 
same time determining the likely effect sizes for a randomised controlled trial. A 
pragmatic, mixed methods approach will be employed. In the quantitative phase, a 
before and after study will determine the impact of the intervention on the quality and 
the quantity of medication error reports submitted, accepting the very high levels of 
bias associated with this approach. The quality of the reports can be assessed in terms 
of the completeness of the report and the depth of information provided on the events 
leading up to the error, the specific details of the error and the outcomes arising from 
the error. In addition to the quantitative phase, there will be a qualitative phase (similar 
to phase 2 but with different participants) of focus groups of purposively sampled health 
professionals who have experienced the intervention. This will provide further in-depth 
data on how the intervention actually worked in practice, any benefits and drawbacks.  
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Phase 4, randomised controlled trial 
Following successful piloting, the intervention can be tested using a randomised 
controlled trial (RCT) to provide the highest levels of evidence of effectiveness of the 
intervention. Some of the most problematic issues in conducting the RCT are: 
1. randomization. The randomization will have to be at the ward or unit level rather 
than the individual practitioner level given that practitioners work in 
multidisciplinary ward based teams. This does mean that there will be a cluster 
sampling approach and that any differences may be as a result of differences 
within the clusters (e.g. leadership in different wards etc.) 
2. even with cluster randomization, there is a chance that the details of the 
intervention may spread throughout the hospital with an effect on the standard 
approach control group.  
3. the leadership and management in the organisation may not support an RCT 
approach, favouring widespread implementation. This issue will have to be 
discussed and resolved, with the argument that only an RCT can provide the 
highest level of evidence of effectiveness.  
4. probably the most difficult issue will be around determining the most appropriate 
outcome measures. The ultimate aim of the reporting system, as described in 
Chapter 1 is the promotion of safe care without harm. Valid and reliable outcome 
quantitative outcome measures of the absence of harm are problematic and 
cannot be easily derived from submitted medication error reports. Even with the 
ideal intervention, it is unlikely that there will be 100% adherence to any 
reporting policy, or to the developed intervention. It may be necessary to conduct 
a systematic review to answer the review question around the most valid, 
reliable, appropriate and feasible outcome measures. 
5. the RCT needs to be adequately powered to determine an important difference. 
6. embedded qualitative research should still be included to generate in-depth 
information as to why the intervention was effective or not.  
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6.5 IMPACT OF RESEARCH  
Research Councils UK (RCUK) defines research impact as 'the demonstrable 
contribution that excellent research makes to society and the economy'. Impact from 
this doctoral research is described at the levels of the organisation, health professional 
and patient.   
 
Organisation 
By considering the behavioural determinants and the barriers (and facilitators) of 
medication error reporting, the organisation will benefit from reviewing the medication 
error reporting policies, structures and processes. Developing and delivering 
interventions in line with this research will result in more effective and efficient error 
reporting. In terms of the organisation, patient care and safety and professional 
practice will be improved leading to the attainment of key organisational goals. There 
will also be economic benefits from reduced patient harm leading to consequences such 
as reduced hospital stay. The overall safety culture of the organisation will be enhanced.  
 
 
Health professional 
The research will impact health professionals (doctors, nurses and pharmacist in the 
UAE). Key barriers (determinants of under-reporting) identified can be altered through 
theory derived interventions. Combined with the enhanced safety culture, health 
professionals can be more confident and less concerned over errors committed by 
themselves or others. Appropriate and rapid feedback from submitted reports should 
lead to changes in health professional education, training and practice. There is also 
opportunity for health professionals to be involved in research relating to patient safety 
with academic impact.  
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Patient 
The most important impacts should be in terms of patient care and patient safety. 
Chapter 1 highlighted the scale of medication errors and the consequences of 
medication errors. There is potential for this research to translate into practice and real 
benefits for patients, as a direct result of optimizing medication error reporting.  
 
Academic impact 
In addition, this research has impacted academia through presentation of research 
findings at national and international conferences and publication in peer reviewed 
journals. Further publications are planned and the results will also be disseminated 
locally, within the UAE.  
 
Overall impact 
The overall impact of this research is that by using the results and findings to design, 
develop, feasibility test, pilot test, full scale test and implement on a wide scale an 
intervention which results in safer work practices with less harm to patients. 
As highlighted in Chapter 1, key goals of NCCMERP are: 
i. Stimulating the ‘development and use of reporting and evaluation systems by 
individual health care organisations’; 
 
ii. Recommending strategies for system modifications, practice standards and 
guidelines; 
 
iii. Heightening awareness of reporting systems available to or within health care 
organisations; 
 
iv. Stimulating and encouraging reporting and sharing of medication errors both 
nationally and locally; and 
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v. Encouraging systems and providing targeted feedback so that appropriate 
prevention strategies can be developed and implemented in facilities. 
 
Effective and efficient reporting systems are fundamental to each of these goals, hence 
this doctoral research has provided original findings which can act as a starting point in 
intervention development. Effective and efficient reporting systems will lead to: 
 Staff working in environments where they can report without concern over the 
consequences to their careers and professional reputations; 
 Rapid reporting following an error (the level of errors to be reported dictated by 
the reporting policy); 
 Full details of errors reported to allow consideration of causes, influencing factors 
etc.; 
 Appropriate response from the reporting organisation; and 
 Appropriate changes to practice where necessary leading safer working making 
it less likely that the error will recur. 
 
In terms of layered ‘Swiss Cheese Model’ described in Chapter 1, more effective and 
efficient reporting will lead to strengthening of the layers and reducing the flaws in each 
layer as a direct result of improvements to practice following reporting and feedback. 
In turn, it will then be less likely that flaws in the layers will align leading to less loss in 
terms of patient harm and safer care.  
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6.6 CONCLUSION 
This doctoral research has generated original findings in relation to the medication error 
reporting literature. In conclusion, several key behavioural determinants impact 
medication error reporting and specifically under-reporting. Interventions to optimise 
the effectiveness and efficiency of error reporting should involve specific BCTs mapped 
to these determinants. Though many determinants were identified, the key 
determinants in both quantitative and qualitative research were around emotions, 
beliefs of consequences and social influences. Interventions are likely to take the form 
of provide training and education, positive reinforcement (fair blame culture), and 
reduce negative emotions (explaining that reporting medication error is an opportunity 
to improve the system and patient safety) as part of BCTs.  
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APPENDICES 
Appendix 1.1: Medication Error Reporting Policy, Health Authority, Abu Dhabi 
 
 
Health Authority – Abu Dhabi 
 
 
 
ــھيئـــــة الصحة -  أبوظبي 
Division/Department/Section: PHP/PHM 
Subject: Reporting Medication Errors. 
Reference Number: PHP/PHM/P0002/09 
Issue Date: May 2009 
Revision Date: May 2011 
Version: 1
 
 
1.  PURPOSE 
 
The  purpose  of  the  policy  is  to  provide  guidance  for  the  health  care  professionals  to  take 
responsibility in medication error detection, reporting, evaluation, and prevention. 
 
The policy also intends  to  delineate  specific  measures  that  should  be  adopted  by  healthcare 
providers  for promoting  the development and use of a continuous quality  improvement  (CQI) 
system to detect and  document,  evaluate,  report,  and  prevent  medication errors. 
 
.2.  POLICY STATEMENT 
 
2.1 Health Authority Abu Dhabi (HAAD) mandates all health care providers to develop  organizational 
policies and procedures for tracking, identifying, documenting and reporting medication errors to 
HAAD. 
 
2.2 Medication errors (see appendix 1) originating in all stages of medication use process should be 
reported, especially which are during: 
 
a) Writing of the prescription order 
b) Filling the order in the pharmacy 
c) Preparing the medication dose at the nursing station, or 
d) Administering the medication at the patient's bedside. 
 
2.3 Errors  that  have  been  detected  and  corrected  through  intervention  by  another  health  care 
professional or patient, before actual medication administration should also be reported. 
 
2.4 Health care professionals should adopt the standard ‘Medication Error Severity’ categorization as 
detailed  in  Appendix  2  to  document  medication  error  severity  in  order  to  facilitate  better 
management of follow up activities upon detection of the medication error. 
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2.5 Medication errors of severity level category G, H and I (see appendix 2) should be reported within 
24 hours of identifying and documenting the error. All other errors (severity level  category A to 
category F) should be reported on a monthly basis to HAAD. 
 
2.6 Health care providers should continuously monitor actual and potential errors and investigate the 
root causes of errors to  identify the ways of  improving the medication use process to prevent 
future errors and patient harm. 
 
2.7 Using  the  principles  of  formulary  system,  a  ‘Pharmacy  and  Therapeutic  Committee’  (or  its 
equivalent)  composed  of physicians,  pharmacists,  nurses  and other  health  care  professionals 
should  be  established  in  all  organized  health  care  settings  to  be  responsible  for  formulating 
policies regarding medication error prevention, evaluation and therapeutic use of drugs. 
 
2.8 It  is  imperative  for  the  institutional  pharmacies  and  community  pharmacies  under  common 
control or ownership to develop quality assurance programme aimed at monitoring, tracking  and 
evaluating medication errors. The pharmacy should also develop and follow procedures designed 
to prevent recurrences and periodically submit medication error reports to HAAD as per the time 
frame outlined in the policy. 
 
2.9 Any  information  related  to  the  identity of  the patient  and/or  the  reporter of  the ME will be 
protected to the fullest extent of law and will not be used in any way against him. 
 
4. APPLICABILITY 
 
The policy is applicable to all health care providers (private and public) in the Emirate of Abu Dhabi. 
 
5. RESPONSIBILITY 
 
It is the responsibility of all health care professionals and health facility management to comply with the 
requirements of the policy. 
 
HAAD to monitor the compliance of ME reporting by health care providers through regular audit and 
inspection visits. 
 
6. PROCEDURE 
 
3.1 The HAAD Pharmacovigilance Center will oversee the reporting of all medication errors within the 
Emirate of Abu Dhabi. 
 
3.2 All reporting should be made in the ME reporting form. (see Appendix 3). The ME reporting form 
is made available by HAAD to all health care facilities (private and public) in the Emirate of Abu 
Dhabi. It is the responsibility of the health care facility management to ensure the availability of 
the concerned ME forms in their facilities. The reporting form can also be accessed electronically 
via http://www.health.ae/pdic, and is also available from HAAD Pharma/ Medicines and Medical 
Products Department. 
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3.3 Applicable sections of the ME reporting form should be filled in as complete as   possible.  A 
separate  form should be used  for each patient and additional pages may be attached  if more 
space is required. If more than one patient was affected by the same medication error, multiple 
reports for the same incident must be completed and submitted. 
 
3.4 The completed ME reporting form may be submitted directly to HAAD Pharmacovigilance centre 
or forwarded electronically via email or by fax (Please see contact information below). HAAD will 
acknowledge the receipt of medication error reports by fax and / or email. Any follow up for an 
already reported ME case should be made by mentioning the unique ‘report number’ provided in 
the acknowledgement letter. 
 
3.5 The Pharmacovigilance Center will perform  in‐depth analysis of the  individual reports with the 
goal  of  identifying  common  causal  factors.  Based  on  the  findings,  HAAD  will  develop  an 
established mechanism  for  tracking  and  identifying  drugs  or  drug  class  that  are  commonly 
involved in medication errors. 
 
3.6 Related facts that will be determined and documented by the Pharmacovigilance Center include 
what  happened, where  the  incident  occurred, why  the  incident  occurred,  how  the  incident 
occurred and who was  involved. Correlation between errors and the current drug prescribing, 
filling,  dispensing,  administering  and  distribution  practices  (unit  dose,  floor  stock,  or  bulk 
medications;  premixed  or  extemporaneously  compounded  products;  and  oral  or  injectable 
products) etc. will also be reviewed. 
 
3.7 Regulatory agencies and manufacturers are notified of needed changes in products  when  safety 
is of concern.  If  necessary,  appropriate  product  evidence  (packaging  and  labeling)  will be 
retrieved and retained for future reference. 
 
3.8 HAAD will also propose  corrective  measures  on  organizational  system  changes  and individual 
practice changes, as necessary, to prevent medication errors in future. It will also collaborate with 
health care facilities to   develop   and    implement   best   practices   /   non   punitive actions and 
regulations that are aimed to promote  patient  safety  and  medication error reduction. 
 
3.9 For more information on ME reporting, additional copies of ME reporting forms or to report a ME, 
health  care providers, professionals and patients are  invited  to  contact  the  following address 
through any of their preferred means: 
 
Health Authority Abu Dhabi Pharma /Medicines and Medical Products Department.  
Pharmacovigilance Center.Phone: 02 4193 586, 348, 580.   
Fax: 02 449 6679 
Email:pv@haad.ae. 
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4. DEFINITION AND ABBREVIATIONS 
 
 
HAAD 
 
Health Authority Abu Dhabi. 
 
ME 
 
Medication Error 
 
Medication Error 
 
A Medication Error is defined as any preventable event that  may cause 
or  lead  to  inappropriate medication  use  or  patient  harm, while  the 
medication is in the control of the health care professional, patient, or 
consumer. Such events may be related to professional practice, health 
care products, procedures, and  systems  including: prescribing; order 
communication;  product  labeling,  packaging,  and  nomenclature; 
compounding;  dispensing;  distribution;  administration;  education; 
monitoring; and use. 
 
 
Potential Error 
 
Errors that have been detected and corrected through intervention by 
another health care professional or patient, before actual medication 
administration. 
 
 
 
 
 
 
 
Non punitive actions 
 
Non punitive action means  there will be no disciplinary action  taken 
against an employee for a medication error that is reported as per the 
time  frame outlined  in  the policy. Under  this policy, nothing will be 
placed in the employees’ permanent employee record or used during 
the  performance  appraisal  process.  Continuing  education,  remedial 
training or an  individualized action plan  is not considered punitive or 
disciplinary action. 
 
Any  information  gathered  through  audits  of  medical  records, 
intentional acts by the employee, (ie not an “error” or not the result  of 
“negligence”),  wrongful  /  unlawful  consumption  of  medications  / 
controlled substances by  the employee making  the error, employees 
who  knowingly  fail  to  report  a  medication  error  are  considered 
exceptions to Non punitive actions. 
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   Appendix 3.1: Appraisal instruments 
 
  QARI appraisal instrument 
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MAStARI Appraisal instrument 
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Appendix 3.2: Data extraction instruments 
 
QARI data extraction instrument 
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MAStARI data extraction instrument 
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Appendix 4.1: The ethical review panel of the School of Pharmacy and 
Life Sciences at Robert Gordon University- Phase 2 & 3 
 
 
 
 
 
 
School of Pharmacy and Life Sciences 
Research Ethics Committee 
 
 
COMPLETED 24 March 2014 
 
Research Student 
Name Mai Alqubaisi 
Principal Supervisor Professor Alison Strath 
Research Project Title Exploring medication error reporting in the United Arab Emirates 
 
 
Dear Mai, 
 
We have reviewed your ethics application (Title above).The panel 
recommends that it is of sufficient standard for you to proceed. We wish you 
well in your researches. 
 
If there are any questions please do not hesitate to get in touch. 
Regards 
 
 
Dr Lesley Diack 
Chair of the School Ethics Review Panel 
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Appendix 4.2: Ethics and Research Committee in Al Mafraq Hospital 
 
 
 
 
 
                        Mafraq Hospital 
 
 
30   June 2014 
 
Ms. Mai  Al  Qubaisi 
Institute for Health & Welfare Research (IHWR) 
Robert Gordon University 
 
 
Administrative Approval: 
 
Exploring medication error reporting in the United Arab Emirates: examining the attitudes, 
beliefs, behaviors and experiences of health care professionals 
 
 
Dear Ms. Mai, 
 
Please be informed that your proposal was approved, and there are no ethical concerns of the 
project. 
 
 
Regards, 
 
 
 
 
 
 
+ v , r oA r , o zLi+ v , r o ·, , , , , , oA rn ··:c,t·t· - '='t;J-:li  .r  o , :y. 
P.O.Box 2951,Abu Dhabi - United Arab Emirates Tel:+971 2 501 1111,5823100 Fax:+971 2 
582 1549 
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Appendix 4.3: Ethic and Research Committee in Zayed Hospital 
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Appendix 4.4: Al Ain Medical District Human Research Ethics Committee 
in Tawam Hospital 
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Appendix 4.5: Email Invitation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Health Care Professionals, 
 
You have been selected to participate in a survey conducted by research student Mai Alqubaisi, 
from Robert Gordon University, funded by UAE government. The survey is about "Exploring 
medication error reporting in the United Arab Emirates: Examining the attitudes, beliefs, 
behaviours and experiences of health care professionals". It is short and should take you only 5‐7 
minutes to complete. All of your answers will be kept strictly confidential and will be used only for 
legitimate research purposes. Your valuable participation will contribute towards identifying 
health care professionals’ perceptions of any facilitators and barriers towards medication error 
reporting, and to explore health care professionals’ perceptions of change to optimize medication 
error reporting. 
To take the Survey, click on this link: 
http://www.rgu.ac.uk/medical‐errors‐uae . 
Thank you for your participation! 
Sincerely, 
Mai Alqubaisi, MPharm 
PhD Student 
Institute for Health & Welfare Research (IHWR) 
Riverside East, Robert Gordon University  
Garthdee Road, Aberdeen 
AB10 7GJ 
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Appendix 4.6 – Participant information 
 
Exploring medication error reporting in the United Arab 
Emirates: Examining the attitudes, beliefs, behaviours and 
experiences of health care professionals. 
You are being invited to take part in a research study.  Before you decide if you wish to take part, it is 
important for you to understand why the research is being undertaken and what it will involve.  Please 
take time to read the following information carefully. Talk to others about the study if you wish.  
Ask me if there is anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part. 
What is the purpose of the study? 
The aim of the research is to explore the attitudes, beliefs, behaviours and experiences of health care 
professionals in the UAE on reporting of medication errors.  
 
Study aim 
This research aims to investigate the attitudes and beliefs of health care professionals towards 
medication error reporting, explore the behaviours and experiences of health care professionals in 
medication error reporting, describe health care professionals’ perceptions of any facilitators and 
barriers towards medication error reporting, and to explore health care professionals’ perceptions of 
change to optimize medication error reporting. 
A researcher (Mai Alqubaisi) from the UAE and former employee at Zayed hospital will carry out the 
study. Mai is currently studying at Robert Gordon University and this work will form part of a 
submission towards a Doctor of Philosophy qualification from Robert Gordon University.The student is 
supported by a team of experienced RGU academics, the principal supervisor Professor Derek Stewar 
thas vast experience in researching the area of medication errors; Professor Alison Strath has strategic 
and policy development expertise;; Dr Antonella Tonna has expertise in secondary care practice and 
associated research; and Dr Shereen Nasr, Head of Quality Department in at Zayed Military Hospital, 
UAE, has a key role in medication error reporting and associated research.  
 
Why have I been chosen? 
You have been chosen because you are a doctor, nurse, pharmacist working in hospital practice in Abu 
Dhabi in the UAE. You therefore have experience in relation to strategic and operational approaches 
around medication error reporting in public or private hospitals in Abu Dhabi. 
 
Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be given this information 
sheet to keep and be asked to sign an informed consent form. You are still free to withdraw at any time 
and without giving a reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect any way your employment with Health Authority of Abu Dhabi (HAAD). 
 
What will happen to me if I take part? 
If you interested, you will be invited to complete an online questionnaires with one reminder email. For 
each questionnaire you will be asked to rate your level of agreement or disagreement with statements 
around attitudes and beliefs, facilitators and barriersof medication error reporting in respect to 
healthcare professional in the UAE. When the questionnaire will be completed you will be invited to 
take a part in phase two of this research with face to face interview for further explanation round 
behaviours, experiences and potential for changes to optimize reporting medication error in UAE. 
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All information provided during the questionnaire and interview will be anonymous and confidential. 
Your name will not appear on the questionnaire or any report of the research. This information may be 
used anonymously in any publication or presentation of the study results.  
 
What do I have to do? 
If you decide to take part in the study, you will be asked to sign an informed consent form and to take 
part in the interview as described above. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you by taking part in the study. However, your participation may assist in 
the future development of medication error reporting in hospitals practice in United Arab Emirates.  
 
Any complaint about the way you have been dealt with during the study will be addressed. If you have 
any complaints or would like further information about the study please contact: 
Professor Derek Stewart 
School of Pharmacy & Life Sciences 
Robert Gordon University 
Aberdeen 
AB10 7QJ 
Scotland  
+44 (0)1224 262432 
a.strath@rgu.ac.uk 
Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  Any data 
relating to your participation will be stored securely at all times and can only be accessed by the 
researcher. 
You will be given a copy of the information sheet and a signed consent form to keep. 
Thank you for taking time to read the information sheet and for considering taking part in this study. 
 
RESEARCH TEAM  
 
Robert Gordon University (RGU):             
Mai Alqubaisi 
Professor Derek Stewart 
Professor Alison Strath 
Dr AntonellaTonna (Supervisor) 
United Arab Emirates (UAE):  
Dr Shereen Nasr (Head of Quality Department, at Zayed Military Hospital)   
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Appendix 5.1 – participant consent form 
 
Exploring medication error reporting in the United Arab Emirates: Examining 
the attitudes, beliefs, behaviours and experiences of health care 
professionals 
 
Researcher 
Mai Alqubaisi 
PhD Student 
Robert Gordon University 
UK 
E-mail: m.m.alqubaisi@rgu.ac.uk 
Participant Study Number................. 
 
 
 Please INITIAL 
box 
 
I confirm that I have read and understand the information sheet 
for the above study and have had the opportunity to ask 
questions. 
 
  
 
I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving reason. 
 
 
 
I agree to take part in the above study. 
 
 
I agree to the interview being audio recorded. 
 
 
I agree to the use of anonymised quotes in publications. 
 
 
________________                   ____              _____________ 
Name of Participant                    Date               Signature 
 
 
 
________________                   ____              _____________ 
Name of Researcher                   Date               Signature 
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Appendix 5.2: Request to complete an online sampling survey providing 
demographic information for interviewee 
 
If you are interesting in possibly taking part in an interview, please click here. You will be 
taken to a separate sheet which cannot be linked to your questionnaire responses in any 
way. Please complete the following 
 
Name   _____________________________ 
 
Email contact  _____________________________ 
 
Phone contact _____________________________ 
 
We will use these details to contact you 
 
 
Please complete the following. If we receive many responses, we will use these data to 
select those for interview 
 
 
Your profession is 
 □Doctor       
 □Nurse      
 □Pharmacist 
 
 
 
You have been registered as a health professional for  
 □<6 years  □6-10 years  □11-15 years  □16-20 years 
 □>20 years 
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Appendix 5.3: Semi-structured interview schedule 
 
 
Exploring medication error reporting in the United Arab Emirates: Examining the attitudes, 
beliefs, behaviours and experiences of health care professionals 
 
Participant Number: 
Date: 
Start time: 
 
Introduction 
 
Hello, thanks for agreeing to be interviewed for this project.  Please, can I check you have read the 
participant information sheet? 
If not, here is a copy to read before we begin. 
 
The main purpose of this interview is to find out your views, experiences and perceptions of 
medication error reporting in the United Arab Emirates (UAE). 
 
Your participation is voluntary and you may withdraw at any point. If you do not want to answer a 
specific question, then please let me know. There is no right or wrong answers and I am interested in 
your personal opinions. Your identity will remain strictly confidential and it will not be possible to 
identify individuals from the study results.  
 
The interview should take approximately 30 to 45 minutes. Are you ok to go ahead? 
 
 
IF NO: That’s okay.  When would be more convenient? Thanks I’ll see you on day/date/time at 
..............location.  Bye. Write the new day/date/time here and in the diary chart: 
IF YES continue:  That’s great, thank you. 
 
 
Recording: As you are aware from the information sheet and consent form, this conversation is being 
audio recorded but I would emphasise that it is confidential.  Please do not use names of patients or 
hospital staff during this interview. It is ok to refer to “a patient”, “another doctor”, “a nurse”, “a 
pharmacist” etc. Are you still OK with that?   
 
 
 
IF NO: That’s fine. I’ll need a bit more time to write down notes as we go through the sections and I 
may ask you to repeat some answers so I don’t miss anything.  
Reminders 
• Take time to write detailed notes 
• If in doubt, ask the interviewee for clarification before you move on to the next section 
 
 
Note: If you decide after the interview you no longer wish to be a part of the research, please 
let me know.  The contact details are on the information sheet. 
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Can I start by asking you about your thoughts on the aims/purpose of the 
reporting system? 
Can you tell me about the safety of reporting medication error in the hospital 
culture? 
 No-blame culture, negative feedback, encouragement  
What is your experience of the incident /medication error reporting system? 
 Definition, recognition of error 
 Why/why not report 
 When report 
 What reported 
 Reporting process – ease, time, memory, 
            do you have sufficient time and resources 
 Expectations 
 Concerns – fear, blame, competence etc 
 Feedback 
 Differences to them, profession, organisation 
What are your thoughts on the good points of the system? 
 Consider patients, them, profession, other professions, organisation 
 Why 
 Describe 
What about negative points 
 Consider patients, them, profession, other professions, organisation 
 Why 
 Describe 
           How you handle it 
Is there any what in which the system could be improved? 
 Consider patients, them, profession, other professions, organisation 
 Why 
 How 
Anything else you would like to add? 
 
Well that’s all of my questions. You’ve been very helpful and I appreciate you taking 
the time to speak to me.  If you think of anything else you would like to add, please 
get in touch.  Thank you very much.  Goodbye!  
 
 
Interview concluded at:00:00 
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